Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" ABCB7 "ABC7, ASAT, Atm1p, EST140535" ENSG00000131269 "ATP binding cassette subfamily B member 7" O75027 X 75051554-75156732 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034982 Approved Supported Mitochondria Mitochondria "HPA034982: AB_10601010" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (1.49e-2)" "unprognostic (1.83e-3)" "unprognostic (4.44e-3)" "unprognostic (1.33e-2)" "unprognostic (6.31e-2)" "unprognostic (4.39e-2)" "unprognostic (1.47e-1)" "unprognostic (2.17e-1)" "unprognostic (4.14e-2)" "unprognostic (2.55e-2)" "prognostic favourable (5.31e-6)" "unprognostic (1.95e-1)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (1.08e-1)" 15.1 18.0 12.3 14.7 14.3 13.0 14.6 26.0 16.2 11.6 15.2 12.0 13.7 19.0 14.7 13.6 14.7 11.7 10.0 21.4 11.7 7.1 15.6 22.4 12.2 15.9 13.0 8.5 16.4 12.4 14.7 22.6 11.5 14.0 10.6 15.4 9.5 12.9 15.5 34.6 15.3 15.9 14.9 12.2 13.9 14.8 5.4 16.2 19.7 12.4 19.3 16.0 13.9 13.3 19.4 19.3 7.0 18.7 12.2 21.5 12.4 11.4 11.2 11.5 14.5 7.6 18.9 5.5 8.1 9.1 7.4 12.7 13.9 17.0 18.0 15.6 6.6 12.0 22.2 10.3 12.6 19.3 18.4 12.1 22.5 10.3 6.3 19.6 10.5 13.4 9.8 10.0 13.1 16.0 13.1 23.3 8.0 6.9 14.8 14.4 19.5 15.7 15.0 22.1 21.0 9.6 11.4 13.8 9.1 19.1 17.5 10.9 7.8 13.8 8.3 7.6 14.8 15.8 7.8 7.6 19.3 16.3 7.4 23.6 8.0 5.9 18.7 7.0 11.5 17.7 12.3 18.1 12.8 12.4 19.3 19.4 21.5 16.0 2.2 12.2 13.4 11.9 17.4 12.4 12.3 14.3 26.0 16.2 11.7 7.1 13.0 8.5 14.0 16.2 ABCB9 EST122234 ENSG00000150967 "ATP binding cassette subfamily B member 9" Q9NP78 12 122920951-122981649 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 6.2" "Group enriched" "Detected in many" 5 "B-cells: 6.2;granulocytes: 4.1;T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033052, HPA035113, HPA035114" Approved Supported Vesicles Vesicles "CAB033052: AB_2273463, HPA035113: , HPA035114: AB_10601329" "unprognostic (1.47e-2)" "unprognostic (6.46e-4)" "unprognostic (3.96e-2)" "unprognostic (2.73e-1)" "prognostic unfavourable (5.65e-4)" "unprognostic (1.46e-1)" "unprognostic (2.67e-2)" "unprognostic (2.35e-1)" "unprognostic (4.08e-2)" "unprognostic (6.07e-2)" "unprognostic (2.28e-1)" "unprognostic (1.24e-1)" "unprognostic (1.37e-2)" "unprognostic (6.97e-2)" "unprognostic (1.70e-1)" "unprognostic (3.58e-3)" "unprognostic (2.71e-2)" 3.6 4.2 9.5 3.0 13.1 5.3 3.8 19.7 17.0 2.9 4.0 5.8 2.3 5.0 4.2 9.7 4.7 4.7 4.6 4.6 9.0 11.5 3.3 2.7 3.4 3.1 10.8 10.9 4.7 4.3 6.6 9.9 3.5 9.8 3.5 4.1 3.0 7.7 5.6 3.4 6.0 6.1 3.9 7.5 4.0 4.0 21.3 6.4 2.5 3.6 2.0 3.7 2.9 2.7 6.2 0.4 4.1 0.7 0.5 1.9 1.8 3.7 6.9 3.8 3.7 1.6 3.2 1.8 2.4 3.5 4.2 2.7 2.9 4.2 4.2 2.8 2.4 3.5 2.8 5.8 1.6 0.8 5.6 18.0 5.6 4.6 1.9 0.8 7.3 4.5 2.3 6.1 1.9 4.6 3.6 3.1 2.3 8.2 1.3 1.7 1.2 6.8 5.0 1.1 3.9 2.0 2.4 4.1 1.3 1.2 8.8 8.5 10.1 1.2 2.0 3.0 10.3 9.3 6.8 10.0 5.6 1.1 5.3 2.0 16.3 4.1 0.7 0.7 0.8 0.4 1.9 6.2 0.8 0.7 0.4 1.2 1.5 1.4 1.7 0.5 0.3 0.3 0.5 1.8 9.5 13.1 19.7 17.0 9.0 11.5 10.8 10.9 9.8 6.4 ADCY7 "AC7, KIAA0037" ENSG00000121281 "Adenylate cyclase 7" P51828 16 50246137-50318135 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 22.9;HMC-1: 63.9;RPMI-8226: 31.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041218, HPA048241" Uncertain Approved Cytosol Cytosol "HPA041218: , HPA048241: " "unprognostic (1.98e-1)" "prognostic unfavourable (5.31e-4)" "unprognostic (1.24e-1)" "unprognostic (1.78e-1)" "unprognostic (3.77e-1)" "unprognostic (2.80e-1)" "unprognostic (3.90e-2)" "unprognostic (7.75e-2)" "unprognostic (1.21e-1)" "unprognostic (2.56e-2)" "unprognostic (1.65e-1)" "unprognostic (1.18e-1)" "unprognostic (5.59e-3)" "unprognostic (7.34e-2)" "unprognostic (2.15e-3)" "unprognostic (2.18e-1)" "unprognostic (9.52e-4)" 6.3 4.3 7.0 17.4 9.7 14.9 3.9 1.2 5.2 3.7 5.0 9.8 0.8 2.8 3.7 4.8 13.2 5.3 6.9 7.3 5.3 4.2 3.3 3.6 16.4 16.5 8.8 4.4 17.1 3.7 1.0 3.4 9.7 8.6 3.5 5.9 6.2 6.5 1.6 1.8 7.9 10.4 5.0 12.3 26.9 4.9 2.1 9.2 21.8 3.7 3.1 26.0 6.6 6.1 3.6 12.5 6.5 16.7 8.4 7.0 5.0 3.9 5.4 0.2 0.7 0.5 7.0 0.5 2.8 1.3 2.1 2.0 5.1 8.2 1.6 7.4 11.1 14.3 5.6 2.4 2.7 15.1 2.0 22.9 4.1 1.4 6.4 4.3 63.9 3.7 2.3 1.6 2.5 0.6 8.3 3.2 3.0 2.3 1.6 10.2 0.9 7.7 1.6 2.1 31.7 1.5 0.3 0.9 2.6 1.5 0.6 1.3 0.1 12.8 5.0 0.3 7.5 0.8 0.7 0.3 0.1 3.5 2.4 9.3 1.0 6.5 7.8 2.9 7.0 11.7 5.1 3.2 2.8 5.0 12.5 3.6 2.6 3.7 4.4 8.4 16.7 6.5 3.9 5.0 7.0 9.7 1.2 5.2 5.3 4.2 8.8 4.4 8.6 9.2 ADGRG2 "EDDM6, GPR64, HE6, TM7LN2" ENSG00000173698 "Adhesion G protein-coupled receptor G2" Q8IZP9 X 18989309-19122637 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "epididymis: 202.4" "Cell line enhanced" "Detected in some" "A549: 6.1;BEWO: 7.7;HeLa: 6.4;NTERA-2: 6.7;SH-SY5Y: 7.0;U-2197: 15.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA001478, HPA050029" Enhanced Approved "Plasma membrane,Cytosol" 7900000 "Plasma membrane, Cytosol" "HPA001478: AB_1078923, HPA050029: AB_2680996" "unprognostic (3.33e-2)" "unprognostic (3.20e-1)" "unprognostic (2.40e-1)" "unprognostic (2.55e-2)" "unprognostic (1.58e-1)" "unprognostic (4.43e-3)" "unprognostic (2.63e-4)" "unprognostic (2.66e-1)" "unprognostic (1.27e-3)" "unprognostic (1.12e-1)" "unprognostic (1.78e-2)" "unprognostic (1.07e-1)" "unprognostic (3.54e-7)" "unprognostic (6.37e-2)" "unprognostic (3.19e-1)" "unprognostic (2.83e-1)" "unprognostic (1.35e-1)" 4.4 0.3 0.4 0.9 0.2 0.2 2.8 0.1 0.2 0.8 1.0 0.1 6.6 0.2 0.5 202.4 0.9 6.9 1.4 1.8 0.6 0.6 0.7 0.9 1.7 3.1 0.2 0.2 0.9 0.9 24.8 1.9 0.6 0.3 3.2 0.2 1.6 9.6 0.8 0.6 0.3 1.4 0.6 0.2 1.2 3.5 4.7 0.2 2.7 1.8 0.6 1.9 1.1 1.5 0.1 0.2 0.9 0.6 0.0 0.2 0.0 0.2 6.1 0.0 0.0 0.1 0.9 7.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 6.4 0.2 0.9 0.0 0.0 0.1 0.1 0.0 1.2 0.0 0.0 0.2 0.0 1.0 0.0 2.3 6.7 2.0 0.0 0.1 4.4 0.0 1.2 2.3 7.0 1.5 0.1 0.0 0.1 0.1 0.1 0.2 0.4 15.3 2.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.9 0.1 0.4 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.0 0.7 0.0 0.6 0.1 0.0 0.0 0.4 0.2 0.1 0.2 0.6 0.6 0.2 0.2 0.3 0.2 AGMO "FLJ16237, TMEM195" ENSG00000187546 "Alkylglycerol monooxygenase" Q6ZNB7 7 15200318-15562015 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 41.9;liver: 57.9" "Cell line enhanced" "Detected in some" "HSkMC: 4.0;Karpas-707: 8.5;NTERA-2: 3.8;SCLC-21H: 3.6;TIME: 4.3;WM-115: 16.8" "Cancer enriched" "Detected in many" 5 "liver cancer: 15.7" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "basophil: 3.6;neutrophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA057900 Uncertain Vesicles Vesicles "HPA057900: " "unprognostic (2.82e-1)" "unprognostic (9.28e-2)" "unprognostic (5.60e-3)" "unprognostic (1.44e-4)" "unprognostic (7.52e-2)" "unprognostic (1.07e-2)" "unprognostic (3.61e-2)" "unprognostic (6.56e-2)" "unprognostic (3.31e-1)" "unprognostic (3.35e-1)" "unprognostic (4.18e-3)" "unprognostic (3.24e-1)" "unprognostic (1.64e-1)" "unprognostic (2.04e-2)" "unprognostic (3.45e-1)" "unprognostic (1.00e-1)" "unprognostic (1.93e-1)" 6.8 0.2 0.8 1.0 1.2 0.1 3.7 0.3 0.5 0.3 16.5 1.1 0.1 4.6 0.3 7.3 0.3 0.3 4.7 0.9 0.7 0.6 5.3 57.9 0.4 0.5 1.1 0.8 0.3 0.3 0.0 0.7 0.4 0.7 0.4 0.3 0.0 0.4 0.1 0.5 0.5 41.9 0.1 1.1 0.3 0.3 1.8 2.0 0.0 0.7 0.1 0.1 1.0 0.4 0.2 0.1 3.6 0.1 0.6 0.1 0.0 0.0 2.4 0.0 2.1 0.2 3.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.1 3.8 0.0 0.0 0.0 1.2 0.0 0.7 3.6 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.5 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.0 16.8 3.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 3.1 0.6 0.0 0.1 0.0 0.0 0.8 1.2 0.3 0.4 0.7 0.6 1.1 0.8 0.7 2.0 AL669918.1 ENSG00000250264 6 32813767-32838822 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 25.5" "Cell line enhanced" "Detected in many" "Daudi: 16.8;HDLM-2: 11.2;HEL: 12.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA001312 Approved Approved "Nuclear speckles,Endoplasmic reticulum" "Nuclear speckles, Endoplasmic reticulum" "HPA001312: AB_1080206" "unprognostic (6.13e-2)" "unprognostic (8.76e-3)" "unprognostic (4.62e-1)" "unprognostic (9.88e-2)" "unprognostic (1.99e-1)" "unprognostic (3.39e-2)" "unprognostic (1.72e-1)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.49e-1)" "unprognostic (8.73e-2)" "unprognostic (2.03e-1)" "unprognostic (1.33e-1)" "unprognostic (1.33e-1)" 6.5 3.6 2.8 25.5 3.1 3.8 3.6 3.1 3.3 4.8 7.7 3.5 1.0 5.7 4.6 2.5 4.8 3.6 5.7 3.5 2.1 2.6 5.3 10.0 8.5 12.6 3.2 2.8 4.7 2.1 1.7 5.0 2.4 3.6 3.8 3.1 3.6 7.0 1.4 2.5 3.3 15.1 2.7 2.8 18.1 12.3 2.5 3.1 14.0 7.5 3.2 10.6 3.8 3.9 8.6 5.5 8.1 4.8 2.3 4.6 5.1 2.0 3.1 0.0 0.7 1.6 1.7 0.5 0.6 0.3 0.0 0.6 0.0 3.2 16.8 2.0 0.2 7.6 1.6 1.7 0.6 11.2 0.2 12.2 2.1 0.3 0.5 0.0 0.5 0.0 0.9 0.5 0.2 0.0 3.0 2.8 0.2 0.6 1.4 0.9 0.2 2.8 5.9 0.6 5.4 0.0 0.0 0.3 0.3 0.5 5.2 1.3 5.0 1.3 0.0 1.2 1.9 0.4 0.6 1.4 2.8 7.5 0.7 3.6 0.4 1.6 3.1 6.1 3.5 3.2 3.4 8.0 2.8 3.9 5.5 8.6 2.1 4.6 8.1 2.3 4.8 5.2 4.2 5.1 2.8 3.1 3.1 3.3 2.1 2.6 3.2 2.8 3.6 3.1 ALG3 "CDGS4, D16Ertd36e, Not56, NOT56L" ENSG00000214160 "ALG3, alpha-1,3- mannosyltransferase" Q92685 3 184242301-184249548 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045103 Approved "HPA045103: AB_10960547" "unprognostic (3.63e-2)" "unprognostic (2.60e-1)" "unprognostic (2.36e-2)" "unprognostic (1.80e-3)" "unprognostic (3.63e-1)" "unprognostic (7.93e-3)" "prognostic unfavourable (1.58e-5)" "prognostic unfavourable (8.67e-5)" "unprognostic (6.18e-2)" "unprognostic (1.24e-1)" "unprognostic (4.19e-3)" "unprognostic (6.15e-2)" "prognostic unfavourable (1.25e-4)" "unprognostic (9.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.64e-1)" "unprognostic (5.02e-2)" 14.2 24.1 7.7 12.2 10.3 11.6 15.4 7.2 12.9 11.5 15.5 13.7 15.2 14.3 12.8 11.2 20.5 11.5 15.4 13.0 7.3 6.5 19.7 74.4 12.9 16.8 11.5 7.3 12.7 37.7 18.4 11.7 26.6 10.2 14.0 16.0 12.4 20.9 13.7 18.9 18.4 16.3 14.0 7.9 14.9 15.0 20.8 10.1 13.9 15.9 14.9 18.8 17.4 15.8 14.2 30.1 6.0 25.4 18.7 18.0 15.5 20.3 17.7 4.8 16.3 19.6 11.2 16.5 11.0 12.5 15.1 12.9 27.1 13.7 17.9 30.0 13.5 24.6 17.5 23.8 9.4 12.9 20.3 16.1 13.6 21.8 18.0 26.0 14.5 13.3 20.0 17.8 25.1 8.2 15.8 36.3 9.7 25.0 12.6 21.1 15.3 23.2 13.1 7.5 71.2 16.9 6.8 12.2 10.3 10.2 40.3 17.5 38.2 14.8 6.5 16.0 10.0 13.9 23.4 19.9 34.9 19.0 14.3 34.2 14.3 0.2 25.4 6.0 16.0 25.0 18.0 14.2 17.3 16.2 30.1 12.3 15.6 15.1 0.9 18.7 19.7 27.4 18.0 15.5 7.7 10.3 7.2 12.9 7.3 6.5 11.5 7.3 10.2 10.1 ALG8 MGC2840 ENSG00000159063 "ALG8, alpha-1,3-glucosyltransferase" Q9BVK2 11 78100936-78139660 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051898 Approved Approved Nucleoplasm Nucleoplasm "HPA051898: " "unprognostic (1.37e-1)" "unprognostic (9.24e-2)" "unprognostic (4.60e-2)" "unprognostic (2.69e-2)" "unprognostic (2.65e-1)" "unprognostic (6.49e-2)" "unprognostic (5.38e-3)" "unprognostic (5.91e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-3)" "unprognostic (5.29e-2)" "unprognostic (1.20e-1)" "unprognostic (1.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.34e-1)" "unprognostic (3.78e-2)" "unprognostic (6.37e-2)" 20.2 24.5 18.0 11.2 22.3 9.7 23.7 13.8 17.9 16.5 15.0 20.7 23.9 10.3 14.5 30.9 13.3 18.4 12.3 13.0 15.9 16.0 24.9 40.8 12.8 15.7 16.0 11.6 22.9 23.4 24.2 23.6 21.7 17.1 15.5 19.0 17.6 23.2 19.5 8.2 13.3 13.3 14.8 17.6 13.8 13.1 38.9 16.5 18.2 29.7 13.1 17.4 13.2 11.2 21.9 19.4 3.0 20.3 18.2 19.0 14.9 9.3 25.9 24.9 21.2 21.5 15.2 13.4 13.8 20.7 23.7 23.0 49.0 34.4 22.0 25.6 16.5 27.1 28.9 19.9 38.3 15.8 17.4 26.5 22.8 22.0 14.0 25.3 17.6 12.1 12.8 27.6 13.8 17.2 32.8 22.7 31.6 13.7 21.1 28.5 27.6 13.6 22.5 11.4 52.3 23.8 14.5 7.3 18.3 19.9 32.3 10.0 36.0 20.0 10.5 16.1 18.7 36.2 11.9 16.3 31.6 32.5 8.9 24.8 27.8 0.3 17.5 3.0 15.7 19.5 17.5 21.9 16.0 16.1 19.4 16.6 19.0 17.2 1.1 18.2 20.3 18.7 13.0 14.9 18.0 22.3 13.8 17.9 15.9 16.0 16.0 11.6 17.1 16.5 ANO1 "DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A" ENSG00000131620 "Anoctamin 1" Q5XXA6 11 70078302-70189528 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Developmental protein, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "ductus deferens: 142.4;epididymis: 38.5;salivary gland: 122.9;seminal vesicle: 93.6" "Group enriched" "Detected in some" 5 "A-431: 33.8;CAPAN-2: 52.0;HaCaT: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA032148, HPA057356" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA032148: , HPA057356: " "unprognostic (2.73e-1)" "unprognostic (7.91e-2)" "unprognostic (3.66e-2)" "prognostic favourable (4.58e-6)" "unprognostic (1.90e-1)" "prognostic unfavourable (7.28e-5)" "unprognostic (1.16e-3)" "prognostic unfavourable (2.40e-4)" "unprognostic (2.13e-2)" "unprognostic (3.51e-1)" "prognostic unfavourable (1.70e-4)" "unprognostic (1.21e-1)" "prognostic unfavourable (4.09e-6)" "unprognostic (1.56e-1)" "unprognostic (1.06e-1)" "unprognostic (8.85e-3)" "unprognostic (1.81e-1)" 6.9 0.4 1.1 2.1 1.1 0.0 17.2 1.6 1.4 9.7 5.3 1.1 142.4 0.2 14.2 38.5 3.6 11.7 10.6 6.9 1.1 0.2 2.6 24.4 4.4 1.5 1.0 1.0 3.9 4.5 0.5 2.0 6.2 1.5 7.2 1.7 1.7 122.9 93.6 3.4 19.1 1.8 5.7 1.0 1.1 9.5 7.6 0.9 1.1 8.9 8.1 3.8 4.5 5.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 33.8 1.3 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 52.0 0.0 0.6 0.0 63.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 4.9 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 10.8 0.2 4.1 0.1 0.1 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 1.6 1.4 1.1 0.2 1.0 1.0 1.5 0.9 ANO10 "FLJ10375, MGC47890, SCAR10, TMEM16K" ENSG00000160746 "Anoctamin 10" Q9NW15 3 43354859-43691594 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 22.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016624, HPA051569" Approved Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA016624: , HPA051569: " "unprognostic (1.51e-3)" "unprognostic (1.38e-2)" "prognostic favourable (6.70e-4)" "prognostic favourable (1.11e-4)" "unprognostic (4.23e-1)" "unprognostic (2.69e-2)" "prognostic unfavourable (3.19e-4)" "unprognostic (7.99e-3)" "unprognostic (1.03e-2)" "unprognostic (1.56e-1)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "prognostic favourable (6.41e-6)" "unprognostic (9.83e-3)" "unprognostic (1.22e-1)" "unprognostic (5.19e-3)" "unprognostic (5.71e-2)" 21.6 12.7 11.8 12.6 13.2 20.6 22.0 18.2 14.1 17.5 27.4 14.3 13.2 42.0 17.9 12.4 19.8 10.4 16.7 10.5 12.3 15.2 22.2 10.5 13.6 10.7 17.3 12.3 12.7 14.4 18.6 14.4 17.5 19.4 10.7 24.4 18.6 23.1 19.5 11.3 24.6 52.9 19.9 23.6 9.4 11.1 9.1 8.8 5.5 17.7 15.8 13.9 13.7 17.0 2.0 8.5 22.4 12.5 6.3 4.6 4.3 8.8 7.1 7.9 8.3 32.2 17.3 9.7 26.2 43.6 13.4 17.1 4.8 8.3 1.0 8.4 34.5 4.9 6.2 14.3 16.3 9.9 4.4 11.6 9.6 5.2 14.1 2.0 9.5 16.1 11.4 16.5 22.5 31.3 8.7 7.6 29.6 6.3 2.2 1.5 9.4 8.3 1.8 5.7 3.0 26.4 9.4 1.9 5.8 10.3 8.5 6.0 18.1 4.3 25.4 20.4 7.6 21.4 11.9 4.9 6.4 0.3 18.6 4.4 13.4 4.4 12.5 0.9 4.6 7.1 2.7 1.9 3.2 3.1 8.5 2.0 2.8 4.3 22.4 6.3 7.7 1.5 3.5 4.3 11.8 13.2 18.2 14.1 12.3 15.2 17.3 12.3 19.4 8.8 ANO2 "C12orf3, TMEM16B" ENSG00000047617 "Anoctamin 2" Q9NQ90 12 5531869-5946232 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "placenta: 46.9;retina: 30.6;testis: 13.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.4;HUVEC TERT2: 8.3;U-2 OS: 22.0" "Cancer enhanced" "Detected in some" "testis cancer: 2.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "basophil: 5.1" "Lineage enriched" "Detected in single" 51 "granulocytes: 5.1" "Region enriched" "Detected in some" 4 "basal ganglia: 20.0" "HPA036276, HPA057499" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA036276: AB_10670713, HPA057499: " "unprognostic (6.32e-2)" "unprognostic (1.01e-1)" "unprognostic (3.77e-1)" "unprognostic (1.25e-2)" "unprognostic (1.55e-1)" "unprognostic (4.05e-3)" "unprognostic (2.86e-1)" "unprognostic (2.62e-1)" "unprognostic (1.11e-2)" "unprognostic (1.90e-1)" "unprognostic (1.84e-3)" "unprognostic (3.78e-3)" "unprognostic (1.04e-2)" "unprognostic (1.10e-2)" "unprognostic (9.93e-2)" "unprognostic (2.27e-1)" "unprognostic (2.17e-1)" 5.8 0.1 1.0 1.3 2.3 0.0 4.3 1.2 1.3 3.3 1.0 1.6 0.9 0.8 1.8 2.1 0.9 1.9 1.5 3.9 1.9 0.9 1.2 0.9 4.7 0.9 1.6 2.0 0.9 0.9 1.4 0.9 46.9 1.2 1.4 0.7 30.6 0.9 1.6 2.3 0.6 0.9 2.1 1.1 1.9 1.0 13.4 0.9 0.9 1.6 1.3 0.9 1.3 2.3 0.0 0.0 5.1 0.0 0.0 0.0 0.2 2.1 0.0 3.9 0.0 0.0 0.2 1.8 0.0 8.4 0.4 0.9 0.0 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.6 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.3 0.0 1.6 0.0 0.8 0.0 0.0 4.0 0.0 1.6 0.0 0.9 0.1 0.1 0.0 0.0 2.0 1.4 0.0 1.1 0.0 0.2 0.0 22.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 1.0 2.3 1.2 1.3 1.9 0.9 1.6 2.0 1.2 0.9 ANO4 "FLJ34221, FLJ34272, FLJ35277, TMEM16D" ENSG00000151572 "Anoctamin 4" Q32M45 12 100717526-101128641 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 20.3;brain: 19.2;seminal vesicle: 14.0" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 14.1;LHCN-M2: 6.8;SK-MEL-30: 10.9;TIME: 22.4;WM-115: 7.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053412 Uncertain "HPA053412: " "unprognostic (1.11e-1)" "unprognostic (3.03e-2)" "unprognostic (4.58e-2)" "unprognostic (1.04e-1)" "unprognostic (1.20e-2)" "unprognostic (2.02e-1)" "unprognostic (3.76e-2)" "unprognostic (1.95e-2)" "unprognostic (1.39e-1)" "unprognostic (1.97e-1)" "unprognostic (4.72e-1)" "unprognostic (6.54e-2)" "prognostic favourable (5.48e-5)" "unprognostic (1.16e-3)" "unprognostic (8.46e-2)" "unprognostic (2.01e-2)" "unprognostic (1.41e-1)" 0.9 20.3 10.3 0.6 16.7 0.6 0.7 2.8 13.0 13.3 0.8 17.2 1.4 1.1 7.9 1.2 0.7 1.0 0.8 0.8 9.5 5.8 0.8 0.6 0.7 0.6 10.9 8.6 13.8 1.6 0.8 2.2 0.7 12.1 8.7 0.9 0.0 3.6 14.0 0.6 0.7 0.9 1.5 4.4 0.6 0.6 2.1 19.2 0.0 0.8 0.0 1.3 1.4 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.8 1.1 0.0 4.9 4.4 4.2 2.0 0.0 0.0 0.0 0.0 14.1 0.2 5.1 4.2 3.9 0.0 0.0 0.0 2.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 6.8 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 10.9 0.0 0.0 22.4 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 16.7 2.8 13.0 9.5 5.8 10.9 8.6 12.1 19.2 ANO8 "KIAA1623, TMEM16H" ENSG00000074855 "Anoctamin 8" Q9HCE9 19 17323223-17334829 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 30.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031787, HPA049206" Uncertain Uncertain "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA031787: , HPA049206: " "unprognostic (5.12e-2)" "unprognostic (2.79e-1)" "unprognostic (1.59e-1)" "unprognostic (3.07e-1)" "unprognostic (2.91e-1)" "unprognostic (2.20e-3)" "unprognostic (1.04e-1)" "unprognostic (3.46e-2)" "unprognostic (3.94e-2)" "unprognostic (1.23e-1)" "unprognostic (1.03e-1)" "unprognostic (5.89e-2)" "unprognostic (3.05e-3)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (2.48e-2)" "unprognostic (4.59e-2)" 8.5 18.1 19.2 6.6 17.9 3.8 6.6 25.1 30.6 4.3 4.3 11.6 4.9 6.6 5.1 2.2 12.5 4.0 7.9 7.1 15.7 10.6 6.1 6.0 6.6 6.2 13.3 10.3 3.2 7.0 14.4 4.0 5.3 23.3 5.4 4.0 3.2 7.9 4.8 11.1 23.2 6.2 4.5 20.1 5.4 12.2 3.4 14.1 5.3 5.2 5.2 4.4 5.1 5.2 0.1 1.8 0.1 0.1 0.0 0.8 0.1 4.1 3.7 10.1 11.5 3.1 2.2 17.6 4.2 2.4 2.2 2.5 1.6 8.9 0.3 4.6 4.1 3.9 2.1 3.4 1.3 18.7 5.2 2.8 10.7 2.4 1.6 0.6 4.8 2.5 3.2 2.8 2.1 1.6 2.0 4.2 1.4 3.1 3.6 1.1 5.8 15.2 6.1 2.1 4.9 3.7 6.8 3.8 12.3 4.6 4.4 3.5 6.3 1.8 1.7 5.2 2.9 15.8 4.6 7.5 6.1 0.7 8.1 5.2 4.9 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.5 0.5 0.0 0.0 0.1 1.8 0.8 0.1 19.2 17.9 25.1 18.6 15.7 10.6 13.3 10.3 23.3 14.1 ATP11B "ATPIF, ATPIR, KIAA0956" ENSG00000058063 "ATPase phospholipid transporting 11B (putative)" Q9Y2G3 3 182793500-182921635 "Enzymes, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036237, HPA036238" Uncertain Approved "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA036237: AB_10673123, HPA036238: AB_10670792" "unprognostic (4.52e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "prognostic unfavourable (3.44e-4)" "unprognostic (1.50e-1)" "unprognostic (1.50e-1)" "unprognostic (6.73e-2)" "unprognostic (2.03e-3)" "unprognostic (7.28e-2)" "unprognostic (1.18e-1)" "prognostic unfavourable (1.09e-4)" "unprognostic (2.02e-1)" "unprognostic (1.71e-1)" "unprognostic (1.62e-1)" "unprognostic (3.22e-1)" "unprognostic (8.66e-2)" "unprognostic (1.35e-1)" 16.8 7.9 7.7 19.7 9.8 35.4 17.0 18.4 9.4 20.5 21.6 8.9 14.3 13.6 15.0 11.7 37.3 11.8 12.7 21.1 6.9 5.9 13.7 14.3 19.4 20.3 10.3 5.7 15.2 14.6 21.0 26.0 8.0 8.3 16.8 16.9 9.8 19.7 13.8 13.1 21.8 22.8 16.5 11.3 23.4 27.6 22.8 8.9 49.0 10.8 20.4 21.9 22.7 25.5 3.6 4.2 7.5 1.8 3.0 3.4 1.3 22.2 3.2 7.0 9.8 15.0 16.4 6.5 10.3 14.2 8.0 9.4 7.9 11.6 10.3 17.7 14.8 13.5 8.4 10.6 14.0 22.9 6.7 24.9 4.3 1.7 8.8 19.6 16.0 11.1 12.0 9.0 13.1 12.6 8.8 32.3 12.9 7.5 16.3 6.3 5.0 6.3 6.8 20.6 12.4 9.7 18.8 4.2 7.6 28.7 3.7 12.5 4.0 14.6 12.3 12.2 13.3 10.5 17.9 44.1 39.4 19.4 8.4 8.4 7.1 7.5 1.7 7.2 3.1 1.8 3.0 3.6 2.7 3.1 1.9 2.4 2.3 3.4 6.8 3.0 1.7 4.2 2.0 1.3 7.7 9.8 18.4 9.4 6.9 5.9 10.3 5.7 8.3 8.9 ATP1A2 "FHM2, MHP2" ENSG00000018625 "ATPase Na+/K+ transporting subunit alpha 2" P50993 1 160115759-160143591 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "brain: 109.8;skeletal muscle: 305.8" "Cell line enhanced" "Detected in some" "AF22: 32.2;HHSteC: 9.4;RH-30: 10.5;U-87 MG: 6.5" "Cancer enriched" "Detected in many" 18 "glioma: 91.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022230 Enhanced "CAB022230: " "unprognostic (1.08e-2)" "unprognostic (4.42e-2)" "unprognostic (3.41e-2)" "unprognostic (2.83e-1)" "unprognostic (2.83e-1)" "unprognostic (7.98e-2)" "unprognostic (2.16e-2)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (8.85e-2)" "unprognostic (8.63e-4)" "unprognostic (1.70e-2)" "unprognostic (9.40e-3)" "unprognostic (1.49e-2)" "unprognostic (2.40e-1)" "unprognostic (7.16e-2)" "unprognostic (5.32e-3)" 12.6 3.9 61.4 2.8 80.1 2.3 6.5 30.4 109.8 4.7 6.6 27.4 2.4 3.7 4.2 7.4 15.3 6.0 5.3 35.4 42.2 27.0 3.3 2.5 3.8 2.4 45.6 37.9 9.9 2.6 2.4 4.6 3.6 58.0 13.8 5.6 12.5 3.1 14.2 305.8 2.8 4.4 5.4 51.5 2.7 2.8 3.9 28.3 0.0 2.6 17.7 2.5 5.5 1.3 0.6 1.4 1.7 0.4 0.6 0.5 0.3 0.0 0.0 32.2 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 2.8 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 1.3 0.4 0.3 0.3 0.3 0.2 0.4 0.3 0.2 0.7 0.6 0.3 0.5 1.7 0.6 0.2 1.4 0.2 0.3 61.4 80.1 30.4 52.0 42.2 27.0 45.6 37.9 58.0 28.3 ATP2A1 "ATP2A, SERCA1" ENSG00000196296 "ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1" O14983 16 28878405-28904509 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 26 "skeletal muscle: 456.3;tongue: 209.0" "Cell line enhanced" "Detected in many" "HEK 293: 19.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "NK-cell: 4.7" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 8 "thalamus: 14.3" "Low region specificity" "Detected in all" "CAB002310, CAB032706" Enhanced Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "CAB002310: AB_564139, CAB032706: AB_2061286" "unprognostic (2.37e-1)" "unprognostic (6.81e-2)" "unprognostic (2.23e-5)" "unprognostic (5.35e-2)" "unprognostic (2.27e-1)" "unprognostic (2.04e-1)" "unprognostic (1.89e-1)" "unprognostic (1.19e-1)" "unprognostic (5.24e-2)" "unprognostic (1.87e-1)" "unprognostic (5.22e-2)" "unprognostic (4.94e-2)" "unprognostic (2.72e-4)" "unprognostic (1.70e-2)" "unprognostic (1.91e-1)" "unprognostic (1.49e-1)" "unprognostic (2.51e-2)" 7.6 0.1 0.1 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.1 1.1 5.2 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.6 0.1 12.6 7.0 0.3 456.3 0.2 0.2 0.1 0.1 0.1 0.1 0.9 0.0 0.0 4.2 209.0 6.5 0.2 0.1 1.6 3.1 0.7 0.2 4.7 1.5 0.6 4.8 5.2 9.6 5.7 0.4 1.6 8.9 2.3 1.3 0.4 0.4 2.9 4.4 7.6 2.7 0.4 5.1 2.4 0.1 0.7 3.8 19.8 2.7 11.8 9.0 0.2 1.1 2.5 4.1 1.1 0.6 0.5 0.2 5.1 6.5 0.3 9.7 10.9 6.1 9.6 7.4 16.8 6.8 5.7 0.0 0.6 6.1 4.9 3.3 4.5 3.4 3.4 2.7 2.0 3.0 6.3 5.6 2.8 9.5 5.7 7.4 5.9 15.0 2.9 0.0 0.1 0.7 1.0 0.0 1.3 1.6 1.1 1.0 0.0 0.8 1.4 1.3 0.0 4.7 0.2 3.1 1.5 0.6 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 ATP2B1 PMCA1 ENSG00000070961 "ATPase plasma membrane Ca2+ transporting 1" P20020 12 89588049-89709300 "Enzymes, Plasma proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.8" "Cell line enhanced" "Detected in many" "hTERT-HME1: 58.4;LHCN-M2: 90.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005605, HPA011166, HPA012945" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483" "unprognostic (6.78e-2)" "unprognostic (5.27e-2)" "unprognostic (1.57e-2)" "unprognostic (8.23e-2)" "unprognostic (1.72e-1)" "unprognostic (6.44e-2)" "prognostic unfavourable (7.74e-4)" "unprognostic (2.77e-2)" "unprognostic (2.46e-2)" "unprognostic (7.82e-2)" "unprognostic (5.98e-2)" "unprognostic (2.68e-1)" "unprognostic (4.60e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-2)" 8.7 5.1 23.4 12.5 53.8 40.5 8.8 30.9 44.1 9.0 14.0 4.1 4.0 17.8 8.2 5.8 6.5 8.4 11.3 5.2 29.0 11.8 7.4 10.0 9.2 11.8 7.8 31.5 7.6 7.4 13.7 8.7 11.7 9.2 6.4 14.8 2.9 5.6 6.9 10.9 11.3 12.8 8.7 6.1 12.7 12.4 9.8 16.4 5.7 6.3 6.0 12.3 9.9 7.4 27.1 16.2 41.5 25.6 8.4 16.3 6.2 4.1 21.1 8.3 4.0 12.1 19.3 3.8 12.8 41.9 12.4 19.8 8.4 3.9 8.2 0.9 17.7 3.7 7.3 3.5 34.7 2.8 8.5 2.9 7.4 7.4 39.5 12.2 4.9 15.9 6.7 38.6 58.4 3.1 4.8 3.0 90.7 6.6 3.8 5.2 6.5 10.1 5.4 26.8 3.4 11.8 19.3 7.9 4.3 14.8 4.2 3.5 6.1 1.4 2.2 33.7 5.5 12.3 13.9 2.3 3.5 8.8 15.3 3.5 7.4 2.7 13.0 6.7 7.1 13.6 9.0 27.1 12.4 9.0 16.2 27.0 4.6 5.7 41.5 8.4 25.6 2.9 16.3 6.2 23.4 53.8 30.9 44.1 29.0 11.8 7.8 31.5 9.2 16.4 ATP2B2 PMCA2 ENSG00000157087 "ATPase plasma membrane Ca2+ transporting 2" Q01814 3 10324023-10708007 "Enzymes, Plasma proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 55.1;liver: 15.2;salivary gland: 28.6;skeletal muscle: 30.3" "Group enriched" "Detected in some" 4 "EFO-21: 5.3;RPMI-8226: 15.0;SCLC-21H: 5.7" "Cancer enhanced" "Detected in some" "liver cancer: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005606 Enhanced "CAB005606: AB_2243199" "unprognostic (2.04e-1)" "unprognostic (1.26e-2)" "unprognostic (6.84e-2)" "unprognostic (1.59e-2)" "unprognostic (3.59e-1)" "unprognostic (3.62e-1)" "unprognostic (4.09e-2)" "unprognostic (4.65e-1)" "unprognostic (5.61e-2)" "unprognostic (1.93e-1)" "unprognostic (2.32e-4)" "unprognostic (2.70e-1)" "unprognostic (1.46e-3)" "unprognostic (1.08e-3)" "unprognostic (1.33e-2)" "unprognostic (8.34e-2)" "unprognostic (7.95e-3)" 1.0 1.5 7.6 1.0 23.0 0.9 1.0 39.9 55.1 3.0 1.0 2.4 0.0 1.0 3.2 1.1 1.1 4.3 1.0 1.0 10.0 6.2 1.1 15.2 1.0 1.0 7.9 14.7 1.0 1.1 0.9 1.7 0.9 15.5 1.0 1.0 0.7 28.6 0.9 30.3 1.3 1.0 2.3 2.5 1.0 1.0 1.5 4.2 0.0 0.9 0.0 1.0 0.9 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 15.0 0.0 0.0 5.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 7.6 23.0 39.9 55.1 10.0 6.2 7.9 14.7 15.5 4.2 ATP6V0A4 "a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2" ENSG00000105929 "ATPase H+ transporting V0 subunit a4" Q9HBG4 7 138706294-138799560 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 40.6;salivary gland: 55.4" "Cell line enriched" "Detected in some" 11 "SK-BR-3: 35.0" "Cancer enriched" "Detected in many" 8 "renal cancer: 25.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA018029, HPA064555" Enhanced Approved Cytosol Cytosol "HPA018029: AB_1845190, HPA064555: AB_2685284" "unprognostic (1.99e-2)" "unprognostic (8.60e-3)" "unprognostic (1.12e-2)" "unprognostic (3.10e-2)" "unprognostic (1.43e-1)" "unprognostic (6.53e-2)" "unprognostic (4.63e-2)" "unprognostic (4.28e-1)" "unprognostic (1.35e-1)" "unprognostic (9.79e-3)" "unprognostic (1.73e-1)" "prognostic favourable (1.32e-6)" "unprognostic (4.35e-1)" "unprognostic (1.56e-1)" "unprognostic (1.02e-1)" "unprognostic (1.10e-2)" 0.1 0.0 0.5 0.0 0.3 0.0 2.2 0.1 0.4 1.7 0.0 0.3 3.1 0.0 0.3 0.5 2.7 0.0 0.0 0.0 0.4 0.3 40.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.6 0.2 1.0 0.2 0.5 0.0 0.3 55.4 1.2 0.0 6.5 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 1.8 7.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.4 1.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 3.0 1.1 0.0 0.1 0.0 0.0 0.4 0.0 2.9 0.1 0.0 0.0 0.0 35.0 1.2 0.1 0.0 0.1 0.4 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.1 0.4 0.4 0.3 0.3 0.0 0.2 0.1 ATP7A MNK ENSG00000165240 "ATPase copper transporting alpha" Q04656 X 77910656-78050395 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012887, HPA048107" Approved Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA012887: AB_1845205, HPA048107: " "unprognostic (3.14e-2)" "unprognostic (3.48e-1)" "unprognostic (4.90e-2)" "unprognostic (1.49e-2)" "unprognostic (1.26e-1)" "unprognostic (1.03e-1)" "unprognostic (7.17e-3)" "unprognostic (2.59e-2)" "unprognostic (3.17e-2)" "unprognostic (2.47e-1)" "unprognostic (2.30e-2)" "unprognostic (1.14e-1)" "prognostic favourable (8.38e-4)" "unprognostic (1.06e-1)" "unprognostic (2.16e-1)" "unprognostic (3.69e-1)" "unprognostic (2.52e-1)" 9.8 7.4 2.6 8.6 4.6 6.4 8.5 2.3 2.9 8.2 7.7 5.9 9.6 4.8 9.5 7.6 10.0 5.7 4.5 5.1 2.9 2.8 9.0 3.3 9.3 9.3 4.1 1.7 7.3 6.3 13.2 15.9 5.0 4.3 8.2 4.4 5.2 12.3 10.3 6.1 15.9 8.5 7.8 6.3 10.8 7.0 2.7 6.0 15.6 6.0 7.1 11.7 11.8 7.0 2.3 1.4 10.7 2.4 1.7 3.0 1.2 2.5 6.7 4.5 4.6 4.3 4.5 0.8 3.9 5.4 2.3 4.8 0.9 3.0 3.7 5.8 3.8 3.1 5.8 3.1 4.4 5.5 4.0 1.9 6.5 0.7 5.4 3.3 3.5 4.8 1.3 5.0 1.5 6.1 15.3 14.4 4.3 2.2 3.5 1.1 1.3 1.4 2.9 7.5 12.6 3.9 7.2 1.4 17.1 9.6 2.4 4.9 1.8 1.1 7.7 3.1 3.1 4.3 1.5 4.7 8.3 4.3 5.1 2.0 4.7 8.3 2.0 5.5 2.4 1.9 1.2 2.0 1.7 1.7 1.3 2.3 2.1 3.0 10.7 1.7 2.4 1.4 0.6 1.2 2.6 4.6 2.3 2.9 2.9 2.8 4.1 1.7 4.3 6.0 ATP7B WND ENSG00000123191 "ATPase copper transporting beta" P35670 13 51930436-52012125 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 18.5;liver: 13.5" "Cell line enhanced" "Detected in many" "BEWO: 18.8;CACO-2: 10.8;HEL: 28.6;Hep G2: 9.9;RPTEC TERT1: 16.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA009137, HPA013187" Supported Supported "Golgi apparatus" "Golgi apparatus" "HPA009137: , HPA013187: AB_1845206" "unprognostic (1.13e-2)" "unprognostic (1.61e-1)" "unprognostic (2.15e-1)" "prognostic unfavourable (5.01e-4)" "unprognostic (3.49e-1)" "unprognostic (5.51e-2)" "unprognostic (1.55e-2)" "unprognostic (1.18e-1)" "unprognostic (2.24e-1)" "unprognostic (5.77e-2)" "unprognostic (8.29e-2)" "unprognostic (1.17e-1)" "unprognostic (3.26e-3)" "unprognostic (4.66e-2)" "unprognostic (3.54e-1)" "unprognostic (6.21e-3)" "unprognostic (1.40e-1)" 3.4 0.7 1.8 2.4 2.9 1.8 1.6 7.0 2.8 1.4 6.8 1.1 1.1 10.5 1.6 1.9 1.1 1.9 18.5 1.8 2.1 2.1 2.1 13.5 1.2 1.1 1.6 1.1 2.0 1.7 7.7 1.2 7.1 3.5 1.9 2.6 1.4 3.0 1.1 1.1 0.7 9.6 1.5 1.1 1.6 4.5 7.1 1.6 1.1 1.1 1.1 1.1 2.1 1.1 0.0 0.0 1.0 0.3 0.0 0.5 0.1 0.4 1.6 2.9 2.6 0.6 0.5 18.8 0.8 0.2 0.9 0.6 10.8 0.1 0.0 0.3 1.4 0.2 2.0 2.4 0.6 0.2 4.0 28.6 0.3 9.9 0.9 0.3 6.7 1.2 2.8 0.1 1.1 2.0 7.6 0.0 0.8 0.5 0.1 0.7 0.9 0.9 1.0 0.8 0.0 16.7 1.8 2.2 1.2 1.0 1.6 1.1 4.5 0.2 1.1 0.1 1.0 1.6 0.3 0.3 0.4 0.1 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.1 1.8 2.9 7.0 2.8 2.1 2.1 1.6 1.1 3.5 1.6 CLN3 "BTN1, BTS, JNCL" ENSG00000188603 "CLN3, battenin" Q13286 16 28474111-28495575 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 52.7;SK-BR-3: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA063280 Uncertain "HPA063280: " "unprognostic (2.38e-3)" "unprognostic (2.41e-2)" "unprognostic (7.06e-2)" "unprognostic (8.83e-2)" "unprognostic (1.04e-1)" "unprognostic (1.68e-1)" "unprognostic (2.36e-2)" "unprognostic (1.69e-2)" "unprognostic (6.38e-3)" "unprognostic (8.16e-2)" "unprognostic (6.27e-2)" "unprognostic (5.26e-1)" "unprognostic (9.90e-2)" "unprognostic (1.06e-1)" "unprognostic (4.45e-2)" "unprognostic (1.62e-1)" "unprognostic (2.05e-2)" 14.0 23.8 10.6 15.7 11.8 9.0 15.8 14.5 10.3 12.5 27.1 14.6 61.5 14.8 11.7 23.0 15.2 10.6 10.1 9.2 10.8 7.1 18.2 22.3 20.6 15.3 14.4 8.0 14.6 18.4 22.2 6.7 26.0 11.4 13.3 20.4 11.9 22.6 45.3 9.3 16.9 17.4 9.6 13.1 15.8 18.6 7.5 16.5 8.9 19.1 9.4 10.0 15.4 14.8 11.6 28.2 39.6 25.0 15.3 24.1 17.6 6.2 10.7 4.4 10.6 11.9 5.9 52.7 3.9 12.1 8.9 10.8 5.2 15.5 4.6 13.2 7.1 6.6 7.6 7.3 3.8 11.3 10.2 4.4 7.3 15.7 18.4 6.6 19.2 8.0 17.5 6.9 4.4 9.8 7.8 14.1 8.9 14.9 5.9 10.9 6.8 6.9 10.2 4.3 14.4 8.6 14.1 6.0 6.2 1.9 51.8 5.0 16.7 9.1 5.3 5.2 3.0 7.3 6.5 16.0 17.9 4.4 8.5 13.7 3.7 18.1 25.0 39.6 24.1 19.5 18.0 9.6 19.4 23.3 27.2 11.6 16.1 18.2 9.4 15.3 14.3 28.2 19.7 17.6 10.6 11.8 14.5 10.3 10.8 7.1 14.4 8.0 11.4 16.5 COQ2 "CL640, FLJ26072" ENSG00000173085 "Coenzyme Q2, polyprenyltransferase" Q96H96 4 83261536-83284914 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Isoprene biosynthesis, Ubiquinone biosynthesis" Transferase "Disease mutation, Neurodegeneration, Parkinsonism, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056599, HPA068727" Approved Approved Cytosol Cytosol "HPA056599: AB_2683184, HPA068727: AB_2686022" "unprognostic (8.26e-2)" "unprognostic (7.40e-3)" "unprognostic (3.95e-3)" "unprognostic (1.55e-1)" "unprognostic (9.22e-2)" "unprognostic (5.59e-2)" "unprognostic (1.26e-2)" "unprognostic (1.52e-1)" "unprognostic (4.09e-1)" "unprognostic (4.16e-2)" "unprognostic (2.08e-2)" "unprognostic (2.77e-3)" "unprognostic (1.56e-2)" "unprognostic (3.73e-1)" "unprognostic (1.40e-1)" "unprognostic (7.82e-2)" "unprognostic (2.46e-1)" 6.6 25.5 4.9 8.4 7.0 8.9 9.9 1.9 6.0 7.4 12.1 5.8 8.4 7.8 8.0 10.2 13.1 5.4 7.4 17.5 4.3 4.1 8.0 14.9 9.8 9.0 6.5 3.4 8.0 5.9 6.7 12.3 7.2 5.0 6.6 12.5 5.2 12.7 8.5 21.8 13.8 8.2 5.8 6.7 14.1 4.8 6.6 6.7 2.9 10.1 23.9 9.2 6.2 7.4 3.6 11.8 6.0 17.4 3.7 2.0 6.8 11.6 6.8 6.8 12.8 5.3 5.4 4.8 7.6 12.5 14.4 16.8 4.7 16.8 7.9 5.5 13.4 9.0 11.4 12.3 18.1 8.0 7.2 7.0 8.9 6.7 5.7 14.2 33.9 8.0 7.8 6.9 12.0 14.3 4.5 9.4 13.3 12.0 3.7 9.6 5.0 9.7 6.5 5.3 10.2 20.9 5.6 4.7 3.1 8.7 11.0 3.8 7.1 7.8 9.9 6.7 7.0 5.1 10.5 2.8 2.2 4.6 13.2 16.8 9.2 1.1 16.3 2.3 1.6 14.4 1.2 3.6 1.8 1.5 11.8 3.5 1.3 2.0 6.0 3.7 17.4 6.2 2.0 6.8 4.9 7.0 1.9 6.0 4.3 4.1 6.5 3.4 5.0 6.7 COX10 ENSG00000006695 "COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor" Q12887 17 14069496-14208677 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heme biosynthesis" Transferase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 34.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032005, HPA032006" Supported Supported Nucleoli,Mitochondria,Cytosol Mitochondria "Nucleoli, Cytosol" "HPA032005: AB_10603560, HPA032006: AB_10670554" "unprognostic (6.17e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.31e-1)" "unprognostic (7.40e-2)" "unprognostic (6.27e-3)" "unprognostic (1.07e-1)" "unprognostic (9.46e-3)" "unprognostic (6.46e-2)" "prognostic favourable (4.32e-6)" "prognostic favourable (8.73e-4)" "unprognostic (8.82e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-2)" 5.5 6.9 5.3 5.7 6.5 7.0 5.4 6.5 7.2 4.4 11.8 4.1 2.9 9.7 5.1 3.6 9.4 4.8 3.5 18.9 5.8 3.8 10.0 9.3 5.2 8.4 4.5 2.8 4.9 9.6 7.2 6.4 6.6 5.7 5.2 10.1 5.5 6.7 4.8 34.9 6.0 10.9 7.2 4.0 4.6 7.7 15.5 4.9 5.9 5.2 9.6 7.4 7.2 5.8 11.9 13.6 4.0 14.1 8.8 17.5 9.8 8.6 16.6 6.9 9.9 6.9 6.3 15.7 10.5 7.4 19.2 13.3 14.5 6.4 20.4 8.3 10.5 16.7 14.1 13.5 15.5 11.0 14.1 12.1 13.4 16.0 12.2 12.5 11.4 9.1 17.0 12.0 15.3 10.1 16.4 7.0 8.4 10.7 10.6 8.2 10.5 8.6 8.9 23.4 14.4 12.1 16.2 5.2 8.8 10.8 14.4 13.0 8.1 7.1 8.3 8.4 7.0 8.5 13.2 8.5 11.9 9.2 12.6 13.0 10.3 3.0 10.6 4.0 9.9 14.1 10.4 11.9 11.6 10.3 13.6 8.2 12.6 11.9 1.2 8.8 11.9 4.6 17.5 9.8 5.3 6.5 6.5 7.2 5.8 3.8 4.5 2.8 5.7 4.9 COX15 CEMCOX2 ENSG00000014919 "COX15, cytochrome c oxidase assembly homolog" Q7KZN9 10 99711844-99732100 "Disease related genes, Predicted membrane proteins" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037727, HPA037728, HPA066096" Uncertain Supported Mitochondria Mitochondria "HPA037727: AB_10672391, HPA037728: AB_10672463, HPA066096: " "unprognostic (9.74e-2)" "unprognostic (1.20e-1)" "unprognostic (1.99e-1)" "unprognostic (6.55e-3)" "unprognostic (1.50e-2)" "unprognostic (1.34e-1)" "unprognostic (5.36e-2)" "unprognostic (2.96e-1)" "unprognostic (6.84e-2)" "unprognostic (1.76e-1)" "unprognostic (3.40e-2)" "unprognostic (8.34e-2)" "prognostic favourable (9.21e-6)" "unprognostic (2.08e-2)" "unprognostic (2.21e-2)" "unprognostic (1.86e-2)" "unprognostic (3.40e-2)" 14.0 31.6 15.5 13.5 23.8 7.8 15.3 15.2 25.6 13.8 17.9 23.0 14.2 15.5 18.2 15.5 17.3 16.4 16.8 19.3 14.4 15.5 25.3 27.1 11.0 15.4 15.2 16.2 20.7 15.3 17.0 26.7 17.1 22.7 15.9 20.1 21.9 13.5 14.0 28.8 14.4 14.1 16.0 14.6 17.0 15.1 14.2 14.0 21.0 18.9 12.0 23.0 19.4 13.6 17.4 18.0 21.7 23.1 11.7 13.0 12.9 14.5 31.5 13.4 29.2 19.3 15.1 10.9 11.2 14.3 16.9 16.0 23.5 20.9 27.2 18.4 9.7 21.5 28.6 15.7 18.4 12.5 14.0 15.6 16.0 24.3 20.3 21.0 14.9 16.4 14.6 17.8 28.9 17.6 17.7 21.1 15.4 15.4 15.1 15.5 14.8 14.9 18.7 19.5 17.5 15.6 10.5 11.0 18.2 20.1 11.0 19.0 42.1 8.7 13.9 8.8 12.6 13.1 16.6 17.2 22.3 18.3 15.6 34.1 7.4 21.7 17.4 16.4 10.7 20.1 12.4 17.4 12.2 12.3 18.0 16.5 12.6 12.9 13.3 11.7 23.1 8.3 13.0 12.9 15.5 23.8 15.2 25.6 14.4 15.5 15.2 16.2 22.7 14.0 DGAT1 "ARGP1, DGAT" ENSG00000185000 "Diacylglycerol O-acyltransferase 1" O75907 8 144314584-144326910 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "intestine: 161.0" "Cell line enhanced" "Detected in many" "Hep G2: 15.8;PC-3: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB032853 Enhanced Approved "Nucleoli,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoli "CAB032853: AB_2090798" "unprognostic (9.24e-3)" "unprognostic (1.61e-1)" "unprognostic (1.75e-2)" "unprognostic (2.23e-1)" "unprognostic (3.49e-2)" "unprognostic (2.30e-1)" "unprognostic (1.11e-1)" "unprognostic (1.42e-2)" "unprognostic (5.10e-2)" "unprognostic (2.78e-2)" "unprognostic (6.88e-2)" "unprognostic (3.52e-1)" "unprognostic (2.65e-3)" "unprognostic (3.83e-2)" "unprognostic (1.69e-2)" "unprognostic (1.16e-1)" "unprognostic (1.67e-3)" 11.8 18.5 3.6 5.7 4.7 6.4 6.8 6.6 5.6 3.3 60.2 4.0 6.4 44.7 3.9 3.6 5.5 3.1 7.9 6.3 3.7 2.7 6.7 14.4 3.8 3.1 4.1 2.7 3.3 3.9 5.0 4.0 4.3 3.6 3.4 6.3 4.1 5.9 4.3 10.0 4.8 161.0 3.6 2.6 5.3 5.7 10.7 4.2 5.1 3.8 6.2 5.0 4.7 3.4 0.7 2.2 2.8 2.0 0.3 1.7 0.8 3.8 4.1 1.9 3.6 3.2 1.3 2.3 2.7 2.7 2.6 1.8 9.7 2.6 1.5 10.6 1.7 3.3 1.6 3.7 0.5 2.8 4.0 2.8 3.3 15.8 2.3 0.7 2.9 1.8 2.9 1.6 1.9 2.0 2.2 3.5 1.7 3.2 4.8 3.1 0.9 17.6 6.2 0.8 2.5 2.4 2.1 2.0 3.4 3.6 4.4 1.8 2.5 2.7 1.6 1.4 4.9 2.8 2.2 2.0 0.4 0.6 1.4 4.9 2.3 0.0 2.0 2.8 1.2 1.3 1.7 0.7 0.9 1.1 2.2 0.5 0.7 0.3 2.3 0.3 1.7 1.1 0.7 0.8 3.6 4.7 6.6 5.6 3.7 2.7 4.1 2.7 3.6 4.2 DPAGT1 "ALG7, CDG-Ij, D11S366, DGPT, DPAGT, DPAGT2, GPT" ENSG00000172269 "Dolichyl-phosphate N-acetylglucosaminephosphotransferase 1" Q9H3H5 11 119096503-119108331 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053878 Approved "HPA053878: " "unprognostic (1.66e-2)" "unprognostic (3.14e-3)" "unprognostic (1.76e-1)" "unprognostic (7.83e-3)" "unprognostic (6.50e-2)" "unprognostic (8.53e-3)" "prognostic unfavourable (2.03e-5)" "unprognostic (2.52e-1)" "unprognostic (3.95e-1)" "unprognostic (9.05e-2)" "unprognostic (2.08e-2)" "unprognostic (7.12e-2)" "unprognostic (2.19e-3)" "unprognostic (1.87e-3)" "unprognostic (1.08e-2)" "unprognostic (2.52e-2)" "unprognostic (4.57e-2)" 13.0 20.0 6.8 9.7 6.7 5.5 10.0 5.2 9.3 13.2 13.1 8.5 13.0 11.0 10.9 12.0 14.5 11.6 11.3 8.3 5.9 5.8 12.5 53.0 10.0 6.9 7.5 3.6 11.6 32.1 18.4 5.8 12.5 7.4 10.6 11.1 8.1 26.3 13.6 8.0 6.9 15.3 10.6 6.4 12.2 11.9 5.4 8.0 7.7 11.8 7.2 12.4 16.1 8.3 10.1 16.4 9.2 14.4 7.6 11.8 8.0 5.5 14.0 4.9 15.1 18.9 11.3 6.7 10.1 10.6 6.8 10.2 13.7 23.5 11.8 16.0 14.4 18.0 13.7 18.4 7.8 6.5 7.5 21.0 4.5 16.7 15.6 13.3 10.5 14.5 15.4 18.5 25.8 15.8 13.0 22.9 15.3 17.6 3.2 8.1 5.6 15.7 5.4 6.7 16.5 17.6 13.1 6.6 6.7 7.4 24.9 4.1 33.5 5.5 8.0 16.9 6.4 7.5 5.3 3.3 8.7 3.8 3.2 17.1 13.1 9.2 14.4 1.4 9.8 13.2 11.8 10.1 7.5 9.7 16.4 7.3 6.0 6.0 1.4 7.6 11.5 15.2 6.7 8.0 6.8 6.7 5.2 9.3 5.9 5.8 7.5 3.6 7.4 8.0 EDNRB "ETB, HSCR, HSCR2" ENSG00000136160 "Endothelin receptor type B" P24530 13 77895481-77975529 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Albinism, Deafness, Disease mutation, FDA approved drug targets, Hirschsprung disease, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 67.5" "Cell line enhanced" "Detected in some" "AF22: 24.6;ASC diff: 18.7;SK-MEL-30: 22.6;U-266/70: 14.8;WM-115: 47.1" "Group enriched" "Detected in all" 7 "glioma: 41.1;melanoma: 127.7;renal cancer: 28.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "classical monocyte: 2.0;intermediate monocyte: 2.1" "Lineage enriched" "Detected in single" 21 "monocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017842, HPA027546" Approved Supported "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "CAB017842: , HPA027546: " "unprognostic (7.75e-2)" "unprognostic (6.73e-2)" "unprognostic (1.41e-3)" "unprognostic (2.59e-2)" "unprognostic (8.37e-2)" "unprognostic (2.45e-3)" "unprognostic (4.17e-3)" "unprognostic (5.43e-2)" "unprognostic (1.02e-1)" "unprognostic (1.38e-2)" "unprognostic (3.40e-2)" "unprognostic (3.01e-2)" "prognostic favourable (7.20e-5)" "unprognostic (1.59e-2)" "unprognostic (3.86e-2)" "unprognostic (4.58e-2)" "unprognostic (6.77e-3)" 25.4 23.2 22.2 10.3 29.8 0.8 23.1 10.3 30.7 8.1 7.2 13.6 2.3 10.9 7.7 3.6 4.9 6.0 8.5 23.7 16.7 16.4 22.3 26.5 28.4 15.6 24.2 8.1 4.9 6.4 7.7 6.3 67.5 33.2 14.9 7.7 51.0 13.4 4.4 6.7 5.1 11.9 7.4 33.4 16.0 5.8 3.1 12.4 0.0 17.6 2.0 2.9 10.9 8.2 0.0 0.0 0.0 2.1 0.0 0.0 0.4 1.9 0.0 24.6 0.0 18.7 0.7 0.3 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 1.3 0.0 0.0 4.9 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 22.6 0.0 0.1 0.1 0.2 0.0 0.0 0.1 14.8 8.3 0.0 0.4 0.0 47.1 0.0 2.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 22.2 29.8 10.3 11.9 16.7 16.4 24.2 8.1 33.2 12.4 FZD1 DKFZp564G072 ENSG00000157240 "Frizzled class receptor 1" Q9UP38 7 91264364-91271326 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 61.2" "Cell line enhanced" "Detected in many" "AF22: 16.3;HSkMC: 21.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.2;non-classical monocyte: 5.4" "Lineage enriched" "Detected in many" 4 "monocytes: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013008 Approved Supported "Plasma membrane" "Plasma membrane" "CAB013008: " "unprognostic (1.46e-1)" "unprognostic (1.70e-1)" "unprognostic (1.15e-1)" "unprognostic (3.16e-2)" "unprognostic (4.51e-3)" "unprognostic (2.09e-1)" "unprognostic (5.29e-3)" "unprognostic (3.70e-2)" "unprognostic (2.36e-2)" "unprognostic (5.48e-3)" "unprognostic (2.14e-1)" "unprognostic (7.39e-3)" "prognostic favourable (8.87e-7)" "unprognostic (1.05e-2)" "unprognostic (4.16e-2)" "unprognostic (5.53e-2)" "unprognostic (4.13e-2)" 5.8 4.6 2.6 4.9 3.5 0.9 10.7 8.2 2.8 17.6 8.5 4.1 9.3 4.9 10.1 9.9 7.8 6.1 11.0 12.3 6.1 1.8 15.3 3.9 10.5 1.4 2.0 3.2 15.0 7.9 2.5 4.6 10.0 5.7 12.3 3.7 11.1 9.2 17.5 3.1 10.7 8.3 7.2 4.6 3.4 4.5 4.4 3.5 1.4 61.2 6.5 2.9 10.4 13.9 0.1 1.3 0.2 5.4 0.0 0.0 0.4 0.5 1.6 16.3 1.7 13.3 11.5 3.0 5.9 3.8 2.2 1.5 0.7 2.8 0.0 1.4 3.8 3.0 2.5 1.3 1.4 0.0 3.2 0.1 3.1 0.8 0.9 2.6 0.7 21.8 2.3 5.0 1.6 0.5 0.9 2.3 6.3 3.9 0.4 0.7 4.2 2.7 3.2 10.0 0.2 3.5 7.6 2.2 4.3 4.5 3.7 0.9 1.9 2.4 2.4 9.3 7.0 9.8 2.4 2.2 1.5 0.2 10.0 2.2 10.7 0.0 1.4 0.0 0.0 4.2 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 5.4 0.1 0.0 0.4 2.6 3.5 8.2 2.8 6.1 1.8 2.0 3.2 5.7 3.5 G6PC "G6PT, GSD1a" ENSG00000131482 "Glucose-6-phosphatase catalytic subunit" P35575 17 42900797-42913369 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Gluconeogenesis Hydrolase "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "liver: 305.4" "Cell line enhanced" "Detected in some" "RH-30: 2.2" "Cancer enriched" "Detected in some" 72 "liver cancer: 151.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.2" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052324 Enhanced "HPA052324: " "unprognostic (4.23e-2)" "unprognostic (1.49e-2)" "prognostic favourable (5.42e-5)" "unprognostic (8.37e-2)" "prognostic favourable (3.79e-5)" "unprognostic (4.79e-2)" "unprognostic (6.46e-2)" "unprognostic (2.56e-3)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 5.0 0.0 0.0 5.8 0.1 0.0 0.1 0.1 1.9 0.1 0.1 0.1 23.7 305.4 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 33.7 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 2.2 0.5 1.1 0.2 0.5 0.4 0.0 0.4 0.2 0.2 0.5 0.6 0.0 0.7 0.2 0.2 0.0 0.1 0.2 0.3 0.7 0.2 0.2 0.4 0.0 0.0 0.2 0.3 0.1 0.1 0.5 0.8 0.0 1.3 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.7 0.0 0.1 0.5 1.1 0.3 0.3 0.6 2.2 0.2 0.1 0.7 0.4 0.6 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.7 0.2 0.9 0.3 1.4 0.2 1.1 0.2 0.1 0.3 0.1 0.2 1.0 0.2 0.2 0.0 2.2 0.4 0.4 1.1 0.5 0.1 0.5 0.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 GPAA1 "GAA1, hGAA1" ENSG00000197858 "Glycosylphosphatidylinositol anchor attachment 1" O43292 8 144082590-144086216 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 69.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077224 Approved "HPA077224: " "unprognostic (2.53e-3)" "unprognostic (1.39e-1)" "unprognostic (3.06e-2)" "unprognostic (2.57e-2)" "unprognostic (2.49e-2)" "unprognostic (4.05e-2)" "unprognostic (1.73e-3)" "unprognostic (2.64e-1)" "unprognostic (8.92e-2)" "unprognostic (1.67e-2)" "unprognostic (2.04e-3)" "unprognostic (4.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.03e-1)" "unprognostic (3.89e-1)" "unprognostic (1.27e-1)" "unprognostic (2.73e-2)" 25.2 35.3 23.0 15.9 25.5 32.1 20.0 19.9 43.7 23.6 24.4 27.1 32.3 28.2 26.3 38.3 23.2 24.0 31.1 35.0 20.3 17.4 29.3 47.2 24.9 31.4 19.9 19.0 23.8 46.6 36.4 17.1 32.9 25.1 23.1 10.7 27.4 46.0 35.4 28.5 23.3 31.0 16.3 22.3 21.9 23.0 24.6 16.1 24.0 29.0 22.2 18.6 19.3 18.6 17.2 41.0 21.7 33.3 24.7 34.5 26.1 16.2 28.7 6.7 21.0 15.6 13.3 23.3 16.6 16.6 14.0 14.6 11.9 26.9 8.8 24.3 18.0 20.2 4.4 16.5 2.0 14.9 15.1 13.9 13.4 8.7 15.1 6.8 20.9 14.6 15.5 14.3 10.0 11.5 10.1 31.4 13.4 57.1 13.1 6.3 6.7 69.8 9.2 8.5 42.2 12.1 11.4 11.6 16.0 21.8 28.1 12.2 18.0 19.2 7.6 13.0 22.6 7.3 18.6 17.5 13.5 5.9 23.0 8.4 17.7 11.8 24.8 21.7 34.5 29.9 23.7 15.5 17.4 27.1 23.1 17.2 17.3 24.1 5.8 24.7 33.3 41.0 15.0 26.1 23.0 25.5 19.9 43.7 20.3 17.4 19.9 19.0 25.1 16.1 GPR108 LUSTR2 ENSG00000125734 "G protein-coupled receptor 108" Q9NPR9 19 6729914-6737603 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041924, HPA041951, HPA063863" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA041924: AB_10804122, HPA041951: AB_10795385, HPA063863: " "unprognostic (2.00e-1)" "unprognostic (1.69e-1)" "unprognostic (1.07e-1)" "prognostic favourable (1.04e-7)" "unprognostic (1.58e-1)" "unprognostic (5.29e-2)" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (4.23e-2)" "unprognostic (3.01e-2)" "unprognostic (7.89e-2)" "unprognostic (3.57e-2)" "prognostic favourable (1.29e-9)" "unprognostic (8.68e-3)" "unprognostic (2.95e-2)" "unprognostic (4.96e-3)" "unprognostic (4.13e-3)" 17.6 29.7 15.4 13.8 17.9 14.2 20.1 15.2 23.1 22.2 24.3 24.3 27.0 20.4 20.6 20.8 25.1 26.1 23.5 14.0 14.6 12.3 35.4 33.9 19.6 17.1 20.5 12.9 22.6 41.5 30.9 15.1 27.1 17.2 24.0 17.7 31.3 35.4 27.4 10.6 19.1 29.2 16.9 15.7 20.9 20.6 26.3 19.4 17.2 38.8 14.7 23.1 21.4 19.8 14.8 25.8 54.3 36.3 23.1 26.7 35.5 11.5 12.6 7.8 15.2 30.6 16.6 8.8 9.0 27.4 12.5 13.4 7.7 13.3 5.5 16.8 18.4 9.9 8.8 18.8 6.5 22.1 10.1 8.9 13.3 10.2 30.1 5.7 12.2 18.0 36.0 12.1 24.5 14.7 8.9 36.9 12.6 8.0 10.0 8.3 5.6 11.2 8.2 8.9 20.8 26.1 11.4 0.0 8.5 9.1 14.9 13.8 14.3 13.9 12.1 7.2 4.6 22.8 9.5 23.9 12.9 3.8 24.7 18.4 7.7 20.4 35.8 35.7 26.7 32.7 24.3 14.8 21.4 22.5 25.8 14.1 15.5 17.7 54.3 23.1 36.3 9.2 23.4 35.5 15.4 17.9 15.2 23.1 14.6 12.3 20.5 12.9 17.2 19.4 GPR37L1 ETBR-LP-2 ENSG00000170075 "G protein-coupled receptor 37 like 1" O60883 1 202122858-202133592 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 44.0" "Group enriched" "Detected in some" 4 "HaCaT: 2.8;MCF7: 3.2;T-47d: 8.7" "Cancer enriched" "Detected in some" 57 "glioma: 36.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064454 Enhanced "HPA064454: " "unprognostic (2.12e-2)" "unprognostic (1.83e-1)" "unprognostic (2.96e-1)" "unprognostic (1.61e-3)" "unprognostic (4.52e-1)" "unprognostic (8.20e-2)" "unprognostic (2.26e-4)" "unprognostic (5.83e-2)" "unprognostic (3.46e-3)" "unprognostic (2.07e-1)" "unprognostic (1.83e-1)" "unprognostic (3.28e-2)" "unprognostic (4.86e-3)" "unprognostic (1.14e-1)" "unprognostic (4.58e-2)" "unprognostic (1.18e-3)" "unprognostic (3.49e-1)" 1.6 2.0 20.5 1.6 25.2 1.9 1.6 13.2 44.0 2.0 2.4 33.4 0.0 1.9 1.8 1.8 1.7 1.8 1.7 1.6 22.3 12.6 1.5 1.6 1.6 1.5 17.7 22.1 1.7 1.5 1.5 0.4 1.6 23.8 1.7 1.9 0.9 1.9 2.3 1.7 1.8 2.1 1.7 11.1 1.6 1.6 1.9 15.7 0.0 1.8 0.0 1.5 1.6 0.2 0.9 0.9 1.8 0.9 0.6 1.4 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.6 0.0 0.1 0.0 2.8 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.1 1.2 0.0 8.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.0 0.8 0.7 0.5 0.9 0.7 0.6 0.3 0.2 0.6 0.9 0.7 0.5 1.8 0.6 0.4 0.9 1.4 0.2 20.5 25.2 13.2 39.3 22.3 12.6 17.7 22.1 23.8 15.7 GPR89A UNQ192 ENSG00000117262 "G protein-coupled receptor 89A" B7ZAQ6 1 145607990-145670648 "Predicted membrane proteins" "Ion transport, Protein transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA076096 Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA076096: " "unprognostic (1.19e-1)" "unprognostic (6.71e-2)" "unprognostic (2.44e-1)" "unprognostic (1.29e-1)" "unprognostic (3.51e-3)" "unprognostic (4.51e-2)" "unprognostic (1.99e-3)" "unprognostic (8.14e-2)" "unprognostic (4.61e-3)" "unprognostic (5.41e-2)" "unprognostic (1.96e-1)" "unprognostic (3.00e-2)" "unprognostic (1.02e-5)" "unprognostic (1.42e-1)" "unprognostic (3.70e-2)" "unprognostic (5.47e-2)" "unprognostic (1.21e-1)" 4.0 9.3 4.3 3.8 5.4 2.2 9.2 4.6 6.9 6.2 4.7 7.0 7.5 5.4 9.0 4.5 4.1 4.7 5.9 5.9 5.2 5.1 17.5 15.3 4.8 9.6 4.9 4.0 4.2 13.6 5.9 4.2 3.5 3.9 5.5 7.5 4.9 9.0 9.9 7.6 3.3 7.0 6.1 4.7 2.9 8.7 6.7 4.0 3.3 6.6 6.5 7.0 5.2 8.8 6.2 5.5 6.3 5.1 7.6 8.3 2.8 10.2 6.8 8.3 3.7 19.3 17.5 8.1 9.7 10.7 13.7 17.5 14.3 8.9 3.1 5.3 13.2 9.0 8.9 9.7 12.6 7.5 6.1 3.8 7.7 7.8 10.9 11.9 3.0 18.4 13.6 11.6 12.9 8.4 11.0 14.7 21.9 13.2 4.9 6.2 10.9 11.0 5.4 9.8 18.2 9.3 5.9 2.6 7.6 9.0 20.3 7.3 15.2 9.3 4.9 13.0 3.3 7.8 10.3 5.9 12.7 8.5 9.4 7.4 9.7 6.3 4.2 4.0 7.1 4.7 8.3 6.2 5.2 7.2 5.5 3.0 5.2 6.1 0.3 7.6 5.1 5.4 6.1 2.8 4.3 5.4 4.6 6.9 5.2 5.1 4.9 4.0 3.9 4.0 GPRC5C RAIG-3 ENSG00000170412 "G protein-coupled receptor class C group 5 member C" Q9NQ84 17 74424851-74451653 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 76.2" "Cell line enhanced" "Detected in many" "Hep G2: 23.9;HMC-1: 42.1;RPTEC TERT1: 56.7;RT4: 26.2;T-47d: 31.9" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 31.1" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 10.2" "Group enriched" "Detected in many" 9 "dendritic cells: 10.2;monocytes: 4.7" "Region enriched" "Detected in many" 9 "cerebellum: 47.7" "Low region specificity" "Detected in all" HPA029776 Enhanced Uncertain "Nucleoplasm,Centriolar satellite,Cytosol" "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA029776: AB_10602324" "unprognostic (1.48e-1)" "unprognostic (3.35e-1)" "unprognostic (6.01e-2)" "unprognostic (2.37e-3)" "unprognostic (1.80e-2)" "unprognostic (1.09e-2)" "unprognostic (4.40e-2)" "unprognostic (1.57e-1)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (9.61e-3)" "unprognostic (1.05e-1)" "prognostic favourable (1.58e-5)" "unprognostic (7.58e-2)" "unprognostic (3.70e-2)" "unprognostic (2.75e-2)" "unprognostic (1.54e-3)" 4.3 4.1 5.2 2.2 5.3 0.0 7.7 31.1 5.7 19.7 15.4 4.4 17.0 10.0 5.8 9.9 5.3 12.5 17.6 7.7 5.3 2.6 43.8 46.1 11.5 2.8 4.8 4.9 12.3 76.2 12.0 3.4 4.5 6.1 15.1 6.2 18.0 16.8 11.7 25.4 9.2 15.2 3.9 4.6 5.1 44.7 4.4 4.1 1.9 42.2 10.2 3.5 12.6 8.0 0.7 10.2 0.1 4.7 0.0 0.1 0.3 4.6 16.6 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 21.4 0.0 13.2 0.1 14.7 2.2 0.3 0.0 0.0 2.7 0.0 1.2 23.9 4.9 0.0 42.1 0.4 7.6 0.0 0.0 0.0 1.2 0.3 0.0 5.2 0.1 4.5 2.7 19.4 0.0 0.0 1.0 56.7 26.2 8.0 0.7 0.8 1.8 0.0 31.9 1.2 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 2.0 0.6 0.1 0.0 1.7 0.1 0.0 3.4 0.0 0.7 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 4.7 10.2 0.0 0.3 5.2 5.3 31.1 5.7 5.3 2.6 4.8 4.9 6.1 4.1 HHAT "FLJ10724, GUP2, MART-2, MART2, rasp, sit, ski, Skn" ENSG00000054392 "Hedgehog acyltransferase" Q5VTY9 1 210328252-210676296 "Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 13.2;LHCN-M2: 11.0;RH-30: 12.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.1" "Group enriched" "Detected in many" 5 "B-cells: 3.0;dendritic cells: 7.1;T-cells: 2.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA016462 Approved Approved "Golgi apparatus" "Golgi apparatus" "HPA016462: " "unprognostic (1.26e-1)" "unprognostic (1.45e-1)" "unprognostic (1.86e-1)" "unprognostic (5.02e-3)" "unprognostic (8.89e-3)" "unprognostic (4.81e-2)" "unprognostic (3.32e-2)" "unprognostic (1.81e-1)" "unprognostic (1.83e-1)" "unprognostic (1.67e-3)" "unprognostic (1.43e-1)" "unprognostic (4.13e-3)" "prognostic favourable (8.47e-7)" "unprognostic (2.55e-1)" "unprognostic (1.74e-1)" "unprognostic (1.13e-1)" "unprognostic (5.67e-2)" 3.8 11.7 5.1 5.4 5.3 1.3 7.5 0.9 5.0 10.4 4.9 3.9 9.7 3.3 12.8 10.6 4.7 8.1 8.5 4.1 3.1 2.6 6.3 4.3 4.1 2.3 2.7 3.8 4.9 5.2 4.2 15.1 3.8 3.3 11.6 4.0 11.5 10.4 6.6 2.8 5.3 4.2 5.1 2.3 3.8 3.9 6.2 2.5 7.1 12.8 3.1 5.7 6.7 4.9 3.0 7.1 0.0 0.7 0.2 2.6 0.7 0.7 0.8 2.3 1.4 1.0 1.3 4.6 1.1 1.0 1.8 3.1 0.2 0.8 0.0 1.1 0.9 0.6 0.5 0.5 2.1 1.5 1.1 0.0 0.1 1.0 0.2 0.3 13.2 1.2 2.6 1.5 1.1 0.3 0.0 0.0 11.0 1.1 0.6 0.0 0.6 0.1 1.2 12.0 0.0 7.2 2.4 1.8 7.6 2.0 0.0 5.5 3.8 0.7 1.6 2.8 8.3 1.6 4.3 3.8 0.1 0.0 1.2 0.8 2.2 0.0 0.6 0.0 1.5 0.7 2.6 3.0 1.8 1.7 0.7 2.7 0.1 0.6 0.0 0.2 0.2 7.1 0.4 0.7 5.1 5.3 0.9 5.0 3.1 2.6 2.7 3.8 3.3 2.5 HMGCR ENSG00000113161 "3-hydroxy-3-methylglutaryl-CoA reductase" P04035 5 75336329-75362104 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008338, CAB016797" Approved "CAB016797: , HPA008338: AB_10960401" "unprognostic (5.07e-2)" "unprognostic (1.65e-2)" "unprognostic (3.65e-3)" "unprognostic (1.02e-2)" "unprognostic (1.65e-3)" "unprognostic (1.02e-1)" "unprognostic (1.45e-1)" "unprognostic (4.41e-2)" "unprognostic (5.45e-2)" "unprognostic (1.90e-2)" "unprognostic (1.41e-1)" "unprognostic (3.99e-2)" "prognostic favourable (9.42e-6)" "unprognostic (2.44e-1)" "unprognostic (2.55e-2)" "unprognostic (3.64e-3)" "unprognostic (4.37e-2)" 5.6 28.9 12.4 8.7 31.1 12.1 16.4 14.4 36.3 13.9 23.0 10.9 7.1 18.9 9.0 14.4 35.0 6.5 8.2 4.0 21.8 16.5 12.1 53.5 12.1 7.0 9.8 19.4 15.2 8.4 16.2 11.4 9.2 29.6 12.4 19.7 7.8 12.4 4.5 3.4 36.1 19.0 6.8 17.0 7.9 14.6 14.0 8.8 13.9 12.5 23.2 12.4 6.2 18.1 4.3 12.5 23.2 11.0 9.5 6.5 5.1 15.8 6.3 63.7 21.9 13.5 26.1 16.0 4.6 12.8 9.4 20.9 23.5 39.2 14.2 16.7 7.4 20.1 33.0 53.7 9.9 4.8 12.1 10.8 9.5 18.1 19.9 9.0 8.0 16.9 31.6 32.6 16.2 7.5 11.6 21.8 14.7 10.4 16.6 9.1 27.2 4.7 11.7 19.0 20.3 38.5 37.2 22.1 10.0 10.1 10.5 9.1 10.3 23.8 8.7 5.1 7.6 5.4 7.8 7.0 8.8 19.6 7.4 17.7 10.5 6.7 11.0 6.3 6.1 6.9 5.1 4.3 4.6 6.4 12.5 4.2 4.5 6.2 23.2 9.5 7.4 3.9 6.5 5.1 12.4 31.1 14.4 36.3 21.8 16.5 9.8 19.4 29.6 8.8 KCNT1 "KCa4.1, KIAA1422, SLACK, Slo2.2" ENSG00000107147 "Potassium sodium-activated channel subfamily T member 1" Q5JUK3 9 135702185-135795508 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.7;skeletal muscle: 19.5" "Cell line enhanced" "Detected in some" "RH-30: 2.0;RPMI-8226: 4.5;SCLC-21H: 6.8;SH-SY5Y: 1.4" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059880 Uncertain "HPA059880: " "unprognostic (1.50e-3)" "unprognostic (1.72e-2)" "unprognostic (2.07e-3)" "unprognostic (2.98e-13)" "unprognostic (9.26e-2)" "unprognostic (7.73e-2)" "unprognostic (9.60e-2)" "unprognostic (1.67e-1)" "unprognostic (1.15e-1)" "unprognostic (1.30e-3)" "unprognostic (9.89e-2)" "unprognostic (6.20e-2)" "unprognostic (4.89e-7)" "unprognostic (9.15e-2)" "unprognostic (2.70e-1)" "unprognostic (2.26e-1)" "unprognostic (1.66e-2)" 1.4 0.8 7.3 1.0 12.4 1.0 0.7 29.7 29.3 0.7 0.9 0.2 0.0 1.0 0.8 0.9 1.2 0.9 1.1 1.8 5.3 4.2 0.7 0.7 0.9 0.8 1.8 12.0 7.3 0.8 0.7 4.7 1.2 6.1 0.8 0.8 0.0 0.7 0.8 19.5 0.8 0.8 0.8 2.1 9.6 1.4 1.9 3.1 0.0 0.8 0.0 0.7 1.1 0.1 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 2.0 4.5 0.0 0.0 6.8 1.4 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 7.3 12.4 29.7 29.3 5.3 4.2 1.8 12.0 6.1 3.1 MBOAT4 "FKSG89, GOAT, OACT4" ENSG00000177669 "Membrane bound O-acyltransferase domain containing 4" Q96T53 8 30131824-30144686 "Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 23.9;stomach 1: 7.7" "Cell line enhanced" "Detected in some" "EFO-21: 2.2;Hep G2: 8.1" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA044509 Supported "Golgi apparatus" "Golgi apparatus" "HPA044509: " "unprognostic (4.35e-3)" "unprognostic (2.08e-1)" "unprognostic (2.55e-1)" "unprognostic (3.99e-1)" "unprognostic (1.03e-2)" "unprognostic (1.76e-2)" "unprognostic (1.85e-3)" "unprognostic (4.48e-2)" "unprognostic (2.56e-1)" "unprognostic (1.07e-1)" "unprognostic (6.30e-2)" "unprognostic (7.02e-2)" "unprognostic (4.24e-6)" "unprognostic (9.87e-3)" "unprognostic (1.58e-1)" "unprognostic (2.18e-1)" "unprognostic (3.66e-2)" 0.4 1.8 0.3 0.5 0.6 1.0 0.3 0.3 0.3 0.3 0.5 0.3 0.3 0.8 0.9 0.3 0.3 3.9 2.1 0.4 0.3 0.1 0.4 1.5 0.9 0.8 0.3 0.3 0.5 23.9 0.0 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.1 1.3 0.3 0.3 1.4 7.7 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.8 0.7 2.6 1.5 2.8 4.1 0.6 0.5 1.1 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.2 2.2 0.0 0.4 0.0 0.1 0.0 0.6 0.4 0.4 0.1 8.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.1 0.6 0.3 0.0 0.0 0.3 0.2 0.0 0.1 0.2 0.2 0.8 0.0 0.1 0.0 0.2 0.2 0.0 0.2 1.5 0.0 0.2 0.1 0.0 0.0 1.3 0.9 0.4 0.6 0.6 2.1 0.5 1.5 2.4 0.0 1.6 2.0 0.7 1.8 2.4 4.1 2.6 2.8 0.2 0.4 0.5 0.6 0.3 0.6 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 MFSD10 "IT10C3, TETRAN" ENSG00000109736 "Major facilitator superfamily domain containing 10" Q14728 4 2930561-2934859 "Predicted membrane proteins" "Apoptosis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 70.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043209 Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA043209: " "unprognostic (1.44e-1)" "unprognostic (2.26e-2)" "unprognostic (7.06e-2)" "unprognostic (2.11e-3)" "unprognostic (7.76e-2)" "unprognostic (9.43e-2)" "prognostic unfavourable (4.49e-4)" "unprognostic (6.82e-3)" "unprognostic (4.70e-3)" "unprognostic (3.21e-1)" "unprognostic (1.91e-2)" "unprognostic (5.42e-3)" "prognostic unfavourable (5.68e-5)" "unprognostic (8.32e-2)" "unprognostic (2.30e-1)" "unprognostic (8.03e-2)" "unprognostic (1.00e-2)" 21.6 9.1 10.3 15.2 10.7 62.9 34.4 20.2 13.0 17.1 18.1 8.9 17.5 13.8 16.0 17.1 18.0 16.3 23.5 13.5 9.6 10.1 15.7 6.0 16.8 17.6 9.1 10.1 20.6 20.9 4.2 13.3 13.5 8.4 22.0 5.2 7.1 27.1 14.5 10.3 10.0 19.0 10.9 7.7 16.3 18.7 11.1 7.4 8.3 29.9 15.0 14.9 15.2 16.7 18.4 22.2 42.5 33.1 16.1 33.2 15.0 12.7 12.0 3.4 8.8 5.9 4.2 9.6 11.7 5.8 5.7 6.6 6.3 30.7 2.2 6.2 7.3 11.9 3.1 17.0 1.6 14.3 10.8 4.8 10.3 6.6 9.9 15.2 7.0 6.4 10.0 6.5 4.1 6.5 6.6 4.7 4.3 13.7 4.3 70.3 11.4 14.5 5.3 1.7 10.5 8.6 7.8 9.1 10.9 2.8 8.2 12.3 21.6 28.9 9.6 4.6 8.1 5.8 9.3 3.1 1.4 3.4 13.4 38.9 7.3 21.0 21.4 42.5 29.9 26.4 25.3 18.4 19.3 33.2 22.2 14.8 9.9 17.3 16.8 16.1 33.1 17.4 12.6 15.0 10.3 10.7 20.2 13.0 9.6 10.1 9.1 10.1 8.4 7.4 MFSD8 "CLN7, MGC33302" ENSG00000164073 "Major facilitator superfamily domain containing 8" Q8NHS3 4 127917732-127966034 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044802 Approved Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA044802: AB_10963221" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (8.10e-2)" "unprognostic (1.57e-1)" "unprognostic (4.12e-2)" "unprognostic (1.18e-1)" "unprognostic (8.99e-2)" "unprognostic (2.19e-2)" "unprognostic (8.69e-2)" "unprognostic (4.51e-2)" "unprognostic (3.44e-2)" "unprognostic (3.93e-3)" "unprognostic (1.70e-1)" "unprognostic (5.61e-3)" "unprognostic (3.14e-1)" "prognostic favourable (2.21e-4)" 8.9 9.6 9.1 11.7 15.4 5.3 13.0 19.6 15.4 12.2 12.1 14.6 9.4 17.1 19.0 11.9 10.3 9.8 9.2 7.5 8.9 10.1 12.6 19.1 9.1 9.7 9.3 11.8 13.2 14.5 16.7 21.5 18.0 15.8 10.2 15.6 14.8 10.9 9.7 7.2 11.0 15.0 12.4 11.8 13.5 12.0 9.4 10.2 12.9 13.6 7.1 15.0 9.9 10.5 7.0 5.8 7.1 8.2 5.4 8.3 4.1 8.3 6.9 7.2 4.0 6.4 5.7 6.2 6.2 8.0 8.1 8.2 4.3 11.9 3.9 12.2 11.2 6.9 8.4 6.3 11.8 9.0 6.7 4.7 7.8 6.6 7.1 5.0 5.9 6.2 2.1 7.6 5.8 8.6 8.1 5.2 11.5 7.6 4.3 1.7 1.4 4.6 4.6 0.5 4.5 5.8 11.8 7.3 2.6 7.8 7.9 3.3 4.6 3.4 4.5 2.7 2.8 10.1 5.8 11.4 18.9 8.8 8.7 4.3 7.3 4.6 5.6 7.1 7.1 6.2 6.2 7.0 7.9 6.6 4.5 3.6 8.3 8.3 6.3 5.4 8.2 5.8 8.0 4.1 9.1 15.4 19.6 15.4 8.9 10.1 9.3 11.8 15.8 10.2 MYADM ENSG00000179820 "Myeloid associated differentiation marker" Q96S97 19 53866223-53876437 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 52.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056301 Approved "Nuclear speckles" 34000 "Nuclear speckles" "HPA056301: " "unprognostic (5.17e-2)" "unprognostic (1.41e-1)" "unprognostic (1.85e-1)" "unprognostic (2.94e-1)" "unprognostic (6.41e-2)" "unprognostic (1.01e-2)" "unprognostic (8.21e-3)" "prognostic unfavourable (8.15e-4)" "unprognostic (3.97e-2)" "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (4.11e-1)" "prognostic unfavourable (7.71e-7)" "unprognostic (2.28e-3)" "unprognostic (1.29e-1)" "unprognostic (2.37e-2)" "unprognostic (6.14e-3)" 58.2 9.5 9.2 26.4 13.9 53.5 39.2 7.4 17.1 67.9 58.9 18.8 25.1 15.8 105.6 33.0 44.6 66.1 40.8 39.9 9.3 11.7 13.0 15.6 42.4 22.3 8.2 11.4 51.7 31.8 8.7 8.9 46.5 13.3 41.9 13.4 22.2 21.1 45.4 13.2 19.5 26.8 76.8 9.6 22.6 37.6 28.7 9.4 20.3 20.5 32.6 15.3 81.6 30.5 2.0 14.3 52.2 11.6 4.1 5.4 3.9 6.4 54.2 6.9 5.6 23.7 16.4 11.1 34.5 24.8 13.7 14.0 22.3 20.1 0.6 12.3 43.9 13.3 3.5 13.1 11.9 8.1 8.1 8.8 9.0 17.0 54.3 18.2 32.0 17.8 3.1 17.5 2.5 12.3 9.3 16.7 8.7 7.7 4.8 14.2 6.6 15.5 19.1 7.5 3.2 15.4 0.7 0.1 10.8 0.3 10.8 3.4 10.6 15.6 25.1 30.9 11.1 4.1 15.5 10.8 6.7 0.1 18.9 8.8 0.5 14.1 11.6 38.3 5.4 6.7 5.1 1.4 3.5 3.9 14.3 2.0 3.4 2.8 52.2 4.1 5.4 5.5 1.3 3.9 9.2 13.9 7.4 17.1 9.3 11.7 8.2 11.4 13.3 9.4 MYADML2 LOC255275 ENSG00000185105 "Myeloid associated differentiation marker like 2" A6NDP7 17 81939645-81947233 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 20 "skeletal muscle: 44.5" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 8.2" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA041856, HPA048476" Uncertain "HPA041856: , HPA048476: " "unprognostic (1.83e-1)" "unprognostic (1.71e-2)" "unprognostic (7.07e-2)" "unprognostic (2.90e-4)" "unprognostic (2.19e-1)" "unprognostic (1.79e-2)" "unprognostic (1.62e-4)" "unprognostic (1.48e-1)" "unprognostic (1.32e-1)" "unprognostic (6.09e-2)" "unprognostic (1.44e-2)" "unprognostic (3.37e-2)" "unprognostic (4.16e-7)" "unprognostic (1.86e-1)" "unprognostic (1.91e-1)" "unprognostic (8.68e-2)" 0.0 0.0 0.7 0.0 2.0 0.0 0.0 0.4 2.2 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 1.5 0.6 1.5 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 44.5 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.3 1.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.6 0.0 0.1 0.6 0.5 0.0 0.4 0.1 0.0 0.2 8.2 0.6 0.2 0.2 0.6 0.2 0.0 0.0 0.3 0.7 0.2 0.0 1.5 1.1 0.3 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NIPA2 SLC57A2 ENSG00000140157 "Non imprinted in Prader-Willi/Angelman syndrome 2" Q8N8Q9 15 22838641-22868384 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067160, HPA071342" Approved Approved "Golgi apparatus" "Golgi apparatus" "HPA067160: , HPA071342: " "unprognostic (2.88e-3)" "unprognostic (1.82e-1)" "unprognostic (9.34e-3)" "unprognostic (1.17e-1)" "unprognostic (4.49e-1)" "unprognostic (2.34e-1)" "unprognostic (3.02e-2)" "unprognostic (1.22e-2)" "unprognostic (2.80e-1)" "unprognostic (1.38e-1)" "unprognostic (2.46e-3)" "unprognostic (2.94e-1)" "unprognostic (7.75e-3)" "unprognostic (3.53e-2)" "unprognostic (1.59e-1)" "unprognostic (3.22e-2)" "unprognostic (2.93e-2)" 19.3 26.9 18.6 26.1 22.2 22.1 19.9 17.7 28.2 16.8 30.0 16.6 23.9 28.4 21.7 18.3 26.5 16.1 21.3 17.4 16.7 21.3 26.3 27.8 22.5 35.0 17.9 13.8 19.0 30.8 21.1 24.7 31.3 18.5 20.6 30.1 20.0 26.9 14.0 18.8 16.4 37.1 18.2 13.5 43.9 21.4 19.5 13.1 27.9 21.1 19.2 31.5 22.2 17.2 38.1 40.3 27.2 26.5 22.1 24.6 21.5 29.8 30.5 15.6 18.4 15.0 17.1 17.7 33.5 29.7 23.1 27.0 22.5 19.0 29.5 21.4 19.3 24.0 28.7 16.9 23.5 31.3 18.6 26.4 20.4 18.2 22.4 37.4 25.1 16.8 19.1 19.0 19.8 26.9 39.5 35.4 29.5 11.8 11.9 17.5 18.3 28.2 25.9 26.6 22.4 22.1 36.7 21.0 22.2 25.6 25.4 28.2 23.1 35.2 27.9 30.5 19.9 22.1 67.9 28.1 40.7 31.9 23.3 37.9 26.2 27.2 21.4 18.0 21.4 26.5 24.4 38.1 19.3 23.5 26.2 32.7 18.4 18.7 15.8 22.1 24.9 40.3 24.6 21.5 18.6 22.2 17.7 28.2 16.7 21.3 17.9 13.8 18.5 13.1 NIPAL4 ICHYN ENSG00000172548 "NIPA like domain containing 4" Q0D2K0 5 157460019-157474717 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" Receptor "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;skin 1: 38.1" "Group enriched" "Detected in some" 11 "hTCEpi: 13.8;RT4: 45.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 33 "memory B-cell: 2.6;naive B-cell: 8.7" "Lineage enriched" "Detected in single" 51 "B-cells: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038259 Approved "HPA038259: AB_10672510" "unprognostic (6.74e-4)" "unprognostic (9.54e-2)" "unprognostic (2.63e-2)" "unprognostic (1.49e-1)" "unprognostic (2.61e-1)" "unprognostic (6.56e-2)" "unprognostic (3.55e-2)" "unprognostic (5.20e-2)" "unprognostic (2.53e-1)" "unprognostic (2.99e-2)" "unprognostic (1.92e-1)" "unprognostic (1.76e-2)" "unprognostic (5.28e-9)" "unprognostic (3.12e-2)" "unprognostic (8.66e-3)" "unprognostic (1.18e-2)" "prognostic favourable (6.82e-4)" 0.6 0.5 1.5 2.5 7.1 3.3 3.0 0.4 7.7 3.6 2.1 25.9 0.0 0.8 1.7 0.6 10.6 0.5 1.0 1.0 3.1 1.7 0.5 0.5 0.5 0.9 8.0 2.5 0.5 0.5 0.5 0.4 1.1 10.9 2.6 1.1 0.0 1.2 1.9 0.6 38.1 0.7 5.8 11.9 0.7 1.9 0.6 6.9 0.0 0.8 15.8 6.0 10.7 7.7 8.7 0.0 0.1 0.0 0.0 0.1 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.2 2.7 0.1 1.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 13.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 45.8 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.1 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 7.1 0.4 7.7 3.1 1.7 8.0 2.5 10.9 6.9 OR1S1 OST034 ENSG00000280204 "Olfactory receptor family 1 subfamily S member 1 (gene/pseudogene)" Q8NH92 11 58212720-58216084 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049304 Uncertain "HPA049304: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T1 OR1-25 ENSG00000175143 "Olfactory receptor family 2 subfamily T member 1" O43869 1 248403048-248408020 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA063064 Uncertain "HPA063064: " 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C5 "OR4C5P, OR4C5Q" ENSG00000176540 "Olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)" Q8NGB2 11 48365485-48366465 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "NTERA-2: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049516 Uncertain "HPA049516: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAQR5 "FLJ20190, MPRG" ENSG00000137819 "Progestin and adipoQ receptor family member 5" Q9NXK6 15 69298947-69407780 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 41.4" "Cell line enhanced" "Detected in many" "A549: 17.1;CAPAN-2: 20.6;fHDF/TERT166: 14.6;HMC-1: 36.2;U-87 MG: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA076729 Approved Vesicles Vesicles "HPA076729: " "unprognostic (4.47e-2)" "unprognostic (3.11e-2)" "unprognostic (1.46e-1)" "unprognostic (4.05e-4)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (3.58e-3)" "unprognostic (6.12e-3)" "unprognostic (1.47e-1)" "unprognostic (1.67e-1)" "prognostic unfavourable (2.15e-5)" "unprognostic (2.00e-1)" "prognostic favourable (1.47e-14)" "unprognostic (5.64e-2)" "unprognostic (1.73e-1)" "unprognostic (4.16e-4)" "unprognostic (4.94e-2)" 1.8 15.4 1.9 4.1 2.6 0.7 1.2 1.5 3.1 1.6 12.3 3.0 1.7 1.5 1.1 1.6 9.0 1.0 1.7 1.9 1.8 1.5 41.4 1.0 10.4 0.3 2.0 1.0 0.5 4.8 5.8 0.9 1.0 3.5 1.1 10.8 3.6 1.8 4.2 0.4 3.2 5.2 3.2 3.8 0.2 4.5 1.5 2.2 0.0 0.6 5.7 4.9 2.3 2.6 0.2 0.2 3.5 0.3 0.4 0.7 0.0 5.0 17.1 0.3 0.3 0.7 1.9 0.1 1.6 9.9 1.9 4.2 0.9 20.6 0.0 2.7 14.6 0.3 4.9 0.2 3.4 0.0 0.7 3.0 2.6 0.3 1.3 0.1 36.2 1.0 0.7 8.8 9.5 0.0 0.0 0.2 8.2 0.6 0.0 0.1 1.1 1.5 0.0 0.2 0.9 7.6 0.4 1.5 0.3 2.7 1.0 1.4 0.4 1.2 0.2 5.9 1.9 0.4 0.2 0.1 0.1 0.0 15.1 0.0 1.6 3.5 0.3 0.1 0.3 0.1 0.2 0.1 0.2 0.2 0.1 0.2 0.3 0.7 1.3 0.4 0.2 0.2 0.1 0.0 1.9 2.6 1.5 3.1 1.8 1.5 2.0 1.0 3.5 2.2 PAQR6 "FLJ22672, PRdelta" ENSG00000160781 "Progestin and adipoQ receptor family member 6" Q6TCH4 1 156243321-156248117 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 138.1" "Cell line enhanced" "Detected in many" "U-266/70: 20.7" "Cancer enriched" "Detected in all" 6 "glioma: 34.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "NK-cell: 10.5" "Lineage enriched" "Detected in many" 6 "NK-cells: 10.5" HPA073505 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA073505: " "unprognostic (1.64e-1)" "unprognostic (2.27e-1)" "prognostic unfavourable (1.60e-5)" "unprognostic (7.42e-2)" "unprognostic (5.52e-2)" "unprognostic (4.50e-3)" "unprognostic (4.75e-1)" "unprognostic (2.25e-1)" "unprognostic (2.57e-1)" "unprognostic (3.13e-1)" "unprognostic (4.25e-3)" "prognostic unfavourable (1.99e-4)" "prognostic unfavourable (1.58e-8)" "unprognostic (1.26e-2)" "unprognostic (1.34e-1)" "unprognostic (8.82e-2)" "prognostic favourable (1.86e-4)" 2.1 3.6 42.5 2.2 38.0 7.6 2.2 8.7 71.6 2.0 2.7 102.9 0.0 2.8 2.3 2.9 2.5 2.2 2.9 2.0 48.1 37.6 2.0 2.1 2.1 2.1 82.7 16.1 1.6 1.6 2.4 1.2 2.2 72.5 3.5 2.3 0.0 3.2 3.0 2.1 11.5 3.0 2.0 138.1 2.3 3.1 2.5 46.0 0.0 2.0 0.0 2.0 2.5 0.3 0.8 1.6 0.0 0.0 10.5 1.2 0.1 1.7 2.0 3.3 3.4 0.6 0.5 8.1 0.2 0.5 0.0 0.2 0.9 6.3 3.2 1.5 0.5 5.7 0.0 0.7 0.4 1.9 2.7 2.0 1.7 0.9 0.3 0.6 5.3 1.6 2.6 2.4 2.4 0.2 1.5 9.4 0.5 6.7 0.2 1.0 3.7 0.9 1.4 0.7 1.5 2.3 10.6 2.8 5.7 0.7 0.7 3.8 10.7 1.1 0.5 1.0 5.3 1.7 0.5 20.7 4.5 2.0 0.2 7.4 0.9 0.0 0.0 0.0 0.4 0.0 1.2 0.8 0.6 0.2 0.0 0.1 0.0 0.0 0.0 10.5 0.0 1.6 0.1 0.1 42.5 38.0 8.7 34.4 48.1 37.6 82.7 16.1 72.5 46.0 PAQR7 "MPRA, mSR" ENSG00000182749 "Progestin and adipoQ receptor family member 7" Q86WK9 1 25861210-25871253 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 29.7;HaCaT: 24.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046936 Approved Approved Cytosol Cytosol "HPA046936: " "unprognostic (1.12e-1)" "unprognostic (2.08e-2)" "unprognostic (8.03e-2)" "unprognostic (4.54e-3)" "unprognostic (1.32e-1)" "unprognostic (3.41e-1)" "prognostic unfavourable (1.14e-4)" "unprognostic (1.47e-1)" "unprognostic (4.59e-3)" "unprognostic (7.79e-2)" "unprognostic (1.29e-1)" "unprognostic (1.31e-1)" "prognostic favourable (1.05e-5)" "unprognostic (1.60e-2)" "unprognostic (2.98e-2)" "unprognostic (1.15e-2)" "unprognostic (1.54e-2)" 1.2 9.5 1.8 0.7 2.3 1.0 1.4 1.8 1.8 2.8 1.6 6.7 4.1 10.2 6.1 6.8 2.1 0.6 1.7 2.6 11.9 1.9 1.6 0.6 2.0 13.2 1.8 3.9 2.1 6.9 2.4 0.4 1.5 8.9 0.2 10.7 5.7 2.9 1.4 3.5 2.3 16.2 1.4 1.0 6.3 4.6 3.2 5.5 10.8 11.7 2.4 1.4 0.8 11.5 2.3 2.3 7.6 2.8 6.1 8.2 7.6 6.8 7.6 6.9 3.8 29.7 0.1 5.4 7.5 24.4 1.2 12.8 4.6 4.5 1.3 9.8 3.2 4.6 4.8 0.1 1.2 6.1 17.2 5.4 4.1 2.9 1.0 0.8 5.6 2.7 0.0 0.7 3.6 3.9 0.8 0.2 1.4 15.5 8.9 1.2 4.6 12.4 16.2 5.6 4.6 1.7 3.1 1.2 3.9 4.1 2.0 0.1 0.1 0.5 5.8 0.3 2.6 3.1 5.7 10.8 1.1 10.2 1.1 3.2 0.6 0.8 5.5 1.2 1.0 1.4 2.6 2.4 11.7 0.6 0.2 0.8 PAQR8 "C6orf33, LMPB1, MPRB" ENSG00000170915 "Progestin and adipoQ receptor family member 8" Q8TEZ7 6 52361421-52407777 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 69.2" "Cell line enhanced" "Detected in many" "Hep G2: 26.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064625 Supported "Golgi apparatus,Plasma membrane" "Plasma membrane" "Golgi apparatus" "HPA064625: " "prognostic favourable (4.61e-4)" "unprognostic (7.39e-3)" "unprognostic (2.77e-3)" "unprognostic (8.23e-2)" "unprognostic (4.33e-1)" "unprognostic (4.08e-3)" "unprognostic (2.66e-2)" "unprognostic (5.67e-2)" "unprognostic (6.37e-2)" "unprognostic (4.30e-3)" "unprognostic (2.10e-1)" "unprognostic (5.55e-2)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (2.12e-1)" "unprognostic (3.14e-2)" "prognostic favourable (6.40e-4)" 2.4 3.5 25.6 6.6 32.4 1.3 2.2 14.9 31.0 4.2 28.9 35.5 14.2 14.5 4.4 6.7 13.7 5.4 4.9 2.9 27.3 17.5 5.3 1.5 5.8 7.2 48.5 15.8 19.5 2.5 3.7 1.8 5.5 28.2 3.8 28.1 1.9 1.9 28.5 1.1 2.7 25.1 5.2 69.2 4.8 24.1 3.1 36.5 3.1 2.6 0.4 6.0 7.3 3.3 1.0 6.0 2.0 2.6 7.0 16.3 3.2 0.6 0.6 7.0 3.0 4.3 7.0 4.8 2.1 7.9 1.3 2.9 2.6 2.4 0.7 0.8 1.4 0.3 0.9 3.4 2.1 9.4 1.2 4.2 0.6 26.5 1.2 1.1 0.6 1.9 0.4 0.9 5.0 7.5 0.9 4.2 5.4 0.9 2.7 3.8 3.6 0.3 7.3 1.1 1.7 8.2 2.0 2.7 5.7 0.5 0.2 8.0 0.2 9.4 3.1 2.7 1.1 0.8 1.2 1.2 1.6 1.0 2.5 10.9 14.0 2.0 2.6 1.3 2.5 0.5 3.8 0.9 7.6 5.2 6.0 1.0 16.3 7.6 0.5 7.0 0.5 3.0 4.7 3.2 25.6 32.4 14.9 22.8 27.3 17.5 48.5 15.8 28.2 36.5 PAQR9 FLJ41938 ENSG00000188582 "Progestin and adipoQ receptor family member 9" Q6ZVX9 3 142949164-142963682 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.1;heart muscle: 12.1;liver: 18.6;testis: 20.8" "Cell line enhanced" "Detected in some" "A549: 5.3;AF22: 3.3;HEL: 3.6;NTERA-2: 4.0;U-266/70: 9.9;U-266/84: 5.4" "Cancer enriched" "Detected in single" 15 "liver cancer: 5.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052798 Uncertain "HPA052798: " "unprognostic (4.13e-2)" "unprognostic (2.54e-1)" "unprognostic (2.81e-1)" "unprognostic (3.09e-2)" "unprognostic (1.21e-2)" "unprognostic (5.98e-2)" "unprognostic (1.12e-1)" "unprognostic (3.56e-2)" "unprognostic (1.23e-2)" "unprognostic (1.09e-1)" "unprognostic (6.91e-2)" 0.4 0.6 2.5 0.3 7.0 7.0 0.3 0.5 10.1 0.3 0.3 0.6 0.0 0.3 0.3 0.3 0.3 0.3 0.4 12.1 3.3 1.7 0.3 18.6 0.3 0.3 0.7 3.1 0.3 0.5 0.3 1.4 0.8 6.0 0.4 0.3 2.7 0.3 0.3 5.9 0.3 0.3 0.3 1.0 0.3 0.3 20.8 0.3 0.0 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.1 0.0 0.3 3.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 4.0 0.5 0.0 0.0 0.0 0.0 0.0 1.6 0.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.7 0.4 9.9 5.4 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 7.0 0.5 10.1 3.3 1.7 0.7 3.1 6.0 0.3 PCNX2 "FLJ11383, KIAA0435, PCNXL2" ENSG00000135749 "Pecanex homolog 2" A6NKB5 1 232983435-233295713 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 29.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013815, HPA014427" Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA013815: AB_2236561, HPA014427: AB_1855081" "unprognostic (3.15e-1)" "unprognostic (5.61e-3)" "unprognostic (1.92e-2)" "unprognostic (1.44e-2)" "unprognostic (2.54e-1)" "unprognostic (1.31e-1)" "unprognostic (1.58e-2)" "unprognostic (1.71e-1)" "unprognostic (4.25e-2)" "unprognostic (3.79e-1)" "unprognostic (2.40e-2)" "unprognostic (1.04e-1)" "prognostic unfavourable (2.27e-5)" "unprognostic (1.12e-1)" "unprognostic (2.92e-2)" "unprognostic (1.49e-2)" "unprognostic (1.29e-1)" 4.7 4.7 11.4 7.5 16.8 4.2 7.7 29.6 23.1 4.9 3.9 6.3 4.2 3.4 6.6 14.0 5.2 9.0 8.1 2.3 11.9 8.2 5.4 1.2 4.7 9.4 8.0 13.1 11.4 5.2 8.6 18.6 2.4 14.3 6.2 4.8 6.0 6.0 8.1 5.6 6.3 5.6 5.2 5.8 5.3 5.8 5.5 5.5 4.0 7.9 3.4 8.8 6.0 5.7 1.5 1.8 0.9 0.9 0.8 3.1 1.1 3.8 9.2 5.1 0.1 8.3 9.0 1.5 2.3 6.7 2.4 4.2 3.0 4.6 8.0 5.4 6.2 6.3 2.2 6.6 5.7 6.7 6.8 0.1 4.7 0.0 3.7 2.6 1.6 6.9 5.8 4.7 18.9 4.5 0.0 4.3 2.3 2.3 7.3 0.2 16.3 5.6 0.1 1.3 1.1 4.3 5.9 8.7 7.2 3.4 1.4 1.4 3.4 0.7 1.7 6.7 4.3 7.6 7.5 5.2 5.3 0.1 6.1 2.9 7.7 0.9 0.9 0.4 3.1 0.5 2.4 1.5 2.5 2.9 1.8 1.3 1.1 2.1 0.7 0.8 0.7 0.6 2.7 1.1 11.4 16.8 29.6 23.1 11.9 8.2 8.0 13.1 14.3 5.5 PHTF1 PHTF ENSG00000116793 "Putative homeodomain transcription factor 1" Q9UMS5 1 113696831-113759489 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059486 Approved "Nucleoli,Nuclear bodies" "Nuclear bodies" Nucleoli "HPA059486: " "unprognostic (1.52e-1)" "unprognostic (3.33e-1)" "unprognostic (2.58e-2)" "unprognostic (4.54e-2)" "unprognostic (5.92e-2)" "unprognostic (1.62e-2)" "unprognostic (6.55e-2)" "unprognostic (1.30e-1)" "unprognostic (3.30e-3)" "unprognostic (1.70e-3)" "unprognostic (1.93e-1)" "unprognostic (2.16e-1)" "prognostic unfavourable (1.21e-6)" "unprognostic (1.26e-1)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.25e-1)" 6.5 10.4 11.5 7.9 8.6 19.5 11.8 31.6 15.1 7.1 5.4 4.0 7.6 4.5 6.6 9.6 3.4 13.1 8.8 8.2 10.1 12.4 8.9 10.1 10.8 11.9 8.2 12.9 4.0 8.2 15.3 20.9 8.5 10.4 5.8 6.5 8.2 5.2 6.9 5.5 2.4 4.9 8.4 6.4 10.5 8.0 33.8 6.6 3.4 6.1 2.4 7.7 8.1 6.3 3.0 4.5 6.0 2.6 4.3 5.7 1.7 12.7 6.7 19.1 10.1 9.5 8.6 5.0 11.8 15.7 10.6 17.4 7.3 10.4 3.7 16.8 8.1 7.1 7.2 4.7 12.2 15.2 7.2 8.9 14.1 8.4 7.9 10.9 12.6 7.2 1.3 14.1 3.1 19.5 5.3 17.0 12.8 19.0 0.1 11.0 15.1 10.9 11.5 28.7 7.3 17.0 5.6 13.4 12.4 13.2 6.5 7.0 2.6 8.8 20.5 8.3 11.5 15.3 11.4 23.8 24.2 6.9 20.5 9.5 22.6 3.0 2.6 4.9 3.0 1.3 2.3 3.0 3.7 3.7 4.5 1.6 0.1 2.6 6.0 4.3 1.7 3.0 5.7 1.7 11.5 8.6 31.6 15.1 10.1 12.4 8.2 12.9 10.4 6.6 PHTF2 DKFZp434D166 ENSG00000006576 "Putative homeodomain transcription factor 2" Q8N3S3 7 77798792-77957503 "Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 67.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "non-classical monocyte: 18.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012312 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA012312: " "unprognostic (1.96e-1)" "unprognostic (2.60e-3)" "unprognostic (4.04e-1)" "unprognostic (1.44e-1)" "unprognostic (5.70e-2)" "unprognostic (1.99e-3)" "unprognostic (5.36e-3)" "unprognostic (2.81e-2)" "unprognostic (1.63e-2)" "unprognostic (1.41e-2)" "unprognostic (3.86e-2)" "unprognostic (2.82e-1)" "prognostic unfavourable (3.09e-7)" "unprognostic (8.28e-3)" "unprognostic (2.28e-1)" "prognostic unfavourable (2.78e-4)" "unprognostic (5.53e-2)" 7.5 4.5 5.6 15.1 8.6 7.7 5.9 8.7 10.3 7.0 5.9 8.9 5.3 3.2 7.3 4.6 6.4 5.7 7.8 9.1 7.0 5.2 5.4 4.7 6.8 13.7 7.0 6.3 7.4 4.7 27.7 8.2 11.4 9.3 5.9 5.1 4.7 5.7 6.9 67.0 5.5 7.8 8.5 8.2 12.1 4.7 9.1 5.8 9.2 5.7 18.2 15.5 7.9 6.3 6.7 2.1 9.2 18.2 3.8 6.2 2.0 15.0 6.9 9.5 19.3 8.3 9.2 7.9 26.7 24.5 16.0 18.2 11.8 12.3 13.6 2.2 20.6 12.5 13.5 6.9 22.8 9.1 10.8 5.5 7.6 3.4 9.0 7.3 15.3 5.4 6.6 9.3 14.1 5.7 9.0 24.1 17.0 9.5 6.0 4.8 8.6 8.2 6.0 19.3 11.0 4.4 20.4 9.2 12.8 14.9 17.0 9.7 18.0 5.7 5.6 27.6 14.9 15.4 15.6 11.4 13.3 16.9 8.7 11.8 23.7 9.2 2.1 3.4 1.5 9.2 3.0 6.7 4.7 1.4 2.1 4.2 1.4 1.5 1.2 3.8 18.2 1.0 6.2 2.0 5.6 8.6 8.7 10.3 7.0 5.2 7.0 6.3 9.3 5.8 PIGQ "GPI1, hGPI1" ENSG00000007541 "Phosphatidylinositol glycan anchor biosynthesis class Q" Q9BRB3 16 566995-584136 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039105, HPA039828, HPA061414" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA039105: AB_10796221, HPA039828: AB_10795158, HPA061414: " "unprognostic (1.23e-2)" "unprognostic (6.12e-3)" "unprognostic (2.81e-1)" "unprognostic (2.65e-2)" "unprognostic (1.09e-2)" "unprognostic (2.42e-1)" "unprognostic (9.58e-2)" "unprognostic (8.05e-2)" "unprognostic (2.12e-1)" "unprognostic (2.02e-1)" "unprognostic (3.02e-2)" "unprognostic (8.98e-2)" "prognostic favourable (2.53e-6)" "unprognostic (2.73e-1)" "unprognostic (2.60e-1)" "unprognostic (2.55e-1)" "unprognostic (2.80e-2)" 13.9 15.7 12.8 8.7 13.9 48.4 8.4 12.8 20.6 8.4 9.7 11.4 16.7 15.4 10.9 23.3 7.2 10.0 13.6 7.4 10.5 11.1 18.9 12.5 13.0 6.2 9.1 13.2 10.4 29.3 18.1 15.3 8.4 9.4 11.2 4.1 15.4 15.5 17.6 12.4 12.8 8.1 5.5 7.2 10.3 13.6 15.3 8.2 11.8 18.4 4.2 7.9 9.8 6.7 5.6 10.5 5.9 6.0 5.5 5.3 3.9 8.5 12.9 4.6 6.4 3.0 1.8 8.7 9.0 3.5 3.9 4.2 9.0 8.0 4.5 11.8 2.0 13.7 2.1 4.0 0.8 13.0 18.9 6.9 14.0 6.4 5.8 6.0 6.5 3.2 6.0 6.5 1.3 3.6 15.4 2.6 1.3 11.1 11.1 6.9 6.2 13.3 21.5 3.8 10.4 3.5 3.4 8.3 13.2 10.2 4.7 6.5 10.7 4.1 8.7 6.6 8.4 7.4 6.2 9.9 2.9 3.6 2.2 3.2 6.4 1.2 4.8 3.0 5.3 5.6 4.6 4.4 4.6 5.1 4.9 5.6 5.1 3.1 5.9 5.5 6.0 10.5 4.2 3.9 12.8 13.9 12.8 20.6 10.5 11.1 9.1 13.2 9.4 8.2 PORCN "DHOF, MG61, por, PORC, PPN" ENSG00000102312 "Porcupine O-acyltransferase" Q9H237 X 48508962-48520814 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 59.9;LHCN-M2: 20.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049215, HPA058413" Enhanced Approved Vesicles Vesicles "HPA049215: , HPA058413: " "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (4.01e-2)" "unprognostic (2.19e-1)" "unprognostic (1.98e-1)" "unprognostic (1.26e-3)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "unprognostic (2.09e-2)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" "unprognostic (2.35e-1)" 4.6 31.4 9.1 4.4 14.1 3.6 4.4 20.0 15.4 12.6 4.6 7.2 12.2 3.4 10.1 3.2 13.9 7.0 6.2 13.4 10.9 9.2 3.3 1.7 5.0 6.6 7.1 8.8 4.9 4.6 6.9 4.1 4.0 8.4 5.0 2.5 7.6 5.8 16.4 5.9 6.8 2.9 6.3 5.5 4.8 5.4 5.4 5.9 2.6 8.5 4.7 5.9 6.5 5.4 4.1 7.2 13.7 5.8 7.8 12.0 4.7 4.3 5.2 1.3 9.1 5.6 3.3 0.5 1.2 2.6 2.0 1.3 0.6 6.7 0.3 5.5 2.8 5.9 1.8 59.9 0.6 2.7 0.6 0.7 3.2 1.2 8.3 0.7 7.8 4.3 7.1 5.8 12.6 1.8 0.3 4.1 20.8 1.2 0.6 0.9 1.6 3.5 1.3 1.6 6.7 3.3 1.7 1.5 2.2 10.4 2.0 2.0 2.3 0.3 1.0 5.2 2.7 12.5 2.2 3.6 2.0 0.5 15.0 1.6 2.9 13.7 5.8 7.1 12.0 5.2 9.4 3.7 8.0 10.0 7.2 4.1 5.4 8.1 1.2 7.8 4.2 3.9 5.2 4.7 9.1 14.1 20.0 14.4 10.9 9.2 7.1 8.8 8.4 5.9 PSEN1 "AD3, FAD, PS1, S182" ENSG00000080815 "Presenilin 1" P49768 14 73136418-73223691 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006844, HPA030760, HPA067496" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" "Golgi apparatus" "Nucleoplasm, Cell Junctions" "CAB006844: , HPA030760: AB_10696211, HPA067496: " "unprognostic (1.67e-1)" "unprognostic (4.79e-2)" "unprognostic (7.39e-2)" "unprognostic (8.68e-3)" "unprognostic (3.84e-1)" "unprognostic (5.48e-3)" "prognostic unfavourable (1.99e-5)" "unprognostic (1.65e-1)" "unprognostic (8.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "prognostic favourable (1.52e-8)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.12e-3)" "unprognostic (1.85e-1)" 16.3 15.3 21.0 13.4 34.9 19.2 15.7 15.5 24.7 16.5 26.2 66.1 9.5 26.6 14.2 15.4 19.0 12.6 17.1 9.9 28.6 18.2 19.7 16.9 16.9 10.8 42.1 20.7 13.5 15.0 21.8 9.2 22.7 31.8 13.6 25.6 15.0 16.8 13.4 13.0 24.7 27.9 14.6 61.9 14.6 16.3 16.8 39.7 15.4 19.7 8.7 15.9 17.2 13.5 9.0 24.4 38.1 34.0 11.7 10.5 17.1 14.2 21.9 20.5 8.1 28.7 20.5 18.7 21.0 24.1 21.5 27.2 27.2 35.7 9.3 13.9 19.9 38.0 17.2 15.9 23.6 21.2 10.7 10.6 14.9 13.2 26.5 10.7 20.8 21.0 28.9 17.8 22.0 17.2 11.8 19.0 20.1 28.3 8.1 13.9 8.9 16.3 10.3 17.4 11.8 30.0 30.3 11.4 15.2 22.9 21.5 18.7 26.6 23.9 18.2 21.9 18.1 17.9 9.9 12.4 18.2 9.4 18.4 13.0 13.3 29.2 27.1 27.1 7.2 30.8 7.0 7.2 7.0 5.9 24.4 9.0 6.6 6.4 38.1 11.7 34.0 12.8 10.5 17.1 21.0 34.9 15.5 24.7 28.6 18.2 42.1 20.7 31.8 39.7 PSEN2 "AD3L, AD4, PS2, STM2" ENSG00000143801 "Presenilin 2" P49810 1 226870184-226896105 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cardiomyopathy, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013634, HPA038005" Supported Nucleoplasm Nucleoplasm "CAB013634: , HPA038005: " "unprognostic (3.40e-2)" "unprognostic (4.73e-3)" "unprognostic (2.94e-1)" "unprognostic (3.86e-2)" "unprognostic (6.54e-2)" "unprognostic (1.64e-3)" "unprognostic (4.72e-2)" "unprognostic (1.31e-1)" "unprognostic (9.98e-2)" "unprognostic (2.73e-2)" "unprognostic (8.25e-3)" "unprognostic (8.53e-3)" "unprognostic (8.45e-2)" "unprognostic (1.17e-1)" "unprognostic (8.36e-2)" "unprognostic (1.68e-1)" "unprognostic (1.06e-1)" 8.9 13.2 9.5 5.9 7.9 1.2 8.1 16.6 10.7 9.2 9.2 5.9 7.3 9.4 16.4 9.0 9.4 8.7 12.0 9.7 6.5 10.8 7.8 7.7 9.0 11.6 8.1 9.3 13.1 31.6 14.0 15.2 7.6 14.8 12.8 6.9 15.9 9.6 13.4 22.1 6.8 12.2 17.0 4.9 10.6 7.1 21.8 5.3 1.4 6.0 7.2 7.0 9.0 7.2 5.1 7.7 19.4 18.7 12.3 3.4 3.1 8.9 13.4 4.0 12.4 5.5 1.8 6.7 7.6 14.9 9.5 7.3 10.5 11.5 0.1 10.3 9.7 4.6 7.1 7.2 3.9 9.6 12.9 6.1 9.5 6.8 9.2 4.7 10.0 5.3 8.1 11.4 6.2 4.4 10.4 4.1 5.5 7.5 0.1 5.4 12.3 11.1 0.1 14.7 14.4 8.4 7.6 7.0 11.7 6.1 16.9 30.2 14.5 6.0 4.8 6.8 5.7 6.2 9.5 16.4 24.1 0.4 12.0 1.5 8.9 19.4 5.7 12.1 3.2 6.5 3.4 5.1 1.1 2.9 7.7 2.6 0.6 1.7 1.2 12.3 18.7 0.6 1.4 3.1 9.5 7.9 16.6 10.7 6.5 10.8 8.1 9.3 14.8 5.3 RHCE "CD240CE, RH" ENSG00000188672 "Rh blood group CcEe antigens" P18577 1 25362249-25430192 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 40.5" "Cell line enriched" "Detected in some" 5 "HEL: 43.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.4" "HPA060951, HPA077385" Supported Uncertain "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA060951: , HPA077385: " "unprognostic (1.37e-1)" "unprognostic (3.53e-1)" "unprognostic (2.38e-1)" "unprognostic (6.75e-2)" "unprognostic (1.41e-2)" "unprognostic (4.91e-2)" "unprognostic (7.01e-2)" "unprognostic (3.12e-2)" "unprognostic (3.81e-2)" "unprognostic (1.35e-1)" "unprognostic (6.08e-2)" "unprognostic (4.61e-2)" "unprognostic (5.77e-5)" "unprognostic (1.38e-1)" "unprognostic (3.94e-2)" "unprognostic (7.15e-3)" "unprognostic (1.63e-1)" 0.6 0.8 2.0 0.6 5.1 40.5 0.9 3.3 4.7 0.8 0.7 3.5 1.0 0.7 0.7 5.2 1.4 1.6 0.8 2.1 2.6 1.5 0.8 2.2 0.7 1.0 2.1 2.5 0.9 9.6 0.5 4.0 1.6 5.9 1.6 0.8 2.2 8.4 0.8 1.9 1.1 0.6 0.5 2.9 2.1 0.8 2.6 1.4 1.2 1.1 1.2 0.8 0.5 0.6 0.1 0.2 2.4 0.2 0.1 0.3 0.9 0.1 0.0 0.1 0.2 0.4 0.3 0.0 0.1 0.1 0.2 0.0 0.0 0.7 0.3 0.5 0.5 0.1 0.0 0.1 0.1 0.2 0.0 43.6 0.0 0.0 0.5 0.0 0.3 0.9 0.7 0.3 0.2 0.0 8.5 0.2 0.2 0.4 0.0 0.3 0.8 0.2 0.0 0.1 1.2 0.0 0.0 0.3 0.4 0.1 0.1 0.5 0.2 0.0 0.0 0.1 0.0 0.4 0.0 2.6 0.6 0.5 1.4 0.4 0.2 2.4 0.2 0.6 0.3 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.2 0.0 1.0 0.1 0.0 0.1 0.3 0.9 2.0 5.1 3.3 4.7 2.6 1.5 2.1 2.5 5.9 1.4 RYR1 "CCO, MHS, MHS1, PPP1R137, RYR" ENSG00000196218 "Ryanodine receptor 1" P21817 19 38433699-38587564 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 231.0" "Cell line enhanced" "Detected in some" "HaCaT: 13.7;RH-30: 11.3;SiHa: 22.3;U-2 OS: 9.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 3.2;myeloid DC: 5.3;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 7 "dendritic cells: 5.3;monocytes: 6.3" "Low region specificity" "Detected in some" HPA056416 Enhanced Approved "Golgi apparatus,Vesicles,Cytosol" "Golgi apparatus, Vesicles" Cytosol "HPA056416: " "unprognostic (2.22e-3)" "unprognostic (1.91e-3)" "unprognostic (9.59e-2)" "unprognostic (5.34e-4)" "unprognostic (2.50e-1)" "unprognostic (6.00e-2)" "unprognostic (2.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (3.20e-3)" "unprognostic (3.52e-1)" "unprognostic (2.35e-1)" "unprognostic (1.07e-5)" "unprognostic (1.13e-2)" "unprognostic (8.10e-2)" "unprognostic (6.62e-3)" "unprognostic (1.34e-1)" 5.3 0.7 3.0 0.6 1.9 0.4 0.6 2.7 1.7 0.6 0.4 2.7 0.0 0.4 0.4 6.7 3.0 0.6 0.5 0.4 1.8 4.0 0.5 0.4 0.7 0.6 1.5 1.3 0.4 0.4 0.3 0.3 0.6 1.9 0.9 0.4 0.4 2.2 0.6 231.0 2.4 0.5 0.4 1.1 0.6 0.5 1.6 1.9 0.0 1.6 55.1 3.2 0.6 0.5 0.7 5.3 0.1 6.3 0.0 0.6 0.6 0.0 5.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.0 0.3 0.3 4.7 0.0 13.7 0.2 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.4 1.3 5.6 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 11.3 1.0 0.6 0.0 0.0 1.1 22.3 0.0 0.0 0.5 4.2 0.0 0.0 9.4 0.2 0.0 0.3 0.9 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.4 3.2 0.5 0.4 0.3 0.6 5.3 0.7 0.0 0.0 0.1 0.0 6.3 0.0 0.6 0.6 3.0 1.9 2.7 1.7 1.8 4.0 1.5 1.3 1.9 1.9 SCAP KIAA0199 ENSG00000114650 "SREBF chaperone" Q12770 3 47413694-47477126 "Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004713 Approved "HPA004713: AB_1079868" "unprognostic (4.02e-2)" "unprognostic (2.56e-1)" "unprognostic (1.91e-1)" "unprognostic (4.74e-2)" "unprognostic (1.51e-1)" "unprognostic (1.26e-1)" "unprognostic (8.74e-2)" "unprognostic (3.85e-2)" "unprognostic (1.28e-2)" "unprognostic (7.10e-2)" "prognostic favourable (7.14e-4)" "unprognostic (4.07e-2)" "prognostic favourable (4.33e-5)" "unprognostic (3.15e-2)" "unprognostic (1.39e-1)" "unprognostic (1.34e-1)" "unprognostic (7.06e-3)" 11.1 47.4 15.9 10.7 21.4 11.3 15.0 23.7 28.7 13.8 18.2 22.6 13.9 17.8 17.7 14.8 17.8 16.0 14.5 10.9 16.9 11.5 13.5 34.1 11.3 17.1 15.6 12.2 18.8 22.1 26.3 15.2 16.9 17.3 13.1 16.0 19.3 16.0 14.2 15.6 26.2 17.1 14.9 11.6 15.0 15.5 19.5 18.5 18.8 15.4 9.4 12.0 18.5 13.6 6.7 7.7 18.3 6.4 7.5 10.5 4.7 10.5 14.9 16.2 24.9 29.3 15.5 28.7 10.3 15.3 17.3 16.4 19.8 17.3 17.5 15.1 17.6 11.4 22.6 21.8 18.0 12.0 16.3 30.2 20.9 21.3 28.5 18.0 18.1 19.4 23.4 21.9 24.2 14.7 20.5 12.2 13.9 14.8 19.7 26.7 16.8 22.2 11.6 14.8 21.0 13.7 20.8 11.2 20.8 15.2 19.3 10.0 16.8 19.9 12.6 16.0 19.1 21.9 14.4 12.1 13.1 10.2 15.1 16.7 11.7 5.8 6.4 6.7 7.8 5.7 10.5 6.6 6.6 7.0 7.7 6.7 7.5 7.3 18.3 7.5 4.5 6.2 8.0 4.7 15.9 21.4 23.7 28.7 16.9 11.5 15.6 12.2 17.3 18.5 SCN8A "CerIII, CIAT, MED, NaCh6, Nav1.6, PN4" ENSG00000196876 "Sodium voltage-gated channel alpha subunit 8" Q9UQD0 12 51590266-51812864 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 27.6;pituitary gland: 9.7" "Cell line enhanced" "Detected in many" "AF22: 11.8;ASC TERT1: 12.4;BJ hTERT+: 11.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022169, HPA043937, HPA073590" Approved "Vesicles,Plasma membrane,Cell Junctions" "Plasma membrane" "Vesicles, Cell Junctions" "CAB022169: , HPA043937: , HPA073590: " "unprognostic (2.96e-2)" "unprognostic (8.49e-2)" "unprognostic (6.93e-2)" "unprognostic (3.52e-6)" "unprognostic (8.13e-2)" "unprognostic (1.51e-2)" "unprognostic (1.16e-1)" "unprognostic (7.77e-2)" "unprognostic (5.44e-2)" "unprognostic (1.16e-1)" "unprognostic (4.73e-4)" "unprognostic (1.69e-2)" "unprognostic (1.29e-5)" "unprognostic (4.38e-1)" "unprognostic (1.56e-1)" "unprognostic (2.37e-1)" "unprognostic (4.75e-2)" 1.1 3.0 9.1 1.5 18.1 1.9 1.9 16.7 27.6 1.0 2.0 1.6 0.0 1.1 1.5 2.0 0.9 1.1 2.5 0.9 12.6 4.5 1.9 4.3 1.0 1.3 3.2 13.7 1.8 3.2 1.5 9.7 0.9 14.8 1.8 2.5 0.9 1.7 1.2 1.0 1.1 1.2 1.0 2.2 1.7 2.7 3.8 1.6 0.0 1.7 0.0 1.2 1.0 0.6 0.4 0.2 0.0 0.0 0.0 1.0 0.0 1.3 1.0 11.8 0.1 1.6 12.4 0.2 6.7 11.0 7.7 7.2 1.9 1.3 0.3 1.5 8.7 0.0 1.9 0.0 9.1 1.2 0.6 0.1 0.1 0.2 0.1 0.2 0.9 1.7 0.0 5.1 1.1 8.2 0.1 0.1 4.8 0.8 1.9 0.1 4.0 3.8 0.0 0.6 0.0 0.0 0.4 4.7 1.9 3.4 1.7 0.2 0.3 0.1 2.2 7.5 5.0 2.7 4.2 0.1 0.1 0.0 1.5 1.6 10.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 1.0 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 9.1 18.1 16.7 25.0 12.6 4.5 3.2 13.7 14.8 1.6 SCN9A "ETHA, Nav1.7, NE-NA, NENA, PN1" ENSG00000169432 "Sodium voltage-gated channel alpha subunit 9" Q15858 2 166195185-166376001 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 17.3;BJ hTERT+: 12.9;HHSteC: 14.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 17 "plasmacytoid DC: 18.6" "Lineage enriched" "Detected in single" 24 "dendritic cells: 18.6" "Region enriched" "Detected in some" 5 "hypothalamus: 10.9" "Low region specificity" "Detected in many" "CAB013679, HPA061843" Uncertain Approved "Plasma membrane,Actin filaments,Focal adhesion sites" "Plasma membrane, Actin filaments, Focal adhesion sites" "CAB013679: , HPA061843: " "unprognostic (2.10e-1)" "unprognostic (2.83e-1)" "unprognostic (1.13e-1)" "unprognostic (8.98e-5)" "unprognostic (1.47e-3)" "unprognostic (9.43e-3)" "unprognostic (2.28e-2)" "unprognostic (2.24e-1)" "unprognostic (2.23e-1)" "unprognostic (3.64e-1)" "unprognostic (1.45e-1)" "unprognostic (2.27e-1)" "prognostic unfavourable (2.30e-5)" "unprognostic (1.69e-3)" "unprognostic (6.74e-2)" "unprognostic (2.46e-2)" "unprognostic (2.46e-1)" 6.6 4.2 3.8 2.8 9.1 4.2 2.7 0.9 4.4 1.8 10.2 0.5 0.1 1.4 0.9 3.8 2.6 1.2 5.8 2.9 2.8 15.9 4.8 8.3 4.5 3.5 4.1 2.3 2.1 4.8 0.6 11.3 9.2 7.3 2.0 7.0 1.7 1.8 1.9 0.9 1.8 4.2 5.2 2.5 12.4 1.7 16.2 0.4 10.3 1.4 1.9 1.2 3.6 1.8 0.0 18.6 0.7 0.1 0.4 0.0 0.0 0.0 1.9 0.1 0.0 7.5 6.5 0.0 17.3 12.9 4.0 1.4 0.5 0.1 0.0 0.0 2.1 0.0 5.0 0.6 6.7 0.0 1.6 1.3 1.5 1.4 14.9 0.0 0.0 0.4 0.2 6.9 1.3 0.8 4.3 5.0 0.6 0.0 2.6 0.0 1.5 0.5 0.7 2.5 6.5 1.8 7.3 0.8 7.3 0.0 0.0 0.3 0.2 0.0 0.0 0.0 1.1 0.1 0.3 0.1 0.0 0.0 2.5 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.7 0.4 0.1 18.6 0.0 0.0 3.8 9.1 0.9 4.4 2.8 15.9 4.1 2.3 7.3 0.4 SGPP1 ENSG00000126821 "Sphingosine-1-phosphate phosphatase 1" Q9BX95 14 63684214-63728039 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 49.4" "Cell line enhanced" "Detected in many" "Daudi: 23.4;U-698: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053149, HPA064908" Approved Enhanced Nucleoplasm Nucleoplasm "HPA053149: , HPA064908: " "unprognostic (1.57e-2)" "unprognostic (1.04e-2)" "unprognostic (5.40e-3)" "unprognostic (7.82e-2)" "unprognostic (9.09e-2)" "unprognostic (4.30e-2)" "unprognostic (6.49e-3)" "unprognostic (1.35e-2)" "unprognostic (1.64e-1)" "unprognostic (7.41e-2)" "unprognostic (1.51e-1)" "unprognostic (3.27e-1)" "unprognostic (8.59e-2)" "unprognostic (1.41e-1)" "unprognostic (1.92e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-3)" 10.5 12.1 12.1 15.7 11.6 4.3 7.6 14.3 12.9 9.2 9.6 15.1 3.9 6.2 8.4 10.3 5.7 5.9 8.9 5.5 13.1 12.6 24.7 29.4 10.3 18.5 13.0 7.0 7.4 14.1 15.5 6.4 49.4 11.1 9.0 8.7 6.7 5.7 7.0 4.4 4.8 8.9 7.9 19.6 16.5 5.8 8.2 9.8 15.4 7.8 3.7 19.1 8.6 7.3 3.2 0.5 8.8 3.3 0.5 2.0 0.5 10.3 3.3 1.6 4.7 6.0 5.6 19.9 8.5 5.9 5.3 6.0 1.4 5.9 23.4 2.5 4.3 11.0 2.6 5.0 8.6 9.1 3.1 2.1 2.0 2.3 7.4 3.8 6.7 4.1 8.1 4.6 7.3 2.5 1.2 0.6 7.7 3.8 4.4 0.0 1.1 7.2 1.1 4.6 1.8 8.4 5.2 1.0 2.7 5.9 5.6 4.4 7.3 1.4 2.8 7.4 5.1 5.2 4.2 5.6 3.4 30.5 5.4 0.0 3.1 8.8 0.3 2.8 1.0 2.3 1.0 3.2 1.0 0.7 0.5 0.8 1.5 1.1 0.4 0.5 3.3 0.3 2.0 0.5 12.1 11.6 14.3 12.9 13.1 12.6 13.0 7.0 11.1 9.8 SLC10A1 NTCP ENSG00000100652 "Solute carrier family 10 member 1" Q14973 14 69775417-69797289 "Predicted membrane proteins, Transporters" "Host-virus interaction, Ion transport, Sodium transport, Symport, Transport" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "liver: 121.2" "Cell line enhanced" "Detected in some" "CACO-2: 4.2" "Cancer enriched" "Detected in some" 79 "liver cancer: 65.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA042727 Approved "HPA042727: AB_10960691" "unprognostic (3.42e-1)" "unprognostic (9.39e-2)" "unprognostic (1.51e-2)" "unprognostic (2.11e-2)" "unprognostic (1.93e-2)" "unprognostic (6.51e-3)" "prognostic favourable (9.53e-6)" "unprognostic (6.07e-3)" "unprognostic (8.95e-2)" "unprognostic (2.17e-1)" "unprognostic (5.75e-3)" "unprognostic (1.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.05e-1)" "unprognostic (3.21e-1)" "unprognostic (2.45e-1)" "unprognostic (5.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 2.7 0.5 0.1 0.6 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.4 0.0 0.0 0.1 0.0 4.2 0.1 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.5 0.6 0.3 0.6 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.8 0.1 0.1 0.8 0.5 0.0 0.4 0.5 1.1 0.1 0.6 0.0 0.3 0.0 0.1 0.8 0.1 0.6 0.1 0.0 0.3 1.7 0.5 0.3 0.4 0.8 0.5 0.2 0.3 1.0 0.6 0.4 2.7 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC10A2 "ASBT, ISBT" ENSG00000125255 "Solute carrier family 10 member 2" Q12908 13 103043998-103066846 "Disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 40.9" "Cell line enhanced" "Detected in some" "AF22: 1.1;HAP1: 2.4;NB-4: 1.2;U-2197: 1.1" "Cancer enriched" "Detected in single" 11 "renal cancer: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA004795 Approved "HPA004795: AB_1856953" "unprognostic (2.82e-2)" "prognostic favourable (5.78e-5)" "unprognostic (1.64e-2)" "unprognostic (1.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 2.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC10A3 "DXS253E, P3" ENSG00000126903 "Solute carrier family 10 member 3" P09131 X 154487306-154490690 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 9 "basophil: 51.2" "Lineage enriched" "Detected in all" 13 "granulocytes: 51.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021656 Approved Approved "Intermediate filaments" "Intermediate filaments" "HPA021656: AB_1856955" "unprognostic (1.60e-1)" "prognostic favourable (4.53e-4)" "prognostic unfavourable (4.15e-5)" "unprognostic (8.00e-3)" "prognostic unfavourable (9.97e-4)" "unprognostic (5.47e-2)" "unprognostic (2.28e-3)" "unprognostic (9.76e-2)" "unprognostic (1.63e-1)" "unprognostic (1.05e-1)" "prognostic unfavourable (7.22e-4)" "unprognostic (3.42e-1)" "unprognostic (2.52e-3)" "unprognostic (6.23e-2)" "unprognostic (2.99e-1)" "unprognostic (7.29e-2)" "unprognostic (2.99e-2)" 14.5 14.6 3.6 11.6 5.1 22.5 13.4 5.0 8.1 21.5 15.3 8.1 16.3 10.6 25.0 36.1 22.8 15.4 21.1 19.5 6.0 4.6 17.7 6.7 16.3 14.0 5.8 6.2 32.3 25.7 6.1 12.7 40.1 7.6 23.7 6.4 12.4 11.7 13.3 13.7 26.2 13.6 20.1 5.3 13.1 12.6 11.6 4.7 12.6 15.7 23.3 18.6 23.3 18.3 1.6 2.7 51.2 1.7 2.2 3.8 1.8 24.6 10.6 2.8 14.5 10.0 10.9 18.8 18.4 11.2 12.4 12.6 9.4 12.0 18.8 35.0 17.6 21.3 9.3 9.4 3.3 12.2 4.4 5.8 14.0 7.4 18.4 6.9 9.5 13.6 10.7 11.6 6.3 8.5 6.5 18.5 8.1 32.8 3.7 6.2 2.2 20.5 6.1 7.6 14.2 9.4 9.2 2.6 4.7 11.6 21.0 4.8 6.8 5.5 11.1 14.9 9.3 34.4 23.2 13.2 12.7 19.4 15.8 14.5 7.6 51.2 1.3 5.6 3.8 1.7 2.9 1.6 2.6 2.8 1.1 1.6 1.9 1.8 1.7 2.2 1.5 2.7 1.8 1.8 3.6 5.1 5.0 8.1 6.0 4.6 5.8 6.2 7.6 4.7 SLC10A4 MGC29802 ENSG00000145248 "Solute carrier family 10 member 4" Q96EP9 4 48483343-48489196 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 12.3;brain: 19.0" "Cell line enhanced" "Detected in some" "HAP1: 10.4;K-562: 10.4;SH-SY5Y: 27.6" "Cancer enhanced" "Detected in many" "glioma: 5.9" "Group enriched" "Detected in many" 7 "basal ganglia: 7.3;cerebral cortex: 6.3;hypothalamus: 6.3;midbrain: 19.0;pons and medulla: 15.3" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Group enriched" "Detected in many" 5 "basal ganglia: 19.0;midbrain: 63.0;pons and medulla: 27.5" HPA028835 Uncertain Supported "HPA028835: AB_10603025" "unprognostic (4.06e-1)" "unprognostic (1.19e-1)" "unprognostic (1.06e-1)" "unprognostic (3.05e-3)" "unprognostic (2.49e-1)" "unprognostic (3.46e-2)" "unprognostic (5.41e-2)" "unprognostic (3.67e-1)" "unprognostic (1.86e-1)" "unprognostic (4.08e-3)" "unprognostic (9.98e-3)" "unprognostic (1.46e-1)" "unprognostic (3.50e-1)" "unprognostic (5.14e-2)" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (8.73e-2)" 0.4 12.3 1.4 2.7 7.3 3.4 0.5 0.5 6.4 2.9 1.6 0.7 0.0 0.8 0.4 0.2 0.4 0.4 0.6 0.6 1.2 6.3 0.3 0.2 1.1 0.3 19.0 0.8 0.3 0.3 0.4 7.5 0.4 15.3 0.4 1.5 4.0 4.9 0.9 0.9 0.4 1.3 0.6 1.1 0.4 0.8 1.2 0.7 0.0 1.5 0.0 0.3 0.4 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 10.4 0.0 0.1 0.0 2.2 4.5 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.2 3.0 0.3 0.0 0.0 0.0 0.0 0.5 0.7 27.6 0.5 0.0 0.1 0.0 4.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 7.3 0.5 6.3 1.2 6.3 19.0 0.8 15.3 0.7 SLC10A6 SOAT ENSG00000145283 "Solute carrier family 10 member 6" Q3KNW5 4 86823468-86849263 "Predicted membrane proteins" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 20.3;breast: 15.2;skin 1: 17.7" "Cell line enhanced" "Detected in some" "ASC diff: 1.9;BJ: 4.8;BJ hTERT+: 3.9;HaCaT: 3.6;HBEC3-KT: 1.6;U-266/84: 2.0" "Group enriched" "Detected in many" 5 "cervical cancer: 3.5;head and neck cancer: 6.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA016662 Enhanced "HPA016662: AB_1856961" "unprognostic (2.79e-2)" "unprognostic (1.86e-1)" "unprognostic (1.05e-1)" "unprognostic (8.31e-3)" "unprognostic (5.88e-2)" "unprognostic (8.87e-3)" "unprognostic (1.32e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (7.51e-2)" "unprognostic (1.08e-1)" "unprognostic (1.73e-1)" "unprognostic (3.84e-4)" "unprognostic (1.54e-1)" "unprognostic (2.06e-1)" "unprognostic (9.22e-2)" "unprognostic (5.89e-4)" 20.3 0.5 0.6 0.9 0.7 0.0 15.2 0.1 0.6 3.7 1.6 0.0 2.1 0.1 2.0 0.8 12.5 0.8 1.4 1.2 0.4 0.2 0.2 0.2 1.2 0.1 2.7 0.0 0.4 1.1 0.9 3.7 0.3 0.9 0.9 0.4 0.0 2.0 0.5 2.3 17.7 0.4 2.4 1.6 0.3 0.5 4.9 1.1 0.0 1.4 11.2 2.9 4.6 5.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 1.9 0.1 0.2 4.8 3.9 0.0 0.0 0.0 0.2 0.0 0.2 0.1 3.6 0.2 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.7 0.1 0.6 0.4 0.2 2.7 0.0 0.9 1.1 SLC14A1 "HsT1341, JK, RACH1, RACH2" ENSG00000141469 "Solute carrier family 14 member 1 (Kidd blood group)" Q13336 18 45687025-45752520 "Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 44.5;prostate: 64.7;urinary bladder: 29.6" "Cell line enriched" "Detected in some" 14 "RT4: 49.9" "Group enriched" "Detected in many" 5 "glioma: 5.3;prostate cancer: 8.6;urothelial cancer: 16.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 2.4;gdT-cell: 2.0;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.4;naive CD8 T-cell: 3.4;NK-cell: 1.8;T-reg: 7.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.4;NK-cells: 1.8;T-cells: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059570, HPA077233" Supported Supported "Plasma membrane" "Plasma membrane" "HPA059570: , HPA077233: " "unprognostic (2.04e-1)" "unprognostic (2.56e-3)" "unprognostic (5.20e-2)" "unprognostic (1.27e-1)" "unprognostic (6.86e-2)" "unprognostic (1.84e-2)" "unprognostic (1.70e-2)" "unprognostic (7.97e-2)" "unprognostic (8.17e-2)" "unprognostic (9.99e-2)" "unprognostic (2.69e-1)" "unprognostic (1.42e-1)" "unprognostic (3.02e-2)" "unprognostic (2.31e-1)" "unprognostic (1.52e-1)" "unprognostic (9.09e-2)" "unprognostic (6.93e-2)" 2.2 2.1 15.6 1.5 21.5 10.3 2.4 4.6 24.2 2.9 1.6 33.7 0.0 1.9 1.1 1.4 1.1 1.0 8.7 8.2 33.7 11.7 10.1 1.5 4.1 2.4 28.0 23.4 1.0 1.5 1.2 0.4 2.0 44.5 64.7 1.8 0.0 2.6 3.2 3.4 1.7 2.1 3.9 34.9 2.6 2.0 1.0 44.0 0.0 3.6 0.0 2.6 29.6 3.0 0.7 0.3 2.4 0.1 1.8 7.2 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 1.3 49.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 0.4 0.0 1.9 0.0 0.0 1.1 0.5 0.5 0.1 0.1 2.4 2.0 0.0 0.1 0.6 2.0 2.4 0.0 0.7 0.5 3.4 0.4 1.8 0.0 0.3 7.2 1.1 15.6 21.5 4.6 24.2 33.7 11.7 28.0 23.4 44.5 44.0 SLC16A3 "MCT3, MCT4" ENSG00000141526 "Solute carrier family 16 member 3" O15427 17 82228397-82261129 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "CAB017490, HPA021451" Approved Supported "Nuclear membrane,Plasma membrane" "Plasma membrane" "Nuclear membrane" "CAB017490: AB_2189333, HPA021451: AB_1853663" "unprognostic (2.49e-1)" "prognostic unfavourable (6.07e-4)" "unprognostic (4.31e-1)" "unprognostic (1.74e-1)" "unprognostic (3.47e-3)" "unprognostic (4.26e-3)" "prognostic unfavourable (1.19e-7)" "prognostic unfavourable (2.02e-5)" "unprognostic (2.52e-1)" "unprognostic (2.09e-2)" "unprognostic (4.35e-3)" "unprognostic (1.53e-1)" "prognostic unfavourable (3.71e-7)" "unprognostic (2.27e-1)" "unprognostic (4.00e-2)" "unprognostic (8.00e-2)" "unprognostic (1.36e-2)" 10.4 4.8 3.9 16.9 5.2 11.2 8.8 1.0 5.2 8.0 10.5 3.8 1.7 8.0 4.8 4.7 12.4 5.0 10.4 7.4 4.1 3.8 10.9 3.7 19.0 14.2 9.6 0.6 8.3 3.9 1.4 3.6 36.7 8.4 6.9 4.3 42.9 8.1 4.8 81.2 2.1 8.0 4.5 8.0 17.3 13.9 12.7 6.9 3.9 8.7 7.3 11.0 13.0 7.4 3.7 10.3 40.4 12.4 9.9 6.2 5.4 11.4 5.7 0.1 0.1 2.5 8.3 11.4 47.9 29.5 34.0 38.7 2.7 30.0 0.1 37.7 33.7 4.1 4.1 69.4 14.3 20.6 0.2 21.8 42.6 50.0 43.9 32.0 27.0 17.0 10.2 22.9 10.5 18.5 0.1 6.8 29.5 3.1 0.3 31.6 0.4 46.6 0.1 0.5 7.5 18.0 0.5 0.7 0.3 46.0 41.0 0.5 5.9 27.0 31.9 67.9 1.1 1.0 49.9 22.0 0.3 1.0 33.3 20.3 0.5 17.5 12.4 34.6 4.1 11.7 6.2 3.7 3.5 4.6 10.3 2.8 1.8 2.2 40.4 9.9 11.8 6.1 3.0 5.4 3.9 5.2 1.0 5.2 4.1 3.8 9.6 0.6 8.4 6.9 SLC1A2 "EAAT2, GLT-1" ENSG00000110436 "Solute carrier family 1 member 2" P43004 11 35251205-35420063 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 160.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.4;BJ hTERT+: 4.8;fHDF/TERT166: 3.4;Hep G2: 5.6;NTERA-2: 6.2;SCLC-21H: 3.2" "Cancer enriched" "Detected in some" 5 "glioma: 28.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002574, HPA009172" Enhanced "CAB002574: AB_564087, HPA009172: AB_1849764" "unprognostic (8.00e-2)" "unprognostic (5.71e-3)" "unprognostic (1.39e-1)" "unprognostic (2.77e-2)" "unprognostic (1.33e-1)" "unprognostic (5.65e-3)" "unprognostic (1.39e-2)" "unprognostic (9.27e-3)" "unprognostic (1.55e-1)" "unprognostic (1.65e-2)" "unprognostic (1.79e-3)" "unprognostic (2.35e-1)" "unprognostic (8.33e-4)" "unprognostic (6.34e-2)" "unprognostic (8.06e-2)" "unprognostic (5.24e-2)" "unprognostic (3.49e-2)" 1.7 4.1 65.1 1.9 79.4 1.8 3.7 7.2 160.9 2.0 1.7 9.8 0.0 1.8 2.1 1.8 1.7 1.7 1.7 2.1 47.6 11.7 1.7 20.5 1.9 2.5 15.2 43.1 1.6 4.2 1.6 0.4 2.1 27.6 1.7 1.7 0.0 3.9 1.7 1.7 2.3 1.6 1.8 17.2 1.8 2.6 2.4 16.3 0.0 1.7 0.0 2.4 1.7 0.3 1.1 0.7 3.9 0.7 1.2 0.9 0.4 0.0 0.2 1.1 0.1 0.5 4.4 0.0 1.0 4.8 0.2 0.2 0.2 0.0 0.1 0.1 3.4 0.3 0.0 0.0 0.4 0.0 0.0 0.4 0.5 5.6 0.2 0.6 0.2 0.9 0.0 0.4 0.0 0.0 0.0 0.4 0.1 2.1 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.3 3.2 0.5 0.0 2.3 0.0 1.1 0.0 0.6 0.2 0.2 0.5 0.1 0.6 0.0 0.0 1.1 0.0 0.3 3.9 0.7 0.8 0.5 0.3 0.3 0.4 0.5 0.4 0.7 1.1 0.9 0.7 2.1 1.2 0.4 0.6 0.4 0.4 65.1 79.4 7.2 64.9 47.6 11.7 15.2 43.1 27.6 16.3 SLC1A3 "EA6, EAAT1, GLAST" ENSG00000079215 "Solute carrier family 1 member 3" P43003 5 36606355-36688334 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 188.6" "Cell line enhanced" "Detected in many" "AF22: 21.2;CACO-2: 34.1;HaCaT: 25.8" "Cancer enriched" "Detected in all" 21 "glioma: 168.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4" "Group enriched" "Detected in many" 39 "dendritic cells: 3.4;monocytes: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002573, HPA037467, HPA037468" Enhanced Supported Approved Nucleoli,Mitochondria Mitochondria Nucleoli "CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371" "unprognostic (1.23e-1)" "unprognostic (2.15e-2)" "unprognostic (2.58e-3)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (7.70e-2)" "unprognostic (3.89e-3)" "unprognostic (2.36e-1)" "unprognostic (1.24e-1)" "unprognostic (2.84e-2)" "unprognostic (4.17e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" "unprognostic (4.17e-2)" "unprognostic (1.03e-1)" "unprognostic (1.31e-2)" 17.3 10.3 76.1 5.9 70.6 3.1 6.3 45.8 188.6 6.9 3.2 26.3 0.0 2.1 2.8 2.3 7.2 5.4 5.9 12.0 57.9 27.3 3.1 3.6 4.7 8.6 32.7 39.6 8.6 4.0 2.6 3.7 12.7 28.5 3.3 2.6 1.9 3.0 4.4 7.6 5.5 2.3 4.1 29.4 5.8 2.9 2.7 33.6 0.0 2.6 0.7 4.5 4.8 1.2 0.0 3.4 0.0 4.3 0.0 0.0 0.8 0.4 0.1 21.2 1.8 2.1 5.9 13.5 0.0 0.0 0.8 1.8 34.1 1.7 0.0 10.3 0.3 25.8 6.2 2.8 0.9 0.3 12.7 0.0 0.1 0.0 0.4 0.4 0.1 10.9 12.8 5.2 2.1 0.0 0.0 0.1 3.6 0.0 0.0 0.0 2.5 2.1 0.0 0.1 0.0 0.0 1.3 1.8 0.0 2.1 6.2 0.3 0.0 1.0 0.0 1.9 3.1 0.0 7.5 0.0 0.0 0.0 8.6 14.3 4.8 0.0 4.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.8 76.1 70.6 45.8 57.8 57.9 27.3 32.7 39.6 28.5 33.6 SLC22A11 OAT4 ENSG00000168065 "Solute carrier family 22 member 11" Q9NSA0 11 64555626-64572875 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "epididymis: 22.2;kidney: 47.6;placenta: 64.7" "Cell line enhanced" "Detected in some" "BEWO: 4.8;CACO-2: 1.1;Hep G2: 3.4" "Group enriched" "Detected in some" 14 "liver cancer: 3.7;renal cancer: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA026076 Enhanced "HPA026076: AB_1854756" "unprognostic (8.21e-5)" "unprognostic (3.29e-2)" "unprognostic (3.57e-1)" "unprognostic (1.57e-1)" "unprognostic (3.20e-2)" "unprognostic (4.57e-3)" "unprognostic (3.48e-1)" "unprognostic (1.93e-1)" "unprognostic (4.86e-2)" "unprognostic (4.51e-2)" "unprognostic (7.56e-2)" "unprognostic (1.13e-1)" "prognostic favourable (3.68e-5)" "unprognostic (4.62e-2)" "unprognostic (6.52e-2)" "unprognostic (3.50e-2)" "unprognostic (8.24e-3)" 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 4.4 0.0 0.1 22.2 0.1 0.1 0.0 0.1 0.1 0.1 47.6 0.4 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.1 64.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 SLC22A12 "OAT4L, RST, URAT1" ENSG00000197891 "Solute carrier family 22 member 12" Q96S37 11 64590641-64602353 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 349 "kidney: 70.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 207 "liver cancer: 4.0;renal cancer: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA024575 Enhanced "HPA024575: AB_1858650" "unprognostic (5.88e-2)" "unprognostic (2.33e-1)" "prognostic favourable (2.63e-4)" "unprognostic (6.19e-2)" "unprognostic (3.91e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A18 "BWR1A, BWSCR1A, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5" ENSG00000110628 "Solute carrier family 22 member 18" Q96BI1 11 2899721-2925246 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 71.4;liver: 44.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 21.3;Karpas-707: 19.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA067812, HPA071461" Enhanced "HPA067812: , HPA071461: " "unprognostic (1.10e-1)" "unprognostic (1.14e-1)" "unprognostic (4.80e-1)" "unprognostic (7.75e-2)" "unprognostic (7.92e-3)" "unprognostic (2.67e-1)" "unprognostic (8.25e-2)" "unprognostic (4.21e-1)" "unprognostic (2.56e-2)" "unprognostic (3.48e-2)" "unprognostic (9.35e-2)" "unprognostic (8.60e-2)" "unprognostic (8.36e-2)" "unprognostic (9.51e-2)" "unprognostic (5.97e-3)" "unprognostic (1.55e-1)" "unprognostic (2.82e-1)" 3.5 1.6 0.5 11.4 1.2 1.4 3.2 0.1 2.0 2.6 36.6 0.8 2.9 36.7 3.1 15.2 6.1 4.7 21.9 8.5 0.9 1.1 18.2 44.3 8.7 8.3 1.0 1.7 2.9 3.0 4.1 1.5 4.9 1.3 4.0 3.7 4.2 8.6 4.3 1.0 6.5 71.4 3.7 1.2 4.7 8.1 2.8 0.8 3.1 8.1 7.6 5.4 4.5 4.4 2.1 8.9 21.7 15.0 2.7 4.6 6.0 1.4 8.5 0.0 4.8 0.9 1.4 3.5 2.9 5.1 1.7 2.9 5.1 21.3 0.6 9.0 3.8 4.6 0.2 0.4 0.4 4.2 0.7 0.1 2.1 4.6 9.4 0.0 4.0 3.9 0.9 1.4 0.3 0.0 0.1 19.7 0.9 4.3 0.1 0.6 0.5 1.9 1.5 0.0 2.6 0.8 2.9 0.1 1.6 1.1 12.4 10.3 2.4 2.5 0.2 1.3 2.7 3.9 0.1 3.5 0.8 0.2 5.2 2.7 4.9 15.3 15.0 12.6 3.5 14.3 2.0 2.1 2.8 2.5 8.9 1.3 1.5 2.2 21.7 2.7 10.8 6.4 4.6 6.0 0.5 1.2 0.1 2.0 0.9 1.1 1.0 1.7 1.3 0.8 SLC22A23 "C6orf85, FLJ22174" ENSG00000137266 "Solute carrier family 22 member 23" A1A5C7 6 3268962-3457022 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 18.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014697 Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA014697: AB_1844371" "unprognostic (4.58e-2)" "unprognostic (2.48e-1)" "unprognostic (1.05e-1)" "prognostic favourable (6.57e-4)" "unprognostic (5.16e-3)" "unprognostic (3.25e-3)" "unprognostic (1.40e-1)" "unprognostic (4.53e-3)" "unprognostic (9.74e-2)" "unprognostic (2.87e-2)" "unprognostic (1.07e-2)" "unprognostic (2.62e-2)" "prognostic unfavourable (2.39e-4)" "unprognostic (8.91e-2)" "unprognostic (4.30e-1)" "unprognostic (4.06e-2)" "unprognostic (1.74e-1)" 7.4 2.2 9.0 4.6 16.2 8.1 9.3 8.4 14.8 5.6 17.4 30.8 3.4 19.6 3.6 11.8 16.8 11.3 7.5 2.2 11.0 8.1 6.9 12.6 8.0 3.9 28.6 8.7 3.0 14.9 14.8 6.5 8.3 17.8 14.2 14.4 5.7 10.0 2.8 5.9 14.9 20.3 3.0 17.5 4.6 26.0 7.2 21.0 5.2 4.1 9.8 9.9 3.8 9.9 0.1 0.7 0.8 0.3 0.3 1.4 1.9 2.4 5.7 12.6 14.0 4.5 5.0 16.1 0.4 0.1 0.7 0.3 12.6 0.4 0.6 1.5 2.7 3.6 2.5 6.7 0.2 2.0 7.8 5.9 2.2 11.1 0.6 0.3 0.4 1.2 13.2 12.2 0.6 0.4 5.3 3.4 0.4 2.9 0.5 1.4 4.3 2.3 1.3 0.8 10.0 0.0 15.4 1.4 0.2 3.3 4.8 4.1 18.7 0.1 3.1 7.4 2.3 9.5 1.5 7.6 0.1 0.2 12.9 0.4 4.5 0.0 0.3 0.0 0.4 0.0 0.2 0.0 1.0 0.4 0.2 0.1 1.4 0.9 0.8 0.3 0.2 0.7 0.0 1.9 9.0 16.2 8.4 14.8 11.0 8.1 28.6 8.7 17.8 21.0 SLC23A3 "FLJ31168, SVCT3, Yspl1" ENSG00000213901 "Solute carrier family 23 member 3" Q6PIS1 2 219161465-219170095 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "intestine: 36.5;kidney: 32.4" "Cell line enhanced" "Detected in many" "hTCEpi: 8.9;U-266/70: 6.5" "Cancer enriched" "Detected in some" 9 "renal cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 1.3" "Low region specificity" "Detected in single" HPA019059 Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA019059: AB_1857017" "unprognostic (2.49e-2)" "unprognostic (6.65e-2)" "unprognostic (2.05e-4)" "unprognostic (6.97e-2)" "unprognostic (8.41e-2)" "unprognostic (1.22e-2)" "unprognostic (9.07e-2)" "unprognostic (1.93e-1)" "unprognostic (4.01e-2)" "unprognostic (4.35e-2)" "unprognostic (3.10e-1)" "unprognostic (6.12e-4)" "unprognostic (9.42e-2)" "unprognostic (6.48e-2)" "unprognostic (2.41e-2)" "unprognostic (3.34e-1)" "unprognostic (6.52e-5)" 0.4 0.0 0.3 2.3 0.3 0.0 0.5 0.3 0.5 0.8 14.9 0.3 0.3 5.3 1.1 0.3 0.9 0.5 0.3 0.3 0.3 0.0 32.4 3.1 0.7 0.3 0.3 0.3 1.0 0.4 0.5 0.3 0.5 0.3 1.4 0.8 0.3 0.4 0.3 0.3 1.1 36.5 0.3 0.3 0.4 0.5 0.3 0.3 0.3 1.3 0.3 0.4 0.6 1.3 0.8 0.0 0.0 0.8 0.0 0.5 0.0 0.9 0.4 0.2 1.1 3.9 2.2 0.8 2.2 0.6 0.4 1.3 2.3 1.6 0.5 0.8 1.5 3.2 0.7 0.3 0.6 1.8 1.8 2.0 1.9 0.1 0.7 0.2 0.9 0.7 8.9 0.9 2.9 1.2 0.3 0.9 0.6 0.3 0.1 1.0 0.0 0.2 0.5 0.5 0.8 3.1 3.7 0.5 1.0 0.2 0.0 2.3 0.9 1.1 2.6 2.1 1.4 2.2 0.7 6.5 0.3 2.9 0.6 0.7 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.8 0.0 0.2 0.0 0.3 0.3 0.3 0.5 0.3 0.0 0.3 0.3 0.3 0.3 SLC26A8 ENSG00000112053 "Solute carrier family 26 member 8" Q96RN1 6 35943514-36024868 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Differentiation, Ion transport, Meiosis, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 65.2" "Cell line enhanced" "Detected in some" "RT4: 2.8;T-47d: 1.0;THP-1: 2.2;TIME: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "neutrophil: 5.4" "Lineage enriched" "Detected in single" 12 "granulocytes: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA038081 Enhanced "HPA038081: AB_10670653" "unprognostic (8.18e-2)" "unprognostic (1.74e-1)" "unprognostic (6.71e-2)" "unprognostic (1.31e-2)" "unprognostic (2.46e-1)" "unprognostic (7.07e-3)" "unprognostic (2.93e-1)" "unprognostic (6.31e-2)" "unprognostic (1.11e-1)" "unprognostic (1.11e-1)" "unprognostic (1.85e-1)" "unprognostic (3.78e-1)" "unprognostic (4.63e-6)" "unprognostic (7.14e-2)" "unprognostic (4.24e-1)" "unprognostic (2.31e-1)" "unprognostic (5.24e-8)" 0.3 0.2 1.3 0.5 2.2 3.7 0.3 4.2 1.8 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 2.1 0.2 0.2 0.2 1.1 0.7 1.7 0.2 0.3 0.2 0.1 0.2 1.9 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.2 0.2 0.6 0.9 0.2 65.2 0.1 0.1 0.4 0.0 0.2 0.2 0.0 0.0 0.2 5.4 0.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.7 0.2 0.0 0.4 0.0 0.0 0.8 2.8 0.8 0.0 0.0 0.0 0.1 1.0 2.2 1.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.2 1.3 2.2 4.2 1.8 0.8 2.1 0.7 1.7 1.9 0.1 SLC2A14 "GLUT14, SLC2A3P3" ENSG00000173262 "Solute carrier family 2 member 14" Q8TDB8 12 7812512-7891148 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis, Sugar transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 52.4" "Group enriched" "Detected in some" 4 "BEWO: 14.6;CACO-2: 23.7;Hep G2: 6.1" "Cancer enriched" "Detected in single" 35 "testis cancer: 7.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 6.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.9" HPA006539 Supported Approved "Plasma membrane" "Plasma membrane" "HPA006539: AB_1078984" "unprognostic (2.52e-1)" "unprognostic (4.74e-3)" "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (3.35e-2)" "unprognostic (1.82e-3)" "unprognostic (8.62e-2)" "unprognostic (7.15e-2)" "unprognostic (1.89e-1)" "unprognostic (9.91e-3)" "unprognostic (1.23e-1)" "unprognostic (1.27e-1)" "unprognostic (8.46e-4)" "unprognostic (3.92e-2)" "unprognostic (3.41e-1)" "unprognostic (3.26e-2)" "unprognostic (1.22e-2)" 0.4 3.1 0.1 0.1 0.6 3.0 0.4 0.1 0.2 0.4 0.4 0.3 0.1 0.0 0.3 0.8 0.8 0.1 0.3 0.1 0.2 0.3 0.1 2.0 0.2 0.2 0.1 0.1 2.7 7.4 0.0 0.6 0.5 0.3 0.6 0.2 0.1 0.1 0.1 0.1 0.1 0.7 0.2 0.1 0.1 0.0 52.4 0.2 0.1 0.1 0.1 0.1 0.6 0.1 0.6 0.4 6.9 0.7 1.3 1.7 0.2 0.0 0.4 0.3 0.3 0.2 0.8 14.6 0.0 0.0 0.0 0.2 23.7 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 2.4 0.6 6.1 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 1.0 0.1 0.0 0.1 0.1 0.1 2.7 0.0 0.2 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.0 1.5 0.3 0.1 0.6 0.4 0.1 0.1 0.1 0.3 0.3 0.0 0.3 5.5 0.7 1.8 1.0 0.2 1.2 0.5 1.0 0.8 0.4 0.6 0.7 0.9 6.9 1.3 0.2 0.3 1.7 0.2 0.1 0.6 0.1 0.2 0.2 0.3 0.1 0.1 0.3 0.2 SLC35A2 "UGALT, UGAT, UGT, UGT1, UGT2, UGTL" ENSG00000102100 "Solute carrier family 35 member A2" P78381 X 48903180-48911958 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036087 Approved Supported "Golgi apparatus" "Golgi apparatus" "HPA036087: AB_10604093" "prognostic unfavourable (3.16e-4)" "unprognostic (3.34e-1)" "unprognostic (4.88e-3)" "unprognostic (1.11e-1)" "unprognostic (8.15e-3)" "unprognostic (4.25e-3)" "prognostic unfavourable (9.64e-5)" "unprognostic (3.47e-1)" "unprognostic (2.50e-1)" "unprognostic (1.63e-1)" "unprognostic (1.94e-3)" "unprognostic (9.58e-2)" "unprognostic (3.16e-2)" "prognostic favourable (8.23e-4)" "unprognostic (1.38e-1)" "unprognostic (1.61e-1)" "unprognostic (5.13e-2)" 11.4 17.2 10.5 9.7 12.2 10.9 21.9 5.9 18.4 16.2 22.7 20.5 13.4 13.5 11.5 24.2 17.2 23.1 14.3 12.8 10.3 10.9 18.8 43.6 14.5 18.9 12.0 9.7 10.6 30.6 18.8 16.2 29.8 12.7 14.1 23.1 10.3 16.9 14.7 12.9 15.9 13.0 9.0 13.8 12.1 19.8 8.8 10.3 8.8 13.3 12.5 13.0 11.3 11.4 7.5 18.5 24.2 15.7 7.8 10.9 6.9 20.4 23.7 8.0 11.5 17.3 14.1 11.9 21.1 20.6 21.2 25.6 25.5 36.2 7.7 10.0 23.2 29.5 21.7 16.3 17.6 10.1 14.7 8.5 14.9 19.9 20.2 16.1 18.4 15.0 27.5 18.6 17.7 12.4 16.1 12.8 15.6 19.5 7.9 13.3 16.8 28.8 8.5 14.4 23.5 19.2 16.8 9.4 15.2 22.0 23.9 12.0 35.2 12.7 8.9 12.8 13.1 23.0 11.9 19.9 13.5 8.4 15.5 13.3 15.7 11.4 14.4 24.2 10.2 15.7 10.9 7.5 9.2 9.6 17.5 7.3 5.8 10.6 15.9 7.8 10.6 18.5 8.8 6.9 10.5 12.2 5.9 18.4 10.3 10.9 12.0 9.7 12.7 10.3 SLC35A3 ENSG00000117620 "Solute carrier family 35 member A3" Q9Y2D2 1 99969351-100035637 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Autism spectrum disorder, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015253 Uncertain "HPA015253: AB_1857106" "unprognostic (1.05e-1)" "unprognostic (2.69e-1)" "unprognostic (1.57e-3)" "unprognostic (5.89e-2)" "unprognostic (9.64e-2)" "unprognostic (1.61e-1)" "unprognostic (1.72e-1)" "unprognostic (4.02e-2)" "unprognostic (2.59e-2)" "unprognostic (1.47e-1)" "unprognostic (1.76e-3)" "unprognostic (1.69e-1)" "unprognostic (1.02e-1)" "unprognostic (1.49e-3)" "unprognostic (2.32e-1)" "unprognostic (2.73e-2)" "unprognostic (9.34e-2)" 10.7 9.4 6.5 16.7 6.8 5.9 16.2 7.4 8.9 12.4 31.4 5.5 16.2 29.1 10.5 10.8 14.9 9.5 12.5 7.1 5.4 4.8 13.2 21.9 18.0 10.9 7.0 6.3 7.9 13.8 12.8 8.6 12.2 9.6 14.4 32.7 6.0 22.3 21.9 7.5 10.0 41.0 15.3 7.6 6.3 19.9 5.1 5.6 24.7 15.3 7.9 8.1 13.9 13.0 4.3 9.0 6.4 3.7 7.7 5.2 3.2 17.1 4.7 4.2 4.5 9.6 8.5 17.0 15.3 9.3 6.1 8.8 3.0 9.3 9.2 19.3 8.9 10.0 8.0 6.9 14.0 11.4 5.8 8.3 6.6 7.2 6.1 13.3 1.0 4.5 7.8 7.3 14.3 7.0 13.8 13.8 12.2 4.2 8.7 7.0 5.2 15.6 2.7 13.0 5.8 11.1 10.0 5.5 3.1 10.6 20.6 8.1 12.5 10.2 8.1 9.3 8.3 20.4 8.2 8.2 9.6 6.9 14.8 8.3 3.8 6.4 3.6 2.0 4.2 3.7 4.7 4.3 4.2 4.9 3.1 3.4 5.2 4.4 1.2 7.7 2.9 9.0 4.8 3.2 6.5 6.8 7.4 8.9 5.4 4.8 7.0 6.3 9.6 5.6 SLC35A4 ENSG00000176087 "Solute carrier family 35 member A4" "Q96G79, L0R6Q1" 5 140564456-140569103 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062210 Approved Nucleoplasm Nucleoplasm "HPA062210: " "unprognostic (3.01e-3)" "unprognostic (1.35e-2)" "unprognostic (5.88e-2)" "unprognostic (1.09e-1)" "unprognostic (2.46e-2)" "unprognostic (1.65e-2)" "unprognostic (1.91e-3)" "unprognostic (9.63e-2)" "unprognostic (3.61e-2)" "unprognostic (9.32e-2)" "unprognostic (1.78e-2)" "unprognostic (2.87e-1)" "prognostic favourable (4.56e-5)" "unprognostic (2.96e-2)" "unprognostic (3.04e-2)" "unprognostic (2.06e-2)" "unprognostic (1.55e-1)" 22.0 30.4 12.3 18.6 17.1 8.4 19.6 14.0 21.8 18.2 25.5 24.9 22.6 19.2 18.2 19.8 30.3 20.6 26.0 25.7 13.1 10.3 35.1 39.2 23.1 22.5 16.0 11.1 19.0 28.3 28.2 14.9 24.6 19.4 20.4 26.5 20.5 32.6 15.9 54.3 28.3 30.6 19.8 13.0 28.5 21.7 30.5 15.3 26.0 29.2 28.0 27.5 18.3 18.0 15.4 32.8 15.8 36.9 26.9 27.6 32.4 15.3 46.1 18.4 34.7 25.3 15.9 27.5 22.3 15.1 27.3 28.8 55.7 17.7 45.4 27.7 21.0 17.0 0.0 32.7 23.5 55.2 25.2 33.9 45.0 0.2 18.0 33.2 25.6 21.0 25.6 27.2 24.3 23.3 26.2 45.8 27.0 28.4 34.5 14.4 12.5 23.5 25.7 37.3 39.3 20.4 30.4 20.6 27.5 28.3 47.1 22.0 39.1 14.2 27.3 24.6 17.1 24.4 25.0 19.1 44.7 19.1 18.1 37.5 28.5 7.5 26.9 15.8 27.6 36.9 26.3 14.3 22.1 24.7 32.8 15.4 25.9 23.0 9.9 26.9 33.3 12.0 14.7 32.4 12.3 17.1 14.0 21.8 13.1 10.3 16.0 11.1 19.4 15.3 SLC35B1 UGTREL1 ENSG00000121073 "Solute carrier family 35 member B1" P78383 17 49700943-49709014 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048655, HPA057418" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" Nucleoplasm "HPA048655: , HPA057418: " "unprognostic (1.35e-1)" "unprognostic (2.15e-2)" "unprognostic (1.09e-3)" "unprognostic (6.36e-2)" "unprognostic (8.31e-2)" "unprognostic (2.86e-3)" "unprognostic (6.17e-3)" "unprognostic (4.39e-2)" "unprognostic (2.47e-2)" "unprognostic (4.00e-3)" "unprognostic (3.37e-2)" "unprognostic (4.42e-2)" "prognostic unfavourable (5.69e-7)" "unprognostic (6.28e-2)" "unprognostic (7.88e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-2)" 8.5 8.3 8.4 7.4 11.8 8.0 10.7 8.2 14.0 9.3 13.0 9.3 9.2 13.7 7.6 26.5 9.4 9.9 7.3 15.8 8.6 9.2 16.0 46.7 10.1 16.0 9.8 7.9 7.5 22.3 13.5 13.2 12.4 9.9 7.4 13.1 8.4 22.4 12.7 33.7 9.2 27.3 8.0 8.1 10.2 9.3 9.1 7.1 6.5 19.7 13.8 10.8 9.9 6.7 6.6 25.0 8.1 15.1 7.0 9.5 7.9 13.5 22.7 17.0 26.7 15.6 9.8 19.2 14.3 23.3 30.5 24.5 46.7 15.8 9.4 33.6 19.8 10.1 26.8 17.1 33.4 11.5 19.5 11.9 14.9 27.3 27.2 22.2 11.2 10.0 18.8 22.0 27.5 18.8 11.6 27.0 20.9 27.5 16.3 14.4 7.6 25.5 11.0 18.3 25.3 15.0 14.3 14.7 18.9 8.4 6.8 9.8 21.5 15.2 8.0 23.3 10.3 24.9 18.8 14.3 23.5 14.0 15.2 16.9 20.4 8.1 15.1 5.0 9.5 13.5 6.9 6.6 6.5 8.9 16.7 3.6 6.6 6.0 6.7 7.0 9.1 25.0 7.4 7.9 8.4 11.8 8.2 14.0 8.6 9.2 9.8 7.9 9.9 7.1 SLC35B2 UGTrel4 ENSG00000157593 "Solute carrier family 35 member B2" Q8TB61 6 44254096-44257890 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029638 Approved Approved Vesicles Vesicles "HPA029638: AB_10602402" "prognostic unfavourable (7.90e-4)" "unprognostic (2.47e-3)" "unprognostic (2.30e-1)" "unprognostic (1.39e-2)" "unprognostic (2.36e-1)" "unprognostic (1.65e-2)" "prognostic unfavourable (8.59e-5)" "unprognostic (3.84e-1)" "unprognostic (2.51e-1)" "unprognostic (7.03e-3)" "unprognostic (4.27e-2)" "prognostic favourable (6.07e-4)" "unprognostic (3.60e-2)" "unprognostic (1.13e-1)" "unprognostic (4.07e-1)" "unprognostic (1.28e-1)" "unprognostic (1.06e-1)" 18.0 28.2 14.8 12.6 15.0 10.7 17.7 16.2 24.8 18.3 18.9 35.8 19.0 13.0 22.6 23.4 14.3 18.6 27.1 17.7 15.2 10.9 32.3 35.5 16.1 12.9 17.1 14.6 16.7 38.1 27.4 11.1 26.1 19.8 19.0 20.2 23.8 49.6 20.4 17.5 15.6 16.4 20.5 24.7 18.4 20.6 16.3 18.7 12.2 19.3 17.8 17.6 19.6 14.3 12.9 14.4 21.8 8.6 10.8 21.1 10.2 25.9 14.9 18.7 35.9 30.8 32.6 13.7 28.5 47.1 28.0 34.5 13.1 24.2 5.8 25.7 35.1 24.8 12.7 32.0 19.8 17.2 16.5 11.7 11.8 15.6 28.8 24.9 19.0 33.4 33.7 25.7 12.7 20.5 16.6 25.1 33.5 30.5 9.1 20.8 8.3 17.4 9.2 12.1 29.6 30.2 19.3 23.4 22.4 14.0 15.6 32.0 28.9 22.8 20.3 22.1 14.7 22.0 24.7 19.4 22.1 13.5 29.5 19.9 44.9 21.8 8.6 13.2 21.1 6.5 17.8 12.9 11.9 16.1 7.7 7.7 11.0 14.2 0.7 10.8 2.3 14.4 9.6 10.2 14.8 15.0 16.2 24.8 15.2 10.9 17.1 14.6 19.8 18.7 SLC35B4 "FLJ14697, YEA4" ENSG00000205060 "Solute carrier family 35 member B4" Q969S0 7 134289332-134317051 "Predicted membrane proteins" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049779 Approved "HPA049779: " "unprognostic (1.84e-1)" "unprognostic (1.94e-2)" "unprognostic (7.19e-2)" "unprognostic (2.49e-2)" "unprognostic (1.77e-3)" "unprognostic (3.47e-2)" "unprognostic (3.23e-2)" "unprognostic (1.25e-2)" "unprognostic (1.57e-1)" "unprognostic (3.32e-2)" "unprognostic (6.88e-3)" "unprognostic (1.86e-1)" "unprognostic (2.24e-3)" "unprognostic (3.18e-2)" "unprognostic (2.86e-1)" "unprognostic (9.81e-2)" "unprognostic (1.00e-1)" 7.8 10.1 9.6 7.4 16.8 2.7 5.3 22.4 21.6 6.8 5.4 10.8 4.8 4.5 9.4 10.1 5.0 6.8 6.1 4.0 10.1 12.4 15.9 11.6 5.1 6.3 9.4 9.6 10.3 4.0 6.4 6.7 17.5 12.7 8.4 5.7 9.9 3.8 10.0 3.5 4.9 5.9 10.8 8.6 6.5 5.2 6.9 8.6 6.8 5.4 2.0 7.2 6.4 4.3 3.2 6.5 1.3 4.6 4.0 5.7 2.9 3.7 12.6 11.1 16.6 10.9 9.1 5.7 9.5 8.0 8.4 7.2 4.9 3.6 12.6 3.2 10.3 4.1 16.4 8.4 14.2 8.0 12.2 8.5 7.4 6.4 8.0 12.0 7.8 8.0 3.6 10.1 8.7 8.2 8.2 4.7 12.6 3.3 10.6 8.8 22.9 11.4 7.7 9.7 6.2 4.8 4.6 3.9 22.8 8.5 2.8 10.4 1.5 6.9 9.1 11.1 3.7 6.6 9.4 15.6 21.4 14.7 19.8 11.4 12.7 1.3 3.4 0.7 3.8 4.6 5.7 3.1 3.5 4.7 6.5 3.2 3.4 5.0 0.4 4.0 3.5 4.5 3.7 2.9 9.6 16.8 22.4 21.6 10.1 12.4 9.4 9.6 12.7 8.6 SLC35D2 "SQV7L, UGTrel8" ENSG00000130958 "Solute carrier family 35 member D2" Q76EJ3 9 96320706-96383710 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA064047 Approved Supported "Golgi apparatus" "Golgi apparatus" "HPA064047: " "unprognostic (3.67e-1)" "unprognostic (5.73e-2)" "unprognostic (2.59e-1)" "unprognostic (1.16e-2)" "unprognostic (3.17e-1)" "unprognostic (8.86e-3)" "unprognostic (4.25e-3)" "unprognostic (2.24e-2)" "unprognostic (4.12e-1)" "unprognostic (5.67e-2)" "unprognostic (1.97e-1)" "unprognostic (1.63e-1)" "unprognostic (1.74e-2)" "unprognostic (1.33e-2)" "unprognostic (2.04e-1)" "unprognostic (1.99e-2)" "unprognostic (1.44e-1)" 8.7 6.1 5.9 7.8 13.6 4.6 8.8 1.6 10.8 7.9 23.8 21.2 4.2 30.7 8.3 8.7 8.7 7.8 16.2 7.3 7.8 5.2 20.1 27.9 13.2 17.6 13.7 4.7 10.5 26.0 8.0 5.1 10.5 9.2 8.0 22.6 13.1 8.5 5.3 2.8 5.7 39.6 11.2 14.3 6.5 18.7 5.1 9.8 2.7 14.3 5.0 7.5 10.0 8.0 1.5 2.4 1.6 1.4 1.9 5.3 1.0 11.4 9.0 5.6 11.6 7.2 14.9 10.8 5.2 10.9 8.0 6.7 18.4 38.0 0.2 8.6 4.6 16.7 7.8 8.1 7.1 5.4 6.4 4.1 3.8 31.6 10.7 0.0 0.0 12.2 9.7 6.1 17.6 17.5 7.7 0.1 8.8 7.8 0.0 0.0 5.0 10.4 0.0 0.0 0.0 19.0 7.0 2.1 13.2 4.5 9.0 22.9 5.7 8.3 15.5 5.6 6.0 8.0 5.0 0.0 0.3 0.0 11.5 0.0 7.6 1.6 1.4 1.0 1.8 1.0 2.4 1.5 2.2 3.5 2.4 0.3 0.7 1.7 0.1 1.9 0.8 0.1 5.3 1.0 5.9 13.6 1.6 10.8 7.8 5.2 13.7 4.7 9.2 9.8 SLC35E1 FLJ14251 ENSG00000127526 "Solute carrier family 35 member E1" Q96K37 19 16549831-16572382 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016570, HPA062214" Approved Enhanced "Golgi apparatus" "Golgi apparatus" "HPA016570: AB_2190214, HPA062214: " "unprognostic (1.76e-2)" "unprognostic (2.81e-1)" "unprognostic (7.31e-2)" "unprognostic (2.92e-2)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.35e-2)" "unprognostic (1.04e-1)" "unprognostic (1.20e-1)" "unprognostic (6.99e-2)" "unprognostic (9.07e-2)" "unprognostic (3.02e-2)" "unprognostic (2.23e-2)" "unprognostic (1.21e-2)" "unprognostic (1.27e-1)" "unprognostic (2.54e-1)" "unprognostic (3.75e-2)" 15.2 12.7 11.9 9.3 12.3 10.3 13.5 11.7 19.2 15.1 12.4 8.7 22.4 9.7 11.3 10.3 14.2 11.2 13.7 12.6 9.3 9.7 11.6 20.1 13.5 9.5 8.3 7.9 11.9 34.5 25.8 14.4 23.9 10.7 17.9 9.4 11.4 23.7 21.4 23.1 14.3 13.4 10.0 5.9 9.7 17.0 6.4 7.2 14.0 13.8 12.3 13.9 15.2 14.1 5.9 3.2 7.9 5.0 4.5 5.2 2.9 17.7 7.0 5.1 11.2 18.8 14.6 11.9 12.9 13.8 10.6 12.6 8.2 12.7 9.3 20.8 20.1 11.9 13.7 14.5 12.1 10.6 19.7 8.4 8.1 9.6 15.1 13.9 10.1 11.6 17.1 11.7 17.6 10.2 12.9 12.6 14.0 16.9 10.1 6.4 5.9 23.8 9.8 7.7 10.9 10.9 11.5 8.5 8.4 8.9 14.3 7.9 10.0 6.8 11.1 14.2 7.0 19.0 14.8 16.3 17.4 10.5 20.9 14.8 8.7 5.0 3.9 7.9 4.1 2.5 5.2 5.9 4.3 3.6 2.7 2.8 3.2 2.5 4.8 4.5 5.0 3.2 4.8 2.9 11.9 12.3 11.7 19.2 9.3 9.7 8.3 7.9 10.7 7.2 SLC35F1 "C6orf169, dJ230I3.1" ENSG00000196376 "Solute carrier family 35 member F1" Q5T1Q4 6 117907526-118317676 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 41.9" "Group enriched" "Detected in some" 9 "AF22: 23.3;WM-115: 39.2" "Group enriched" "Detected in some" 16 "glioma: 15.1;melanoma: 3.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019576 Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" Nucleoplasm "Centriolar satellite, Cytosol" "HPA019576: AB_2190216" "unprognostic (1.46e-1)" "unprognostic (5.67e-2)" "unprognostic (7.08e-2)" "unprognostic (1.37e-3)" "unprognostic (3.31e-1)" "unprognostic (4.99e-2)" "unprognostic (1.39e-1)" "unprognostic (4.04e-1)" "unprognostic (3.64e-2)" "unprognostic (3.04e-2)" "unprognostic (4.44e-3)" "unprognostic (2.19e-1)" "unprognostic (8.83e-4)" "unprognostic (3.04e-3)" "unprognostic (6.03e-2)" "unprognostic (8.32e-2)" "unprognostic (2.02e-1)" 2.8 2.7 13.8 2.1 14.5 0.9 1.2 3.6 41.9 1.7 3.5 4.3 0.0 1.6 2.7 5.5 1.8 1.5 1.8 5.3 10.4 10.2 1.7 1.0 1.1 1.0 9.3 15.3 1.4 1.4 1.0 0.6 1.0 5.6 2.3 2.3 2.6 1.7 2.9 1.2 1.6 1.8 2.6 4.1 1.6 1.4 1.8 5.6 0.0 1.8 0.0 1.0 1.4 2.6 0.2 0.6 1.0 0.1 0.3 0.9 0.1 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 2.9 3.3 0.0 0.0 0.1 0.0 39.2 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 1.0 0.3 0.0 0.6 0.0 0.1 13.8 14.5 3.6 17.4 10.4 10.2 9.3 15.3 5.6 5.6 SLC35F2 FLJ13018 ENSG00000110660 "Solute carrier family 35 member F2" Q8IXU6 11 107790991-107928293 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 43.2" "Cell line enhanced" "Detected in many" "PC-3: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048185, HPA050695, HPA060150" Approved Approved Mitochondria Mitochondria "HPA048185: , HPA050695: , HPA060150: " "unprognostic (7.73e-2)" "unprognostic (3.28e-3)" "unprognostic (8.37e-3)" "unprognostic (5.77e-2)" "unprognostic (1.38e-3)" "unprognostic (3.07e-2)" "unprognostic (7.26e-2)" "prognostic unfavourable (4.03e-4)" "unprognostic (6.22e-2)" "unprognostic (8.20e-2)" "prognostic unfavourable (5.92e-6)" "unprognostic (1.24e-1)" "unprognostic (4.10e-2)" "unprognostic (1.34e-1)" "unprognostic (7.33e-2)" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" 3.0 2.5 2.4 7.4 2.2 1.3 2.7 2.1 2.4 7.4 8.1 1.8 3.8 8.4 2.6 4.8 5.0 6.2 5.9 2.4 3.7 2.6 5.6 2.0 4.0 7.7 2.4 2.2 3.4 3.4 0.3 2.6 9.7 1.9 10.6 9.8 5.2 43.2 2.7 2.3 8.5 7.4 1.8 4.2 2.7 2.8 3.7 2.3 1.8 3.2 6.7 6.9 3.4 3.7 9.3 5.9 0.5 0.2 2.9 11.2 1.6 8.5 5.6 0.6 7.9 4.7 6.9 8.0 2.0 1.1 5.2 6.8 24.0 8.9 14.1 20.1 5.8 17.7 11.2 18.0 10.5 11.8 10.3 7.8 5.5 9.9 7.7 18.3 3.9 4.8 10.4 17.4 37.6 27.3 20.6 5.8 3.7 5.1 7.5 17.7 6.0 54.3 15.3 7.1 18.4 28.1 7.7 13.7 5.8 6.4 14.8 3.9 10.9 3.9 20.3 9.7 16.0 0.2 20.2 15.3 17.2 15.5 6.1 5.8 6.3 0.1 0.2 0.0 2.8 0.1 7.3 9.3 4.8 4.9 5.9 6.1 1.8 2.5 0.5 2.9 0.0 0.3 11.2 1.6 2.4 2.2 2.1 2.4 3.7 2.6 2.4 2.2 1.9 2.3 SLC35F4 "C14orf36, FLJ37712" ENSG00000151812 "Solute carrier family 35 member F4" A4IF30 14 57563922-57982194 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 29.5;seminal vesicle: 10.5" "Group enriched" "Detected in some" 4 "RPMI-8226: 4.4;U-87 MG: 6.1" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "cerebellum: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043853 Uncertain Approved "Nucleoli fibrillar center" "Nucleoli fibrillar center" "HPA043853: AB_10963083" "unprognostic (2.37e-1)" "unprognostic (2.10e-1)" "unprognostic (3.56e-1)" "unprognostic (2.66e-4)" "unprognostic (4.88e-2)" "unprognostic (8.64e-2)" "unprognostic (1.38e-1)" "unprognostic (1.76e-2)" "unprognostic (3.94e-2)" "unprognostic (1.39e-1)" "unprognostic (4.03e-3)" "unprognostic (3.50e-2)" "unprognostic (1.05e-2)" "unprognostic (9.68e-3)" "unprognostic (9.23e-2)" 0.1 0.1 1.2 0.1 4.9 0.1 0.1 29.5 1.1 1.0 0.2 0.1 0.5 0.2 1.5 0.2 0.1 0.2 0.5 0.1 0.9 2.2 0.4 0.1 0.1 0.1 0.8 1.2 0.3 0.1 0.1 0.2 0.1 2.9 3.5 0.1 2.4 0.1 10.5 0.1 0.1 0.4 1.1 1.3 0.1 0.1 2.7 0.7 0.0 2.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 4.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 4.9 29.5 1.1 0.9 2.2 0.8 1.2 2.9 0.7 SLC36A1 "LYAAT-1, PAT1, TRAMD3" ENSG00000123643 "Solute carrier family 36 member 1" Q7Z2H8 5 151437046-151492381 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 15.9;classical monocyte: 6.6;neutrophil: 14.5" "Group enriched" "Detected in many" 5 "granulocytes: 15.9;monocytes: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035937 Approved "HPA035937: AB_10672995" "unprognostic (5.49e-2)" "unprognostic (4.04e-2)" "unprognostic (1.24e-1)" "unprognostic (8.27e-3)" "unprognostic (1.91e-1)" "unprognostic (2.02e-1)" "prognostic unfavourable (6.30e-5)" "unprognostic (1.86e-1)" "unprognostic (2.44e-1)" "unprognostic (1.29e-3)" "unprognostic (5.08e-2)" "unprognostic (2.78e-1)" "prognostic unfavourable (1.83e-6)" "unprognostic (2.66e-2)" "unprognostic (1.03e-2)" "unprognostic (2.49e-1)" "unprognostic (1.42e-1)" 5.6 4.7 5.1 6.0 11.1 19.3 4.4 43.3 15.3 3.8 11.1 5.0 11.6 32.5 4.6 3.8 5.4 3.8 8.3 3.7 4.2 4.1 7.3 3.5 6.0 4.5 6.0 6.8 4.0 6.5 32.1 6.3 4.4 13.9 9.9 17.5 4.1 5.1 7.6 7.6 3.9 28.7 5.2 4.1 9.2 4.8 11.2 5.0 7.1 3.7 3.6 4.2 7.2 4.5 1.7 2.1 15.9 6.6 0.3 1.9 0.8 3.8 6.7 3.5 2.3 8.9 6.5 19.1 11.3 6.4 7.9 8.9 15.4 5.7 9.0 6.7 13.5 9.6 11.1 7.0 7.8 2.5 9.7 2.8 10.9 5.1 11.4 6.6 15.3 4.7 8.2 6.6 4.4 6.9 6.3 7.9 6.6 4.2 1.9 3.3 3.5 6.3 0.0 8.5 3.5 2.0 5.8 3.2 6.1 7.0 8.5 4.0 6.4 9.7 6.9 10.5 5.9 17.0 6.3 3.7 5.2 5.8 6.7 11.6 6.9 15.9 6.6 2.5 1.2 2.8 0.8 1.6 1.1 1.9 2.1 1.7 0.9 0.8 14.5 0.3 2.8 0.4 1.1 0.8 5.1 11.1 43.3 15.3 4.2 4.1 6.0 6.8 13.9 5.0 SLC36A2 "PAT2, TRAMD1, tramdorin" ENSG00000186335 "Solute carrier family 36 member 2" Q495M3 5 151314978-151347590 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "kidney: 60.3;skeletal muscle: 36.8;tongue: 16.1" "Cell line enhanced" "Detected in some" "NB-4: 2.0" "Cancer enriched" "Detected in single" 9 "renal cancer: 0.5" "Region enhanced" "Detected in single" "midbrain: 1.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA044002, HPA062229" Enhanced "HPA044002: AB_10964214, HPA062229: " "unprognostic (3.47e-1)" "unprognostic (3.40e-1)" "unprognostic (2.26e-2)" "unprognostic (6.23e-2)" "unprognostic (8.38e-3)" "unprognostic (4.66e-3)" "unprognostic (3.03e-1)" "unprognostic (7.73e-2)" "unprognostic (1.92e-2)" "unprognostic (2.11e-1)" "unprognostic (1.92e-1)" "unprognostic (1.20e-3)" "unprognostic (1.43e-1)" "unprognostic (1.05e-1)" "unprognostic (2.18e-1)" "unprognostic (3.89e-2)" 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 2.6 0.5 0.1 0.0 0.2 0.1 0.1 60.3 0.1 0.1 0.0 1.2 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.1 0.0 1.1 2.0 0.0 36.8 0.1 0.1 0.0 0.2 0.1 0.1 0.7 0.0 0.0 0.1 16.1 1.4 0.1 0.1 2.1 1.5 4.3 0.8 1.5 0.9 0.3 0.1 0.3 0.4 0.7 0.3 0.1 1.0 0.4 0.0 0.1 0.0 0.6 0.3 0.8 0.3 0.2 0.4 0.0 0.7 0.0 1.4 1.5 0.3 0.8 0.3 0.0 1.8 0.5 0.1 0.1 0.0 0.0 0.5 0.1 1.4 0.2 0.3 0.4 2.0 1.1 0.2 0.5 0.3 0.2 0.2 0.1 0.4 0.4 0.1 1.2 0.0 0.3 0.3 0.5 0.2 0.2 1.2 0.2 0.5 0.2 0.4 0.3 0.3 0.1 3.2 0.8 0.9 0.7 0.6 0.6 1.1 0.6 0.6 0.2 2.1 0.7 0.9 4.3 1.5 0.6 1.5 0.5 0.3 0.1 0.1 0.1 0.1 0.1 0.1 1.2 0.0 0.4 0.0 SLC38A2 "ATA2, KIAA1382, SAT2, SNAT2" ENSG00000134294 "Solute carrier family 38 member 2" Q96QD8 12 46358189-46372867 "Predicted membrane proteins" "Amino-acid transport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 136.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035180 Approved Approved Vesicles Vesicles "HPA035180: AB_10669901" "unprognostic (6.61e-3)" "unprognostic (2.87e-2)" "unprognostic (4.88e-2)" "unprognostic (2.51e-2)" "unprognostic (2.96e-1)" "unprognostic (1.00e-2)" "unprognostic (7.78e-2)" "unprognostic (5.50e-3)" "unprognostic (1.20e-1)" "unprognostic (3.79e-1)" "unprognostic (9.24e-3)" "unprognostic (1.75e-1)" "unprognostic (1.47e-1)" "unprognostic (5.08e-2)" "unprognostic (3.80e-1)" "unprognostic (1.83e-1)" "unprognostic (8.68e-2)" 44.7 45.4 19.9 23.3 34.5 27.0 72.0 34.5 40.6 36.2 25.5 23.6 20.0 11.6 45.2 16.2 47.1 36.6 46.8 39.2 24.2 14.0 27.4 102.9 51.9 34.5 54.4 15.2 49.3 27.3 54.3 16.2 76.6 32.6 25.7 17.8 17.7 36.6 20.3 47.8 69.5 25.1 40.4 60.0 28.6 29.2 19.7 43.8 40.7 32.0 35.6 26.2 36.0 49.3 12.1 24.7 17.9 13.5 30.0 15.3 12.7 8.5 20.1 17.5 47.9 40.8 41.1 12.7 40.3 103.6 35.4 29.2 11.9 16.2 0.0 54.3 68.9 29.3 12.1 37.6 34.7 6.8 6.8 11.1 24.5 36.8 62.6 8.9 11.7 41.1 81.8 22.3 136.6 30.0 10.8 17.2 62.7 10.7 10.9 13.2 14.9 21.1 9.9 12.9 21.1 21.7 19.2 11.6 10.0 27.3 7.7 24.6 15.5 21.0 49.3 17.0 13.4 7.2 6.4 19.8 18.7 10.4 16.4 32.6 8.4 17.9 13.5 10.5 14.3 7.8 11.1 12.1 12.0 14.2 20.8 11.9 15.2 15.3 10.5 30.0 10.1 24.7 13.9 12.7 19.9 34.5 34.5 40.6 24.2 14.0 54.4 15.2 32.6 43.8 SLC38A5 "JM24, SN2" ENSG00000017483 "Solute carrier family 38 member 5" Q8WUX1 X 48458537-48470256 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pancreas: 87.7" "Cell line enhanced" "Detected in many" "HBEC3-KT: 53.2;HeLa: 52.4;hTCEpi: 39.6;Karpas-707: 46.8;RPMI-8226: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047411 Approved Approved "Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" Cytosol "HPA047411: AB_10964355" "unprognostic (2.81e-1)" "unprognostic (4.87e-2)" "unprognostic (7.92e-3)" "unprognostic (1.58e-1)" "unprognostic (1.29e-3)" "unprognostic (1.26e-1)" "unprognostic (7.75e-2)" "unprognostic (5.79e-2)" "unprognostic (1.52e-1)" "unprognostic (3.80e-3)" "prognostic unfavourable (2.13e-4)" "unprognostic (2.99e-2)" "prognostic unfavourable (2.22e-16)" "unprognostic (1.27e-3)" "unprognostic (1.45e-1)" "unprognostic (2.86e-1)" "unprognostic (2.20e-1)" 1.5 0.9 5.3 4.7 7.1 17.3 0.9 3.5 11.6 4.0 4.9 7.7 0.1 5.1 1.8 1.3 3.7 2.0 1.5 2.4 6.9 5.7 0.7 0.4 9.4 3.3 7.0 2.7 3.7 87.7 0.4 0.4 2.8 14.6 5.1 6.4 1.5 4.4 3.7 0.4 8.0 3.5 2.8 7.3 4.8 4.5 0.5 4.6 2.4 7.9 3.6 3.4 4.8 3.1 7.4 8.3 0.3 0.4 5.4 16.2 5.7 22.5 0.0 0.0 0.2 0.4 2.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 23.7 0.0 9.9 34.9 27.0 53.2 0.0 7.5 0.0 12.9 52.4 16.3 3.9 26.3 0.0 3.7 39.6 0.4 0.1 0.4 23.6 46.8 5.3 0.0 5.7 9.1 12.2 0.1 20.9 0.1 86.2 0.0 0.0 2.2 0.1 0.0 0.1 0.0 0.0 1.1 0.7 0.1 0.0 0.0 0.0 0.0 0.1 8.5 0.2 0.1 0.1 0.0 0.2 0.2 11.5 0.4 16.2 7.4 12.6 10.8 1.5 4.7 6.0 7.7 0.3 5.4 0.0 8.3 13.0 5.7 5.3 7.1 3.5 11.6 6.9 5.7 7.0 2.7 14.6 4.6 SLC39A3 ZIP3 ENSG00000141873 "Solute carrier family 39 member 3" Q9BRY0 19 2732204-2740152 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 88.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042139, HPA058526" Uncertain Approved Vesicles Vesicles "HPA042139: AB_10793875, HPA058526: " "unprognostic (1.81e-1)" "unprognostic (1.47e-2)" "unprognostic (1.16e-1)" "prognostic favourable (9.76e-5)" "unprognostic (2.26e-1)" "unprognostic (2.44e-2)" "unprognostic (9.88e-3)" "unprognostic (1.01e-1)" "unprognostic (6.03e-2)" "unprognostic (3.66e-2)" "unprognostic (4.37e-3)" "unprognostic (4.07e-2)" "unprognostic (1.75e-3)" "unprognostic (9.22e-3)" "unprognostic (6.58e-2)" "unprognostic (7.97e-2)" "unprognostic (1.80e-2)" 11.1 15.5 13.3 8.3 18.0 23.9 13.3 10.6 28.0 12.7 10.8 14.0 8.3 10.2 14.3 19.5 10.5 14.6 10.5 11.7 14.4 13.0 11.0 23.6 9.0 11.7 11.5 12.9 11.0 11.9 17.8 15.5 10.6 14.9 10.8 8.8 10.7 12.4 11.7 11.2 8.1 9.4 14.0 11.1 12.9 9.3 50.1 8.8 13.0 12.5 6.8 9.4 14.2 7.8 24.4 38.0 29.6 17.5 13.1 17.5 15.4 11.6 9.5 7.2 17.6 14.9 10.2 7.3 8.5 10.1 15.8 16.2 10.2 7.6 7.2 5.5 14.6 9.5 10.9 11.4 9.9 0.0 7.8 31.9 7.0 10.3 16.4 26.4 46.7 9.1 18.4 11.7 9.6 8.0 34.9 32.4 10.5 7.5 12.9 19.8 7.6 12.7 17.1 4.7 21.6 7.5 9.2 9.9 9.0 7.4 5.3 17.8 9.3 34.6 4.9 11.0 6.1 17.2 12.4 8.8 13.8 6.9 8.3 88.8 13.1 16.4 17.5 29.6 17.5 16.1 15.4 24.4 15.4 14.9 23.4 24.4 12.9 14.5 7.8 13.1 15.5 38.0 9.7 15.4 13.3 18.0 10.6 28.0 14.4 13.0 11.5 12.9 14.9 8.8 SLC41A3 FLJ20473 ENSG00000114544 "Solute carrier family 41 member 3" Q96GZ6 3 126006355-126101561 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045847 Approved Supported "Plasma membrane" "Plasma membrane" "HPA045847: " "unprognostic (1.77e-1)" "unprognostic (3.35e-2)" "unprognostic (1.11e-1)" "unprognostic (3.37e-2)" "unprognostic (7.68e-3)" "unprognostic (2.20e-1)" "prognostic unfavourable (1.49e-7)" "unprognostic (1.36e-1)" "unprognostic (3.23e-2)" "unprognostic (2.82e-3)" "unprognostic (5.74e-2)" "unprognostic (3.57e-1)" "prognostic favourable (6.04e-7)" "unprognostic (1.26e-1)" "unprognostic (5.88e-2)" "unprognostic (2.85e-1)" "unprognostic (7.54e-2)" 11.2 20.2 21.3 10.7 20.7 5.3 22.2 29.8 43.4 18.6 10.6 12.6 12.1 10.1 21.1 32.9 10.8 24.0 16.3 17.1 17.9 20.6 14.0 8.5 9.5 14.3 17.1 16.5 31.2 17.6 19.7 16.9 10.9 21.4 12.5 10.9 18.6 16.7 14.5 25.5 10.7 8.9 17.1 11.7 8.8 10.7 30.5 6.0 27.7 18.0 11.5 10.4 12.3 11.9 9.0 8.6 9.3 8.2 13.0 18.8 5.6 17.5 7.3 12.0 10.1 34.2 20.1 18.1 10.0 17.5 14.0 16.6 9.6 16.0 12.9 19.1 19.8 13.8 4.4 17.5 12.3 12.4 13.8 7.0 13.6 13.8 28.3 12.7 7.8 19.4 21.5 8.4 17.4 19.3 5.8 10.8 18.4 9.4 14.0 10.4 9.1 11.3 7.4 12.4 17.4 16.7 13.0 9.3 10.1 15.5 5.0 42.6 5.1 17.1 13.2 13.1 10.1 19.8 11.3 8.2 6.7 6.3 11.9 5.7 11.9 9.3 5.7 3.9 11.2 8.2 9.1 9.0 10.6 11.5 8.6 8.4 9.2 8.7 1.2 13.0 5.1 8.4 18.8 5.6 21.3 20.7 29.8 43.4 17.9 20.6 17.1 16.5 21.4 6.0 SLC43A2 MGC34680 ENSG00000167703 "Solute carrier family 43 member 2" Q8N370 17 1569267-1628886 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 92.7" "Cell line enhanced" "Detected in many" "CACO-2: 15.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021564 Enhanced "HPA021564: AB_1857169" "unprognostic (5.95e-3)" "unprognostic (4.45e-2)" "unprognostic (1.72e-1)" "unprognostic (2.42e-2)" "unprognostic (2.58e-2)" "unprognostic (2.80e-2)" "unprognostic (1.05e-2)" "unprognostic (5.02e-2)" "unprognostic (6.49e-2)" "unprognostic (2.80e-1)" "prognostic favourable (1.05e-6)" "unprognostic (1.96e-1)" "prognostic favourable (5.40e-5)" "unprognostic (1.84e-1)" "unprognostic (4.14e-2)" "unprognostic (1.01e-1)" "unprognostic (2.20e-1)" 5.5 2.7 5.4 13.7 5.7 12.2 3.6 14.8 11.9 2.6 2.6 5.0 2.1 7.0 2.1 4.1 1.4 5.9 3.9 1.6 5.6 7.2 15.8 3.0 6.8 8.3 5.1 3.8 2.3 1.6 1.5 6.2 92.7 5.8 2.8 2.4 4.9 4.0 3.5 23.2 1.3 11.6 4.7 3.5 8.9 2.8 1.5 1.3 5.0 5.8 2.2 3.5 5.0 1.3 1.3 3.1 15.0 5.4 0.5 0.3 2.0 0.9 2.5 0.8 7.5 1.5 1.3 10.2 0.5 0.2 1.8 0.8 15.2 1.7 4.4 5.1 0.7 1.8 4.6 0.9 0.3 0.0 0.4 0.8 2.3 3.8 1.8 0.1 1.4 1.6 1.4 1.1 0.5 7.2 1.9 0.0 0.3 3.6 9.1 0.8 0.8 0.3 2.5 0.0 5.2 3.4 8.7 3.1 1.6 2.3 6.2 0.2 6.1 5.3 9.3 0.2 1.1 2.0 0.6 0.5 9.2 2.2 0.4 0.9 0.2 2.5 5.4 5.3 0.3 4.6 0.1 1.3 0.2 0.2 3.1 1.2 0.2 0.2 15.0 0.5 4.5 1.7 0.2 2.0 5.4 5.7 14.8 11.9 5.6 7.2 5.1 3.8 5.8 1.3 SLC49A3 "FLJ22269, LP2561, MFSD7" ENSG00000169026 "Solute carrier family 49 member 3" Q6UXD7 4 681829-689441 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 7.3;SK-BR-3: 7.2;T-47d: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043593 Uncertain "HPA043593: AB_10959611" "unprognostic (1.10e-2)" "unprognostic (1.91e-1)" "unprognostic (8.77e-2)" "unprognostic (4.70e-2)" "unprognostic (9.40e-2)" "unprognostic (1.84e-3)" "unprognostic (2.22e-1)" "unprognostic (1.56e-2)" "unprognostic (1.83e-1)" "unprognostic (2.56e-1)" "unprognostic (9.22e-2)" "unprognostic (2.08e-1)" "prognostic favourable (2.66e-5)" "unprognostic (8.35e-2)" "unprognostic (4.92e-2)" "unprognostic (7.48e-2)" "unprognostic (1.11e-1)" 13.8 3.3 4.8 5.4 3.1 3.8 13.9 4.6 4.5 4.7 6.5 1.7 4.1 7.4 4.2 10.0 7.5 3.5 5.0 8.9 1.8 1.5 7.7 8.8 17.6 9.2 2.4 2.4 2.8 8.7 11.1 2.4 4.1 3.6 5.3 2.8 7.4 10.6 2.8 2.9 9.6 7.2 4.2 3.0 9.7 9.8 23.6 2.2 2.2 9.2 4.6 2.8 4.9 5.2 0.0 0.6 4.2 1.8 1.2 0.3 0.9 0.1 0.1 2.4 1.7 1.6 3.8 7.3 0.8 0.0 0.8 0.5 0.4 4.9 0.1 0.1 3.8 0.2 0.0 0.0 0.2 0.5 0.4 1.4 0.6 0.2 0.6 0.0 1.0 2.3 0.0 3.1 0.0 1.1 0.3 0.5 0.0 0.1 0.1 0.5 0.2 0.3 0.0 0.3 0.5 0.0 0.3 0.8 0.6 0.0 7.2 0.4 22.6 1.4 0.3 0.7 0.2 0.3 0.2 2.5 1.3 0.1 0.2 0.6 0.0 0.0 1.8 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 4.2 1.2 0.7 0.0 0.3 0.9 4.8 3.1 4.6 4.5 1.8 1.5 2.4 2.4 3.6 2.2 SLC52A3 "bA371L19.1, C20orf54, hRFT2, RFVT3" ENSG00000101276 "Solute carrier family 52 member 3" Q9NQ40 20 760080-776015 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 32.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 27.0;RT4: 6.3;SK-BR-3: 9.9;T-47d: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049391, HPA059078" Approved "HPA049391: , HPA059078: " "unprognostic (4.53e-2)" "unprognostic (1.11e-1)" "unprognostic (8.60e-2)" "unprognostic (7.84e-2)" "unprognostic (1.29e-1)" "unprognostic (9.03e-3)" "unprognostic (2.12e-3)" "unprognostic (1.43e-3)" "unprognostic (1.15e-2)" "unprognostic (4.36e-2)" "unprognostic (4.39e-3)" "unprognostic (4.82e-2)" "unprognostic (2.04e-3)" "prognostic favourable (5.51e-6)" "unprognostic (3.04e-1)" "unprognostic (2.21e-1)" "unprognostic (1.44e-1)" 2.0 0.4 7.3 1.4 5.9 0.5 2.8 3.5 9.0 2.6 9.6 2.1 12.0 13.1 1.8 1.9 4.6 2.0 3.0 3.3 6.6 4.2 10.0 0.4 1.4 0.7 5.6 1.3 1.2 2.2 0.6 0.5 6.7 7.3 7.9 6.3 0.5 5.5 15.8 1.0 1.7 16.3 1.5 4.7 0.4 5.2 32.5 6.0 0.0 0.7 1.2 0.9 4.7 2.2 1.1 0.7 2.4 0.6 1.1 0.8 0.4 3.4 1.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.4 27.0 0.0 4.0 0.0 3.9 0.0 2.9 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 2.4 0.0 0.0 0.3 0.0 6.3 0.0 0.1 3.9 9.9 0.0 12.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.6 0.5 0.4 0.2 0.4 0.5 0.4 0.4 0.1 1.1 0.4 0.8 2.2 1.1 0.4 0.7 0.3 0.4 7.3 5.9 3.5 9.0 6.6 4.2 5.6 1.3 7.3 6.0 SLC9B2 "FLJ23984, NHA2, NHEDC2" ENSG00000164038 "Solute carrier family 9 member B2" Q86UD5 4 103019868-103085829 "Predicted membrane proteins, Transporters" "Antiport, Hydrogen ion transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 45.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 5.6;NK-cells: 12.2;T-cells: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047008 Uncertain Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA047008: " "unprognostic (1.85e-1)" "unprognostic (5.43e-2)" "unprognostic (2.68e-1)" "unprognostic (1.11e-1)" "unprognostic (8.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.43e-2)" "unprognostic (3.78e-2)" "unprognostic (3.26e-1)" "unprognostic (2.53e-2)" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (2.51e-5)" "unprognostic (2.23e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-2)" "unprognostic (2.35e-5)" 7.3 7.9 8.8 6.3 13.3 5.3 5.5 16.5 24.5 5.6 5.0 5.2 0.4 2.0 8.5 4.2 4.7 5.9 9.8 5.5 8.9 12.5 1.9 45.6 3.3 7.2 10.3 13.4 8.0 2.4 1.2 8.8 5.2 20.8 5.6 3.9 8.3 2.1 6.7 4.5 3.7 3.0 9.8 9.8 4.6 5.7 4.8 4.7 2.5 2.6 1.8 6.9 5.5 8.5 5.6 1.7 0.0 0.1 12.2 6.3 1.8 2.6 1.3 3.1 6.4 15.5 13.0 0.0 11.9 4.7 2.0 1.8 1.3 1.7 16.8 2.1 13.8 0.8 7.0 5.0 2.8 14.7 4.9 16.8 4.2 12.1 8.3 11.7 5.3 11.4 6.7 4.2 14.5 8.5 5.6 12.3 6.2 1.0 9.4 7.2 2.3 3.8 0.0 3.4 7.3 5.7 1.0 10.7 9.7 5.4 1.4 3.5 1.4 7.8 10.5 4.4 2.7 6.9 4.1 10.5 7.6 12.2 5.3 10.3 1.7 0.0 0.1 0.0 5.1 0.0 6.3 5.6 5.6 4.5 0.9 3.6 3.4 4.2 0.0 12.2 0.1 1.7 2.4 1.8 8.8 13.3 16.5 21.2 8.9 12.5 10.3 13.4 20.8 4.7 SLCO1A2 "OATP, OATP-A, OATP1A2, SLC21A3" ENSG00000084453 "Solute carrier organic anion transporter family member 1A2" P46721 12 21264600-21419594 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5" "Cell line enhanced" "Detected in some" "NTERA-2: 13.7;RPMI-8226: 9.5;U-266/70: 20.5;U-266/84: 8.2" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071152 Supported "Plasma membrane" "Plasma membrane" "HPA071152: " "unprognostic (5.43e-3)" "unprognostic (2.33e-1)" "unprognostic (1.28e-1)" "unprognostic (8.59e-2)" "unprognostic (1.08e-1)" "unprognostic (6.36e-2)" "unprognostic (7.63e-2)" "unprognostic (1.53e-1)" "unprognostic (3.82e-2)" "unprognostic (1.54e-2)" "unprognostic (1.51e-1)" "unprognostic (8.82e-2)" "unprognostic (1.66e-4)" "unprognostic (2.52e-2)" "unprognostic (3.20e-1)" "unprognostic (1.24e-1)" 0.2 0.1 3.3 0.0 3.4 0.0 3.6 3.4 17.9 0.1 0.1 1.9 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.9 4.1 2.5 1.1 11.2 2.7 0.6 3.0 4.0 0.2 2.3 0.5 0.5 1.2 9.7 0.7 0.0 14.2 14.5 0.0 0.4 0.4 0.2 0.0 2.9 0.4 0.4 1.6 1.4 0.0 0.3 0.0 0.3 0.4 0.1 1.3 0.7 4.3 0.4 1.1 2.3 0.2 2.1 0.5 0.8 0.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 3.0 1.7 0.1 2.1 0.1 0.2 0.2 0.1 0.4 0.5 0.7 0.0 0.5 1.1 0.0 0.3 0.2 0.0 1.4 0.1 0.1 0.1 3.5 1.4 0.0 2.1 0.3 0.1 13.7 0.1 0.1 0.2 9.5 0.0 2.1 1.9 2.3 0.0 0.2 0.2 2.7 0.7 0.0 0.0 1.4 0.7 0.3 20.5 8.2 0.1 0.2 0.2 0.1 0.6 0.4 0.3 1.4 0.3 2.3 1.3 2.2 1.5 0.1 1.0 2.1 1.6 4.3 1.1 0.1 0.7 1.8 0.2 3.3 3.4 3.4 5.0 4.1 2.5 3.0 4.0 9.7 1.4 SPPL2A "IMP3, PSL2" ENSG00000138600 "Signal peptide peptidase like 2A" Q8TCT8 15 50702266-50765808 "Enzymes, Plasma proteins, Predicted membrane proteins, Transporters" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036062, HPA067304" Enhanced Supported Vesicles Vesicles "HPA036062: AB_10611670, HPA067304: " "unprognostic (1.66e-1)" "unprognostic (1.03e-1)" "unprognostic (2.70e-1)" "unprognostic (5.82e-3)" "unprognostic (3.71e-1)" "unprognostic (1.70e-1)" "unprognostic (2.15e-1)" "unprognostic (1.88e-1)" "unprognostic (2.22e-2)" "unprognostic (6.36e-2)" "unprognostic (2.04e-2)" "unprognostic (4.00e-2)" "unprognostic (3.11e-2)" "unprognostic (2.26e-2)" "unprognostic (1.44e-2)" "unprognostic (6.96e-2)" "unprognostic (3.66e-1)" 20.5 23.5 6.9 18.0 8.6 15.0 23.3 6.2 8.1 16.4 29.3 10.8 15.3 24.9 14.5 17.9 18.7 13.0 14.9 37.6 7.8 5.3 23.3 44.8 19.2 23.9 8.3 6.1 13.2 32.7 61.0 11.8 32.2 14.4 14.7 26.9 14.9 21.7 15.5 63.1 15.8 39.2 20.5 8.5 21.2 18.3 10.2 7.4 21.6 15.6 17.4 17.7 19.7 13.9 9.8 19.4 24.0 27.3 11.9 15.4 22.4 15.2 26.5 10.3 13.7 40.9 24.4 16.3 24.6 41.3 22.6 32.3 30.7 17.7 9.5 18.4 48.1 23.0 12.4 14.9 25.3 19.4 7.6 18.0 18.2 15.9 33.8 11.1 29.4 21.2 27.5 18.7 30.3 22.2 13.5 37.4 29.8 35.2 5.2 4.3 4.5 6.0 6.5 16.1 20.8 31.1 35.5 8.3 9.4 14.8 28.6 16.6 20.3 22.1 27.0 36.6 14.7 23.4 28.9 15.2 26.0 10.5 16.5 18.8 24.9 21.2 26.9 24.0 15.4 24.6 9.7 9.8 12.6 13.9 19.4 9.3 7.2 11.5 19.4 11.9 27.3 17.1 15.4 22.4 6.9 8.6 6.2 8.1 7.8 5.3 8.3 6.1 14.4 7.4 SURF4 "ERV29, FLJ22993, MGC102753" ENSG00000148248 "Surfeit 4" O15260 9 133361449-133376166 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064613 Approved 470000 "HPA064613: " "prognostic unfavourable (5.85e-4)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (2.04e-2)" "unprognostic (3.40e-2)" "prognostic unfavourable (1.47e-5)" "prognostic unfavourable (8.11e-4)" "unprognostic (1.10e-3)" "unprognostic (3.13e-2)" "unprognostic (1.90e-1)" "unprognostic (5.30e-3)" "unprognostic (1.23e-1)" "unprognostic (9.76e-3)" "unprognostic (7.58e-3)" "unprognostic (1.25e-1)" "unprognostic (2.29e-1)" "unprognostic (4.29e-3)" 31.1 33.7 11.4 19.0 15.3 29.1 34.4 9.9 23.4 24.0 36.9 19.3 29.5 40.4 26.6 27.2 24.6 23.5 32.4 24.4 10.9 11.0 28.6 120.0 27.1 26.7 12.6 12.1 27.2 60.3 16.8 29.4 48.7 13.2 22.3 20.0 18.9 65.6 30.8 18.0 19.2 61.5 22.5 13.5 19.8 26.2 26.5 11.5 21.3 35.5 21.0 23.2 20.2 20.6 7.7 18.9 18.8 19.0 13.7 29.7 28.0 14.3 24.1 16.7 22.9 35.3 37.0 32.4 44.8 45.1 32.6 32.3 36.1 21.3 10.1 17.5 63.2 38.1 19.1 23.6 25.1 21.1 11.1 17.7 22.9 38.3 41.0 30.3 24.1 39.4 22.0 28.0 31.1 29.9 21.1 28.0 41.5 32.2 14.4 28.2 18.2 23.0 10.0 22.9 38.3 25.6 14.0 13.7 16.7 33.7 25.5 23.1 27.1 18.7 31.4 46.5 16.6 35.0 29.2 14.4 20.2 11.5 43.1 16.5 34.7 18.8 19.0 16.6 27.0 15.7 29.7 7.7 19.2 24.7 16.3 6.3 11.8 18.2 13.8 13.7 14.0 18.9 22.3 28.0 11.4 15.3 9.9 23.4 10.9 11.0 12.6 12.1 13.2 11.5 TAP2 "ABCB3, D6S217E, PSF2, RING11" ENSG00000204267 "Transporter 2, ATP binding cassette subfamily B member" Q03519 6 32821833-32838780 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 28.3;U-251 MG: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA001312 Approved Approved "Nuclear speckles,Endoplasmic reticulum" 14000 "Endoplasmic reticulum" "Nuclear speckles" "HPA001312: AB_1080206" "unprognostic (2.95e-3)" "unprognostic (2.35e-1)" "unprognostic (3.77e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.28e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-2)" "prognostic unfavourable (1.51e-4)" "unprognostic (1.90e-1)" "prognostic unfavourable (5.22e-8)" "unprognostic (5.32e-1)" "unprognostic (4.17e-2)" "unprognostic (2.35e-1)" "unprognostic (4.71e-2)" 12.8 8.4 6.5 22.5 6.9 14.7 9.5 6.3 7.3 8.8 15.0 7.6 3.3 15.3 9.6 5.9 17.4 7.9 11.5 7.7 5.2 6.0 10.8 19.0 18.0 14.0 7.1 6.3 9.7 6.1 2.6 5.8 5.7 7.9 8.2 11.9 7.9 12.1 5.2 5.8 9.6 28.0 7.0 6.1 24.9 7.7 3.3 6.9 25.9 14.7 7.1 20.1 23.6 10.7 0.9 2.8 4.9 5.4 2.9 4.1 1.9 7.8 0.0 0.0 2.3 2.2 3.0 0.0 0.5 1.6 6.2 8.4 2.1 16.1 15.4 3.0 3.9 8.2 7.1 28.3 2.4 10.4 0.9 1.8 6.0 0.7 1.0 0.0 12.2 0.3 0.4 8.4 13.0 4.0 8.5 5.2 0.0 0.6 2.0 1.0 0.3 3.9 8.4 0.0 5.9 5.2 0.1 0.1 0.0 7.6 16.2 1.6 0.8 0.0 2.3 8.7 2.0 2.3 28.0 8.0 13.3 14.4 8.0 10.8 1.5 1.7 2.0 1.8 4.1 5.4 2.0 0.9 1.2 2.7 2.0 0.6 1.0 0.6 4.9 2.9 4.1 2.8 1.9 1.9 6.5 6.9 6.3 7.3 5.2 6.0 7.1 6.3 7.9 6.9 TAS2R60 T2R60 ENSG00000185899 "Taste 2 receptor member 60" P59551 7 143443453-143444409 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.3;liver: 1.4;pancreas: 1.3" "Cell line enhanced" "Detected in some" "NTERA-2: 2.3;U-937: 1.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA030416 Uncertain "HPA030416: AB_10603344" "unprognostic (1.78e-2)" "unprognostic (7.98e-2)" 0.1 0.0 0.0 0.4 0.0 0.9 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.2 0.0 0.0 1.3 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 1.0 0.9 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 1.3 0.5 1.0 0.0 0.9 0.0 0.0 0.3 TCIRG1 "a3, Atp6i, ATP6N1C, ATP6V0A3, OC-116, OC116, TIRC7" ENSG00000110719 "T cell immune regulator 1, ATPase H+ transporting V0 subunit a3" Q13488 11 68039016-68050895 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 40.0;RPMI-8226: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038742 Approved Approved Mitochondria Mitochondria "HPA038742: AB_10795138" "unprognostic (5.35e-2)" "unprognostic (5.01e-2)" "unprognostic (1.81e-2)" "unprognostic (1.50e-2)" "unprognostic (6.98e-3)" "unprognostic (1.25e-1)" "unprognostic (5.07e-2)" "unprognostic (6.43e-2)" "unprognostic (7.03e-2)" "unprognostic (2.47e-2)" "unprognostic (1.36e-1)" "unprognostic (2.15e-1)" "prognostic unfavourable (1.50e-11)" "unprognostic (2.48e-3)" "unprognostic (7.88e-3)" "unprognostic (2.50e-1)" "prognostic favourable (9.45e-6)" 25.8 24.1 5.0 20.1 7.2 39.5 10.2 1.3 5.4 20.1 21.8 3.9 19.9 20.1 14.1 27.1 11.9 12.5 16.4 5.9 2.4 1.6 8.9 25.2 24.1 20.7 7.1 2.2 11.4 69.6 2.6 4.7 14.4 6.9 15.7 4.1 6.8 18.3 11.0 3.5 5.2 25.8 10.8 7.7 44.7 17.4 4.2 5.5 7.5 11.7 8.3 24.3 13.0 13.4 3.3 13.4 40.4 36.8 8.2 4.9 10.7 9.1 16.8 0.2 0.0 7.7 6.1 11.8 18.2 8.8 5.2 5.0 0.3 27.4 0.8 9.9 6.4 11.5 1.1 7.0 1.1 23.7 0.5 6.3 20.5 5.4 7.2 4.6 40.0 7.0 4.1 6.4 0.4 3.5 3.3 2.5 1.7 3.1 0.2 27.8 1.0 4.3 7.8 0.2 39.8 4.9 5.2 0.9 0.2 7.6 10.0 4.9 10.9 12.0 12.4 10.1 8.0 28.1 3.2 0.4 0.3 1.3 22.6 7.7 4.8 5.5 16.6 18.8 4.5 28.8 3.7 3.3 3.4 4.9 13.4 2.2 2.0 2.1 40.4 8.2 36.8 9.0 3.3 10.7 5.0 7.2 1.3 5.4 2.4 1.6 7.1 2.2 6.9 5.5 TM6SF1 ENSG00000136404 "Transmembrane 6 superfamily member 1" Q9BZW5 15 83107407-83144854 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.3;skeletal muscle: 37.8" "Cell line enhanced" "Detected in some" "HEL: 9.4;HHSteC: 22.3;HUVEC TERT2: 11.7;THP-1: 6.5;TIME: 30.6;U-698: 7.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 44.3;neutrophil: 26.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 44.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016051, HPA056857" Uncertain "HPA016051: AB_2203924, HPA056857: " "unprognostic (8.09e-2)" "unprognostic (1.31e-1)" "unprognostic (2.87e-2)" "unprognostic (4.67e-1)" "unprognostic (1.96e-1)" "unprognostic (1.43e-1)" "unprognostic (6.46e-2)" "unprognostic (3.52e-3)" "unprognostic (1.73e-1)" "unprognostic (1.70e-2)" "unprognostic (2.80e-1)" "unprognostic (2.55e-1)" "prognostic favourable (6.79e-4)" "unprognostic (1.15e-2)" "unprognostic (4.65e-3)" "unprognostic (2.60e-2)" "unprognostic (1.70e-1)" 9.6 3.4 4.9 4.9 6.8 4.7 11.2 4.4 13.9 4.0 3.0 6.8 0.9 2.3 3.2 4.1 2.4 3.4 3.9 9.2 7.2 6.7 2.9 2.5 10.6 9.0 8.0 7.1 2.1 1.5 1.8 1.7 7.2 10.0 2.5 2.9 3.4 3.2 1.9 37.8 1.7 2.6 3.8 12.5 5.2 2.1 4.1 3.7 0.6 9.9 3.5 3.0 4.9 2.4 0.2 4.6 44.3 7.8 1.0 1.2 2.8 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 1.8 0.0 0.0 0.0 0.2 9.4 0.0 0.0 22.3 0.5 0.0 0.1 0.0 0.0 0.0 11.7 0.4 0.0 0.2 0.0 0.0 0.7 0.2 0.0 0.0 1.6 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.8 0.0 6.5 30.6 0.3 0.4 0.0 0.1 0.9 0.0 7.0 0.0 1.2 0.0 14.1 7.8 44.3 1.2 3.3 0.0 0.0 0.1 0.1 4.6 0.2 0.0 0.1 26.4 1.0 1.4 0.6 0.0 2.8 4.9 6.8 4.4 13.9 7.2 6.7 8.0 7.1 10.0 3.7 TM6SF2 Lpr4 ENSG00000213996 "Transmembrane 6 superfamily member 2" Q9BZW4 19 19264364-19273391 "Predicted membrane proteins" "Lipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 89.4" "Cell line enhanced" "Detected in some" "Hep G2: 3.3;HHSteC: 4.9;LHCN-M2: 3.8;NTERA-2: 2.6;SH-SY5Y: 4.3" "Cancer enhanced" "Detected in many" "liver cancer: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA066026 Uncertain "HPA066026: " "unprognostic (2.41e-1)" "unprognostic (4.81e-3)" "unprognostic (1.49e-1)" "unprognostic (1.15e-3)" "unprognostic (3.29e-1)" "unprognostic (2.35e-1)" "unprognostic (1.39e-3)" "unprognostic (4.00e-2)" "unprognostic (4.15e-2)" "unprognostic (4.53e-4)" "unprognostic (9.55e-3)" "unprognostic (4.37e-2)" "unprognostic (1.38e-1)" "unprognostic (1.61e-1)" "unprognostic (4.56e-2)" "unprognostic (1.51e-1)" "unprognostic (6.15e-2)" 0.1 0.1 0.2 0.2 0.1 0.0 0.3 0.3 0.3 0.6 43.2 0.2 0.2 36.8 0.4 1.7 0.2 0.2 1.0 0.4 0.2 0.5 3.2 18.5 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.1 0.5 0.5 0.9 0.4 0.2 0.4 0.0 0.1 89.4 0.2 0.1 0.1 1.1 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.9 0.0 0.0 0.4 0.1 2.1 1.2 1.0 1.3 1.0 0.1 0.0 1.0 1.7 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 3.3 4.9 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.8 2.6 0.0 0.0 0.0 0.4 0.0 0.0 1.9 4.3 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.3 0.2 0.5 0.1 0.1 0.5 0.1 TM7SF2 "ANG1, DHCR14A, NET47" ENSG00000149809 "Transmembrane 7 superfamily member 2" O76062 11 65111845-65116384 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 78.1" "Cell line enhanced" "Detected in many" "MCF7: 21.6;RPTEC TERT1: 24.9;T-47d: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 22.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030691, HPA072704" Enhanced Supported "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum" Vesicles "HPA030691: AB_10602480, HPA072704: " "unprognostic (1.62e-1)" "unprognostic (5.23e-2)" "unprognostic (1.70e-2)" "unprognostic (1.78e-1)" "unprognostic (5.74e-2)" "unprognostic (1.10e-1)" "unprognostic (5.98e-2)" "unprognostic (6.06e-2)" "unprognostic (5.72e-2)" "unprognostic (1.74e-2)" "unprognostic (7.06e-2)" "unprognostic (1.69e-1)" "prognostic favourable (8.49e-8)" "unprognostic (8.77e-2)" "unprognostic (1.90e-1)" "unprognostic (1.35e-1)" "unprognostic (3.44e-2)" 27.7 78.1 6.9 2.2 12.5 2.0 10.0 5.6 21.7 4.7 3.1 22.4 5.1 4.8 1.5 11.0 11.5 6.4 8.5 28.2 7.4 6.6 8.3 38.6 5.1 1.7 10.3 9.6 13.5 22.6 11.8 6.2 2.2 13.2 19.8 2.3 5.4 28.5 3.3 3.3 17.9 2.8 1.3 7.3 1.9 8.8 5.3 8.8 1.9 7.4 13.6 10.4 2.6 6.1 7.4 22.6 1.8 1.0 7.3 7.6 3.0 2.6 3.5 8.3 12.0 3.3 0.2 5.3 0.6 1.3 1.0 1.1 8.6 12.2 5.3 9.4 0.4 4.3 3.7 5.8 0.7 5.0 1.8 3.3 1.0 17.3 6.8 1.3 3.6 1.5 1.8 4.8 0.6 0.9 1.9 4.1 0.3 21.6 2.2 5.7 4.5 4.0 7.1 0.4 12.4 24.9 3.8 9.5 10.6 0.4 9.1 2.1 48.4 3.5 0.6 0.1 1.2 1.2 0.8 9.4 5.9 3.0 0.8 2.0 0.3 0.5 1.0 1.8 5.5 0.8 4.3 7.1 3.5 4.5 0.9 7.4 7.6 5.5 0.7 7.3 0.5 22.6 3.1 3.0 6.9 12.5 5.6 21.7 7.4 6.6 10.3 9.6 13.2 8.8 TMBIM1 "LFG3, PP1201, RECS1" ENSG00000135926 "Transmembrane BAX inhibitor motif containing 1" Q969X1 2 218274192-218292586 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 84.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012093, HPA070824" Approved Supported Vesicles Vesicles "HPA012093: AB_1858056, HPA070824: " "unprognostic (4.36e-2)" "unprognostic (1.70e-1)" "unprognostic (1.13e-1)" "unprognostic (1.73e-3)" "unprognostic (2.34e-3)" "unprognostic (3.81e-3)" "unprognostic (8.91e-3)" "unprognostic (5.58e-3)" "unprognostic (9.85e-2)" "unprognostic (3.76e-3)" "prognostic unfavourable (4.22e-4)" "unprognostic (1.69e-1)" "prognostic favourable (3.38e-4)" "unprognostic (1.22e-1)" "unprognostic (4.63e-2)" "unprognostic (2.75e-2)" "unprognostic (4.50e-1)" 64.3 34.6 26.5 22.1 45.0 23.0 84.3 11.0 38.3 35.7 42.2 43.1 33.7 41.8 35.0 30.0 86.8 25.1 50.3 34.6 21.0 17.2 50.7 69.3 46.7 34.3 37.5 13.7 27.9 87.6 31.3 15.0 92.7 40.9 31.6 40.1 23.9 40.1 43.7 53.2 49.5 70.6 41.2 50.3 22.7 57.8 13.2 32.5 9.4 66.4 42.1 36.3 57.7 54.5 17.0 19.6 60.3 43.5 13.0 24.0 33.6 26.8 9.7 0.5 7.1 62.9 26.6 29.0 26.4 32.6 15.6 18.0 24.8 66.7 6.1 19.3 38.8 46.0 9.0 59.2 15.4 22.1 3.7 38.9 6.7 29.7 28.5 0.5 38.5 25.1 55.7 32.0 40.9 16.6 24.2 11.5 27.3 1.1 0.4 6.7 0.4 8.7 0.9 4.3 4.8 21.0 84.8 0.5 0.5 8.7 32.4 18.3 8.7 5.9 25.1 28.2 7.8 13.0 9.5 5.6 6.5 2.7 27.7 6.1 15.9 60.3 27.7 59.9 24.0 36.2 20.5 17.0 22.0 19.5 19.6 14.0 14.7 15.8 35.5 13.0 43.5 5.3 23.5 33.6 26.5 45.0 11.0 38.3 21.0 17.2 37.5 13.7 40.9 32.5 TMC5 FLJ13593 ENSG00000103534 "Transmembrane channel like 5" Q6UXY8 16 19410496-19499113 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "intestine: 108.7" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 38.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA040810, HPA042037" Enhanced Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA040810: AB_10795627, HPA042037: AB_10804126" "unprognostic (2.47e-2)" "unprognostic (3.68e-1)" "unprognostic (3.50e-2)" "unprognostic (2.74e-3)" "unprognostic (1.01e-1)" "unprognostic (3.64e-2)" "prognostic unfavourable (7.96e-4)" "unprognostic (1.21e-1)" "unprognostic (1.59e-1)" "unprognostic (9.74e-2)" "unprognostic (3.27e-2)" "unprognostic (3.71e-1)" "unprognostic (2.28e-2)" "unprognostic (2.69e-1)" "unprognostic (7.88e-2)" "unprognostic (8.88e-3)" "unprognostic (1.75e-1)" 0.7 0.3 0.3 4.8 0.3 0.1 5.6 0.3 0.7 3.8 66.1 0.6 0.6 19.1 2.1 16.9 1.4 1.9 15.9 0.4 0.4 0.3 0.3 1.8 17.6 0.2 0.3 0.4 1.8 5.4 4.5 1.0 3.7 1.0 8.4 9.8 1.7 18.9 0.2 0.3 0.8 108.7 0.3 0.2 0.3 19.5 2.6 0.2 0.2 0.8 1.7 4.1 1.5 1.1 0.5 0.7 2.2 0.6 0.9 0.8 0.3 3.6 6.0 0.0 0.1 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 38.9 0.0 0.2 0.0 2.4 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.1 1.4 1.7 0.0 0.0 1.4 0.1 0.1 0.4 0.1 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.6 0.2 0.3 0.3 0.2 0.4 0.8 0.3 0.2 0.5 0.2 0.3 2.2 0.9 0.4 0.7 0.1 0.3 0.3 0.3 0.3 0.7 0.4 0.3 0.3 0.4 1.0 0.2 TMEM117 DKFZp434K2435 ENSG00000139173 "Transmembrane protein 117" Q9H0C3 12 43835967-44389762 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 8 "B-cells: 2.6;NK-cells: 1.1;T-cells: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046223 Uncertain "HPA046223: AB_10960636" "unprognostic (1.37e-2)" "unprognostic (2.99e-1)" "unprognostic (4.32e-1)" "unprognostic (2.39e-2)" "unprognostic (3.57e-2)" "unprognostic (7.08e-2)" "unprognostic (3.07e-1)" "unprognostic (7.33e-2)" "prognostic unfavourable (3.94e-4)" "unprognostic (2.89e-1)" "unprognostic (6.26e-2)" "unprognostic (1.99e-3)" "unprognostic (1.74e-2)" "unprognostic (2.30e-2)" "unprognostic (2.65e-1)" "unprognostic (9.20e-3)" "unprognostic (3.80e-1)" 4.5 4.5 4.9 5.0 6.6 0.3 5.5 2.6 6.6 8.6 10.8 3.9 23.5 11.4 8.0 6.8 12.5 4.7 6.9 8.4 5.0 5.1 4.4 4.1 2.8 6.0 6.1 5.3 5.2 6.9 7.3 14.5 5.7 10.0 7.3 7.0 8.2 7.4 16.9 6.6 10.4 21.9 7.9 10.3 2.8 5.2 4.3 4.4 1.9 4.6 9.2 7.0 8.0 10.5 2.6 0.3 0.0 0.0 1.1 4.5 1.0 1.1 0.4 4.0 6.7 4.6 9.9 0.1 12.4 6.2 2.4 2.8 9.7 4.3 4.3 0.9 8.9 6.3 2.6 2.8 1.7 1.8 7.0 1.2 2.8 3.9 1.4 1.8 4.7 5.1 10.0 1.3 0.7 0.4 2.1 1.9 4.4 1.0 0.0 1.1 0.8 2.4 2.8 4.5 1.7 4.7 2.6 0.6 6.1 4.7 1.5 9.8 0.3 4.6 1.4 3.5 1.2 1.8 3.2 3.4 3.7 2.6 1.7 2.0 1.2 0.0 0.0 0.0 3.0 0.0 4.5 2.6 0.8 3.2 0.0 1.9 1.3 1.5 0.0 1.1 0.0 0.3 0.4 1.0 4.9 6.6 2.6 6.6 5.0 5.1 6.1 5.3 10.0 4.4 TMEM161A "FLJ20422, FLJ39645" ENSG00000064545 "Transmembrane protein 161A" Q9NX61 19 19119169-19138513 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043365 Approved Approved Cytosol Cytosol "HPA043365: AB_10796793" "unprognostic (4.31e-2)" "unprognostic (9.13e-2)" "unprognostic (2.34e-2)" "unprognostic (7.42e-3)" "unprognostic (6.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-2)" "unprognostic (3.51e-2)" "unprognostic (2.04e-1)" "unprognostic (2.74e-1)" "unprognostic (9.42e-2)" "unprognostic (2.46e-1)" "unprognostic (9.15e-2)" "prognostic favourable (2.99e-4)" "unprognostic (4.18e-1)" "unprognostic (2.79e-1)" "unprognostic (4.89e-3)" 10.4 18.3 10.6 9.2 13.5 8.1 10.3 12.8 11.7 12.2 10.5 9.8 15.8 10.0 17.2 8.6 11.7 12.4 15.5 12.7 8.6 6.9 12.7 21.1 9.1 12.1 13.4 8.4 14.2 18.6 17.3 6.6 6.4 9.9 12.8 5.3 12.7 17.1 13.6 34.5 13.5 9.1 9.9 7.8 8.8 10.6 5.3 11.6 15.0 20.8 13.8 9.1 10.8 12.6 6.8 23.5 1.5 7.2 6.7 13.5 5.4 16.0 11.2 6.4 13.7 13.8 9.2 10.1 6.8 8.3 8.4 11.1 9.4 20.0 14.0 33.4 5.1 13.0 10.2 15.7 5.5 6.3 37.3 5.4 6.2 12.7 18.4 7.1 9.0 14.4 13.2 8.4 12.4 9.4 17.9 17.0 5.9 19.4 10.2 14.9 6.1 18.4 16.4 5.4 27.8 6.5 6.6 8.7 8.7 10.2 13.0 8.2 10.4 12.6 5.5 7.8 3.8 17.6 12.6 15.8 9.8 8.4 8.6 14.6 11.3 1.5 7.2 1.4 10.0 6.3 8.8 5.7 9.1 8.1 10.1 6.8 10.8 9.1 0.8 6.7 6.3 23.5 13.5 5.4 10.6 13.5 12.8 11.7 8.6 6.9 13.4 8.4 9.9 11.6 TMEM161B MGC33214 ENSG00000164180 "Transmembrane protein 161B" Q8NDZ6 5 88189633-88269476 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 35.4;HMC-1: 38.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044562 Uncertain "HPA044562: AB_10794291" "unprognostic (2.08e-1)" "unprognostic (6.02e-2)" "unprognostic (2.06e-2)" "unprognostic (5.64e-2)" "unprognostic (2.27e-1)" "unprognostic (1.05e-1)" "unprognostic (3.07e-2)" "unprognostic (1.12e-1)" "unprognostic (7.38e-2)" "unprognostic (1.18e-3)" "unprognostic (1.58e-1)" "unprognostic (1.01e-1)" "unprognostic (6.96e-3)" "unprognostic (1.55e-2)" "unprognostic (3.04e-1)" "unprognostic (7.62e-3)" "unprognostic (9.35e-2)" 9.7 11.7 10.5 13.0 12.8 6.7 19.2 34.0 14.7 10.4 12.2 10.4 13.5 14.6 15.4 17.6 13.9 10.6 7.2 10.0 10.8 10.3 13.4 14.5 11.9 10.0 11.1 10.7 13.8 16.2 29.5 24.0 15.3 10.9 15.0 13.8 9.6 15.9 11.4 15.4 17.9 17.2 7.9 11.0 11.9 25.1 16.1 13.6 13.5 24.8 9.7 13.2 11.2 11.8 4.8 5.2 2.8 5.7 5.6 6.3 2.3 5.2 3.5 4.0 4.3 2.5 4.9 8.4 4.5 6.9 6.8 10.0 4.1 13.8 8.0 2.5 3.4 5.5 4.5 6.0 8.6 7.1 5.0 35.4 4.4 2.5 6.7 7.1 38.7 4.4 8.7 5.8 8.5 2.9 17.1 7.4 5.9 2.5 5.0 5.9 2.5 6.6 4.3 4.7 8.8 6.1 7.4 5.1 4.4 2.7 7.4 10.7 4.5 6.1 2.5 4.3 4.0 6.4 8.5 9.3 14.5 6.7 10.6 6.8 6.2 2.8 3.0 1.9 6.3 5.7 6.1 4.8 5.4 4.6 1.6 4.8 5.5 4.1 1.7 5.6 2.0 5.2 4.3 2.3 10.5 12.8 34.0 14.7 10.8 10.3 11.1 10.7 10.9 13.6 TMEM175 MGC4618 ENSG00000127419 "Transmembrane protein 175" Q9BSA9 4 932387-958656 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057160 Approved Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA057160: " "unprognostic (3.84e-1)" "unprognostic (4.27e-2)" "unprognostic (1.28e-2)" "unprognostic (9.61e-3)" "unprognostic (2.43e-1)" "unprognostic (2.33e-3)" "unprognostic (1.12e-2)" "unprognostic (3.25e-3)" "unprognostic (1.22e-2)" "unprognostic (1.50e-2)" "prognostic favourable (9.85e-5)" "unprognostic (4.71e-2)" "unprognostic (5.08e-2)" "unprognostic (1.07e-1)" "unprognostic (3.74e-1)" "unprognostic (1.96e-1)" "unprognostic (7.51e-3)" 17.2 22.9 20.5 13.5 24.0 17.8 12.2 29.0 27.6 17.4 10.8 23.5 16.8 13.6 13.4 14.9 13.4 12.9 16.0 13.3 18.4 19.8 11.7 24.2 14.1 21.9 16.9 25.4 9.3 26.3 18.7 26.4 11.8 20.4 15.0 6.2 17.1 26.8 16.8 14.5 25.8 12.4 10.4 17.2 18.7 14.8 11.8 17.9 13.0 19.7 9.2 12.0 16.2 9.6 13.8 29.3 16.9 23.4 9.5 13.6 11.8 3.3 6.0 3.5 4.8 16.7 8.8 8.1 8.1 5.9 5.0 7.4 2.8 13.2 2.5 5.1 8.5 5.5 3.2 6.4 2.2 6.2 7.4 5.1 8.8 2.8 9.7 2.7 9.6 12.4 7.8 4.4 3.0 3.1 5.2 20.7 4.3 10.8 6.8 11.1 2.2 17.0 4.8 2.1 7.1 4.7 3.1 9.5 8.4 5.7 3.6 5.4 15.8 7.4 4.0 9.2 2.1 10.6 6.2 14.1 3.7 4.8 8.9 5.9 7.4 16.9 19.8 15.5 13.6 23.4 9.1 12.5 11.7 10.1 17.2 13.8 8.4 11.9 16.4 9.5 21.6 29.3 11.0 11.8 20.5 24.0 29.0 27.6 18.4 19.8 16.9 25.4 20.4 17.9 TMEM181 "GPR178, KIAA1423" ENSG00000146433 "Transmembrane protein 181" Q9P2C4 6 158536436-158635428 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 49.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040189 Approved Approved "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA040189: AB_10793959" "unprognostic (1.93e-2)" "prognostic unfavourable (7.26e-4)" "unprognostic (9.87e-2)" "unprognostic (6.51e-2)" "unprognostic (3.09e-1)" "unprognostic (1.49e-2)" "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (2.07e-1)" "prognostic unfavourable (1.09e-4)" "unprognostic (1.14e-1)" "unprognostic (2.34e-1)" "unprognostic (4.07e-2)" "unprognostic (1.46e-1)" "unprognostic (1.93e-1)" "unprognostic (4.36e-1)" "unprognostic (3.26e-1)" 7.1 5.6 32.4 4.8 49.2 3.1 8.6 5.3 36.6 13.4 10.1 4.2 6.5 10.9 8.4 3.9 6.3 5.8 7.3 5.3 18.5 8.7 3.3 6.4 6.7 3.4 5.5 23.3 5.6 18.5 8.1 21.5 6.5 11.2 9.4 11.5 4.3 22.4 10.0 4.9 7.0 12.6 7.8 7.3 7.6 16.3 16.0 8.5 2.3 9.7 2.1 3.2 9.9 7.0 1.0 2.1 7.7 3.4 3.9 4.7 1.4 10.3 6.0 8.5 13.1 22.5 20.7 16.3 23.5 13.8 12.3 14.1 10.2 12.8 4.3 12.2 19.5 15.4 12.6 15.5 19.6 6.4 9.0 8.1 8.9 21.4 18.5 10.1 7.8 17.1 15.3 13.6 18.6 19.6 15.4 5.5 20.0 6.2 4.4 12.7 6.6 7.6 4.4 9.8 4.9 11.7 8.1 25.2 17.3 17.2 16.2 11.2 6.1 14.3 18.7 12.7 8.6 21.0 20.2 3.2 2.2 4.8 15.3 12.7 12.1 7.7 2.2 5.7 4.7 2.3 3.6 0.9 2.7 3.7 1.6 1.0 2.4 3.2 1.6 3.9 3.4 2.1 2.6 1.4 32.4 49.2 5.3 36.6 18.5 8.7 5.5 23.3 11.2 8.5 TMEM184C "FLJ10846, TMEM34" ENSG00000164168 "Transmembrane protein 184C" Q9NVA4 4 147617383-147672044 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 107.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054013 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA054013: " "unprognostic (5.45e-3)" "unprognostic (2.49e-2)" "unprognostic (3.93e-3)" "unprognostic (3.58e-2)" "unprognostic (2.02e-1)" "unprognostic (8.14e-2)" "unprognostic (1.32e-2)" "unprognostic (7.72e-3)" "unprognostic (1.48e-1)" "unprognostic (1.99e-1)" "prognostic unfavourable (6.37e-4)" "unprognostic (1.13e-1)" "prognostic favourable (2.31e-7)" "unprognostic (4.68e-2)" "unprognostic (3.03e-1)" "unprognostic (2.20e-1)" "unprognostic (4.31e-3)" 10.4 18.4 11.3 9.6 13.1 5.5 10.0 12.3 15.9 11.8 13.0 12.3 14.3 11.8 12.4 9.8 10.7 10.0 9.6 14.3 11.8 11.3 18.0 18.7 9.2 7.7 16.1 11.8 15.7 11.6 107.2 10.5 14.0 12.7 12.0 11.6 9.3 12.1 12.8 16.2 9.5 14.8 10.1 14.0 10.0 10.6 8.3 14.1 11.7 32.9 10.3 9.4 11.8 11.2 12.8 17.3 17.7 18.1 14.7 22.8 11.6 9.1 14.3 18.2 13.9 24.9 24.3 11.9 17.1 20.1 12.8 14.8 11.8 17.5 8.5 8.6 13.3 11.0 14.7 13.1 14.1 18.9 8.5 11.0 11.1 8.5 19.2 14.6 16.4 18.1 17.7 14.0 14.7 16.4 14.0 24.0 17.8 13.7 12.7 5.3 11.7 8.4 12.7 6.3 14.7 14.2 17.1 14.2 18.3 9.3 14.6 14.9 14.5 9.2 16.1 16.2 8.8 13.2 10.9 26.3 34.4 11.4 19.0 8.8 17.5 17.7 14.1 15.5 18.0 18.0 22.8 12.3 16.7 16.4 17.3 12.8 15.9 14.8 11.0 14.7 18.1 11.9 15.3 11.6 11.3 13.1 12.3 15.9 11.8 11.3 16.1 11.8 12.7 14.1 TMEM185A "CXorf13, FAM11A, FRAXF" ENSG00000269556 "Transmembrane protein 185A" Q8NFB2 X 149596556-149631912 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048295, HPA071744" Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA048295: , HPA071744: " "unprognostic (9.76e-2)" "unprognostic (2.83e-2)" "unprognostic (7.73e-2)" "unprognostic (2.71e-3)" "unprognostic (4.08e-1)" "unprognostic (1.97e-1)" "unprognostic (4.34e-3)" "unprognostic (1.71e-1)" "unprognostic (1.83e-1)" "unprognostic (1.92e-1)" "unprognostic (2.78e-2)" "unprognostic (2.69e-1)" "unprognostic (3.17e-1)" "unprognostic (1.37e-2)" "unprognostic (1.90e-1)" "unprognostic (1.07e-1)" "unprognostic (1.40e-1)" 4.3 5.0 6.8 4.8 6.2 1.7 4.1 7.2 8.2 5.1 3.8 3.1 7.3 2.3 6.2 7.4 5.8 5.8 5.3 12.0 4.4 4.4 3.1 3.4 3.3 3.0 3.3 13.8 5.4 7.3 4.8 10.8 6.0 5.5 3.5 6.3 4.8 7.2 4.5 6.2 3.3 6.6 3.7 7.8 2.7 12.3 4.0 3.8 3.8 4.5 4.3 4.6 5.8 5.3 7.7 12.2 5.0 13.5 10.4 6.3 11.0 11.2 12.9 7.6 17.6 11.9 5.1 10.9 13.3 11.0 16.7 6.8 19.1 13.5 24.3 12.0 14.0 14.9 10.3 12.0 8.7 11.1 7.8 13.0 7.3 12.7 11.3 8.0 11.3 17.5 11.4 7.1 9.5 3.2 8.8 7.9 18.0 7.8 7.8 9.6 12.5 7.6 19.6 7.7 12.7 14.5 4.5 6.4 8.3 14.3 14.2 7.6 6.5 11.4 8.4 7.7 15.4 13.3 8.3 7.3 19.8 14.9 13.4 11.5 2.2 5.0 12.2 10.1 3.0 9.0 5.3 7.3 10.4 7.7 5.0 10.3 9.2 7.1 13.5 2.5 5.7 9.0 6.3 TMEM185B "FAM11B, FLJ20979" ENSG00000226479 "Transmembrane protein 185B" Q9H7F4 2 120221278-120223408 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048295, HPA071744" Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA048295: , HPA071744: " "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "prognostic unfavourable (5.44e-4)" "prognostic unfavourable (4.96e-6)" "unprognostic (1.35e-2)" "unprognostic (1.55e-2)" "prognostic unfavourable (5.71e-7)" "unprognostic (3.09e-3)" "unprognostic (1.65e-1)" "unprognostic (9.01e-2)" "unprognostic (1.96e-2)" "unprognostic (8.28e-2)" "unprognostic (6.03e-3)" "unprognostic (1.72e-1)" "unprognostic (1.61e-1)" "unprognostic (2.03e-1)" "unprognostic (1.04e-1)" 16.9 14.2 10.4 12.7 14.2 14.4 15.7 8.3 15.2 14.4 12.7 24.7 9.9 9.8 17.7 10.6 16.3 17.1 12.4 18.3 13.2 9.7 12.3 19.1 14.5 18.4 15.3 9.2 14.6 20.2 46.3 12.2 13.8 13.1 16.1 10.4 15.1 16.2 12.6 16.5 11.9 12.6 16.8 14.5 12.6 13.4 19.4 13.4 16.3 19.1 15.5 13.2 15.9 12.9 1.4 2.6 5.8 3.4 4.6 2.4 0.6 24.3 10.2 6.9 11.3 12.1 17.0 18.1 17.6 16.8 17.2 15.1 30.7 24.0 0.0 17.4 15.3 15.7 7.1 14.7 19.3 10.5 13.9 10.8 7.1 7.0 17.4 0.0 19.4 14.5 18.2 18.3 22.4 12.1 12.5 12.6 14.9 16.7 9.2 10.8 10.5 21.8 7.3 0.0 8.0 13.7 16.4 10.6 8.8 16.0 19.4 14.3 11.2 12.2 14.4 7.6 20.9 13.6 6.6 8.7 10.9 10.1 9.1 10.7 17.9 0.0 1.9 2.3 1.6 3.4 1.9 0.8 2.0 1.0 2.6 1.4 1.6 2.4 5.8 4.6 2.2 0.8 1.9 0.6 10.4 14.2 8.3 15.2 13.2 9.7 15.3 9.2 13.1 13.4 TMEM260 "C14orf101, FLJ20392" ENSG00000070269 "Transmembrane protein 260" Q9NX78 14 56488354-56650606 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 61.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003502 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA003502: AB_1078314" "unprognostic (4.63e-2)" "unprognostic (2.41e-2)" "unprognostic (1.98e-1)" "unprognostic (1.73e-2)" "unprognostic (2.51e-1)" "unprognostic (3.58e-2)" "unprognostic (2.04e-1)" "prognostic favourable (7.11e-4)" "unprognostic (7.14e-2)" "unprognostic (1.89e-1)" "unprognostic (1.95e-3)" "unprognostic (3.22e-1)" "unprognostic (2.23e-3)" "unprognostic (5.81e-2)" "unprognostic (8.11e-2)" "unprognostic (1.32e-1)" "unprognostic (3.84e-2)" 7.8 7.4 7.3 11.0 10.6 3.8 9.1 13.3 9.9 61.0 8.8 13.7 11.6 8.1 11.8 12.1 6.7 11.4 10.3 6.0 8.9 8.6 10.7 8.7 8.4 8.8 10.8 7.5 14.8 13.6 12.4 17.2 8.7 9.7 8.7 9.1 8.7 7.4 13.0 5.2 8.6 10.7 8.9 12.2 9.2 8.4 10.1 8.3 17.6 12.6 4.6 8.8 10.1 9.7 2.0 4.6 2.9 2.8 6.3 3.5 2.0 7.3 5.2 4.0 8.5 14.3 11.8 7.9 7.9 8.8 5.2 6.2 2.4 5.5 6.0 7.8 5.9 8.6 9.3 5.7 8.2 7.4 4.7 3.9 2.4 3.2 10.1 5.4 9.3 14.5 10.4 2.9 10.1 6.8 4.7 6.5 6.8 4.9 2.8 2.0 3.7 8.3 4.0 6.4 2.0 8.8 11.0 8.5 4.2 8.9 6.4 5.2 8.2 8.4 9.5 10.6 4.0 7.9 3.9 3.9 3.1 3.5 6.6 4.0 5.2 0.0 2.8 2.9 3.5 1.9 2.4 1.8 2.4 1.8 2.2 2.0 3.2 2.3 1.4 6.3 1.7 4.6 2.9 2.0 7.3 10.6 13.3 9.9 8.9 8.6 10.8 7.5 9.7 8.3 TMEM39B FLJ10315 ENSG00000121775 "Transmembrane protein 39B" Q9GZU3 1 32072031-32102866 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040191, HPA040224" Approved Approved Vesicles Vesicles "HPA040191: AB_10805706, HPA040224: AB_10795274" "unprognostic (1.74e-2)" "unprognostic (2.20e-2)" "unprognostic (4.38e-2)" "prognostic unfavourable (3.00e-4)" "unprognostic (1.06e-1)" "unprognostic (1.14e-2)" "prognostic unfavourable (2.82e-6)" "unprognostic (1.10e-2)" "unprognostic (3.37e-2)" "unprognostic (1.74e-1)" "unprognostic (3.63e-2)" "unprognostic (4.47e-2)" "prognostic unfavourable (5.11e-9)" "unprognostic (2.20e-1)" "unprognostic (5.80e-2)" "unprognostic (4.45e-2)" "unprognostic (2.10e-1)" 13.4 10.2 6.2 7.4 10.1 6.1 10.8 6.2 14.3 18.2 10.7 11.5 8.2 7.1 18.8 11.9 8.2 11.8 9.4 10.0 5.8 7.9 6.7 13.7 9.3 13.5 7.2 11.7 16.1 6.6 7.8 9.9 16.9 8.3 9.7 8.1 10.8 8.5 13.7 9.9 13.0 8.4 12.6 7.0 9.5 9.0 18.3 7.1 22.9 10.8 10.3 13.1 12.7 11.3 11.5 21.6 5.1 14.1 4.4 10.6 8.3 8.0 2.4 2.9 7.8 9.9 6.0 4.1 7.7 11.8 9.3 9.0 4.2 12.0 8.7 11.6 5.3 9.2 2.3 11.3 2.6 4.8 7.5 5.6 5.2 2.2 12.0 10.1 5.8 8.7 4.2 14.1 10.3 5.6 7.3 7.8 8.0 3.8 6.4 3.0 10.4 5.7 12.0 11.2 12.3 4.1 4.4 7.2 4.3 10.5 5.4 8.1 4.2 4.8 8.4 14.6 9.6 5.3 7.5 3.9 5.9 9.5 8.9 8.7 11.1 2.5 14.1 5.1 5.3 12.0 7.2 11.5 7.9 6.6 14.4 11.5 10.6 8.6 3.7 4.4 8.7 21.6 8.2 8.3 6.2 10.1 6.2 14.3 5.8 7.9 7.2 11.7 8.3 7.1 TMEM45B "BC016153, FLJ40787" ENSG00000151715 "Transmembrane protein 45B" Q96B21 11 129815819-129860003 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 106.6" "Cell line enhanced" "Detected in some" "CACO-2: 14.5;Hep G2: 14.8;PC-3: 18.7;RT4: 49.6;T-47d: 14.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 3.6;naive CD4 T-cell: 4.3;neutrophil: 13.1" "Group enriched" "Detected in many" 12 "granulocytes: 13.1;T-cells: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015474, HPA015878" Approved Approved Nucleoplasm Nucleoplasm "HPA015474: , HPA015878: AB_2205046" "unprognostic (4.92e-3)" "unprognostic (7.94e-2)" "unprognostic (5.98e-2)" "unprognostic (1.81e-1)" "unprognostic (5.44e-3)" "unprognostic (7.11e-2)" "unprognostic (1.17e-1)" "unprognostic (6.53e-2)" "unprognostic (1.76e-1)" "unprognostic (1.02e-3)" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (1.04e-1)" "unprognostic (1.42e-2)" "unprognostic (2.24e-1)" "unprognostic (1.68e-2)" "unprognostic (1.52e-1)" 0.2 0.2 0.6 9.0 0.9 0.0 4.0 0.3 0.7 6.6 50.3 0.5 1.7 40.4 1.2 4.1 29.5 6.5 9.3 0.4 1.2 0.6 9.6 13.2 4.5 1.9 0.4 0.7 1.4 3.1 0.0 2.9 1.2 2.3 4.0 29.0 0.3 7.3 2.4 0.2 10.9 106.6 1.5 0.5 0.6 7.4 0.7 0.2 0.5 9.1 21.9 19.9 9.4 10.9 0.6 0.4 13.1 0.6 0.7 4.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 14.5 6.3 0.1 2.7 0.0 8.4 0.0 0.0 0.0 0.0 0.2 0.1 0.8 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.5 0.0 18.7 0.1 0.0 0.9 8.0 49.6 1.5 0.2 0.0 4.1 0.0 14.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.6 0.1 0.3 0.2 0.3 0.2 3.6 0.9 0.0 0.6 4.3 0.7 13.1 0.7 0.2 0.4 0.6 1.3 0.6 0.9 0.3 0.7 1.2 0.6 0.4 0.7 2.3 0.2 TMEM86A FLJ90119 ENSG00000151117 "Transmembrane protein 86A" Q8N2M4 11 18693122-18704785 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 6.5" "Group enriched" "Detected in many" 12 "dendritic cells: 6.5;monocytes: 3.7;T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057119 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA057119: " "unprognostic (1.25e-1)" "unprognostic (1.09e-3)" "unprognostic (8.08e-3)" "unprognostic (1.89e-1)" "unprognostic (2.53e-1)" "unprognostic (1.10e-1)" "unprognostic (4.05e-2)" "unprognostic (2.94e-1)" "unprognostic (3.73e-1)" "unprognostic (1.74e-1)" "unprognostic (8.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.36e-1)" "unprognostic (1.50e-2)" "unprognostic (7.92e-2)" "unprognostic (4.20e-1)" "unprognostic (3.24e-1)" 6.9 4.9 4.7 3.6 5.7 0.7 5.6 3.4 9.7 3.8 3.3 7.0 1.2 2.5 4.0 3.8 3.9 4.4 6.6 8.1 6.9 3.7 15.3 6.7 5.7 11.1 6.7 3.2 12.3 8.2 7.0 3.9 7.1 5.0 2.9 3.2 16.7 4.6 2.7 4.7 24.4 3.2 3.4 7.2 9.2 3.3 4.1 3.7 5.3 3.7 3.9 4.2 5.2 5.4 0.2 6.5 0.3 3.7 0.2 1.7 1.4 0.0 0.2 0.7 3.4 3.0 0.0 0.1 0.7 0.5 0.6 0.5 0.0 0.4 0.0 1.3 0.6 0.3 0.2 0.1 0.4 0.2 1.9 0.2 0.1 0.0 2.4 0.0 3.0 4.2 1.3 0.1 0.2 1.8 0.6 0.0 1.4 1.7 0.0 0.0 0.2 1.7 0.0 5.5 0.0 18.8 4.0 1.0 1.4 1.0 3.5 1.4 4.2 0.4 2.0 0.5 0.3 0.2 0.1 3.4 2.7 0.0 1.2 0.0 1.2 0.0 3.7 0.3 0.4 2.8 1.0 0.0 0.4 0.9 6.5 0.2 1.0 1.7 0.0 0.2 0.9 3.8 1.0 1.4 4.7 5.7 3.4 9.7 6.9 3.7 6.7 3.2 5.0 3.7 TMEM8B "C9orf127, NAG-5, NGX6" ENSG00000137103 "Transmembrane protein 8B" A6NDV4 9 35814451-35865518 "Predicted membrane proteins, Transporters" "Cell adhesion, Growth regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 27.2" "Lineage enriched" "Detected in many" 18 "dendritic cells: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052130, HPA062701" Approved Approved Vesicles Vesicles "HPA052130: , HPA062701: " "unprognostic (5.54e-2)" "unprognostic (3.32e-1)" "unprognostic (3.96e-1)" "unprognostic (3.53e-2)" "unprognostic (3.81e-1)" "unprognostic (1.42e-1)" "unprognostic (4.09e-2)" "unprognostic (2.67e-2)" "unprognostic (2.97e-1)" "unprognostic (1.62e-1)" "prognostic favourable (3.14e-4)" "unprognostic (5.93e-2)" "prognostic favourable (1.89e-15)" "unprognostic (8.00e-2)" "unprognostic (1.26e-1)" "unprognostic (1.68e-2)" "unprognostic (3.29e-2)" 9.7 19.5 28.2 5.7 30.4 3.4 9.4 22.9 34.4 15.5 13.0 16.9 14.9 8.7 18.4 11.5 9.3 18.3 12.1 17.8 25.3 14.1 11.3 4.7 10.4 5.9 12.9 21.2 33.3 14.6 28.4 23.6 7.7 18.3 19.3 9.4 17.5 19.9 24.0 19.1 9.2 8.4 18.1 13.0 8.7 13.1 13.6 15.4 5.6 17.3 5.1 4.9 14.2 11.9 0.9 27.2 0.6 1.5 0.5 0.6 1.1 2.9 3.2 11.2 8.8 12.6 10.6 1.4 2.7 5.2 3.0 3.7 1.3 0.8 2.3 6.4 7.2 1.2 2.9 4.4 2.4 1.8 5.0 0.7 2.2 3.1 8.9 0.2 0.3 9.8 5.8 3.0 3.2 1.7 1.1 6.6 5.2 1.1 6.1 1.3 1.6 4.4 6.8 2.3 5.8 3.1 1.4 2.6 7.8 4.1 1.9 4.0 3.1 1.2 2.7 7.0 2.3 6.9 1.0 8.9 2.7 2.6 6.4 1.2 4.3 0.4 1.5 0.1 0.6 0.3 0.5 0.9 0.6 0.6 4.7 0.9 0.6 0.5 0.6 0.5 0.3 27.2 0.4 1.1 28.2 30.4 22.9 34.4 25.3 14.1 12.9 21.2 18.3 15.4 TPCN2 TPC2 ENSG00000162341 "Two pore segment channel 2" Q8NHX9 11 69048897-69162440 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA016561, HPA027080" Supported Approved Nucleoli Nucleoli "HPA016561: AB_1858207, HPA027080: AB_10600917" "unprognostic (1.29e-1)" "unprognostic (1.53e-2)" "unprognostic (1.39e-1)" "unprognostic (2.95e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (2.96e-4)" "unprognostic (7.60e-2)" "unprognostic (7.04e-2)" "unprognostic (3.59e-1)" "prognostic unfavourable (1.49e-4)" "unprognostic (4.15e-2)" "unprognostic (1.89e-2)" "unprognostic (6.87e-2)" "unprognostic (2.22e-1)" "unprognostic (2.24e-3)" "unprognostic (5.01e-2)" "unprognostic (4.88e-2)" 11.0 6.2 6.3 8.7 11.1 9.2 9.4 14.5 14.0 18.0 18.0 9.2 11.3 15.0 22.4 12.4 11.2 13.8 12.1 7.5 6.2 4.9 11.6 15.7 8.7 10.4 6.0 7.7 12.1 6.8 6.4 7.2 7.1 8.8 13.1 7.4 20.7 8.1 17.8 8.1 16.1 13.7 15.6 6.0 10.9 11.4 8.5 4.9 6.4 7.3 7.4 10.1 11.0 11.2 2.0 7.5 7.1 9.9 6.9 3.2 3.6 3.4 8.8 2.7 4.1 2.6 2.0 11.6 3.8 4.7 4.6 2.8 7.5 10.8 4.4 5.6 4.8 7.9 2.2 4.4 1.4 2.8 2.3 6.0 9.4 2.5 2.4 4.3 8.2 3.3 2.3 2.4 2.5 3.2 2.9 20.9 2.9 8.0 3.6 10.2 3.1 3.1 3.4 2.2 5.5 4.7 5.5 2.4 3.1 4.4 10.1 15.5 6.5 5.7 2.9 3.1 4.7 5.8 3.5 5.5 2.2 2.2 5.1 4.5 6.7 4.3 9.8 2.9 1.0 9.8 0.9 2.0 2.1 2.1 7.5 1.5 1.7 2.0 7.1 6.9 9.9 3.2 3.2 3.6 6.3 11.1 14.5 14.0 6.2 4.9 6.0 7.7 8.8 4.9 TRAM1 "TRAM, TRAMP" ENSG00000067167 "Translocation associated membrane protein 1" Q15629 8 70573442-70608387 "Plasma proteins, Predicted membrane proteins" "Host-virus interaction, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023929 Approved "HPA023929: AB_1858239" "unprognostic (3.85e-2)" "prognostic unfavourable (2.06e-4)" "unprognostic (8.34e-3)" "unprognostic (1.31e-1)" "unprognostic (3.52e-2)" "unprognostic (5.93e-2)" "unprognostic (8.94e-2)" "unprognostic (2.21e-2)" "unprognostic (1.86e-1)" "unprognostic (2.12e-1)" "unprognostic (3.39e-3)" "unprognostic (3.61e-2)" "prognostic unfavourable (7.79e-4)" "unprognostic (7.45e-2)" "unprognostic (1.61e-1)" "unprognostic (2.31e-1)" "unprognostic (3.85e-2)" 38.0 31.3 14.6 22.8 15.5 20.8 33.4 10.3 13.0 36.6 36.0 18.5 37.7 21.6 32.9 37.7 26.6 28.7 28.7 30.7 15.7 15.0 59.4 123.7 58.6 31.9 19.0 10.4 32.9 89.0 23.6 30.9 45.9 14.6 32.2 19.4 23.5 84.4 45.1 16.1 19.2 40.0 23.2 24.0 46.8 24.9 26.9 16.0 49.1 60.9 19.0 31.5 33.0 30.6 34.2 59.3 35.4 33.2 40.0 51.0 63.5 26.5 26.2 11.5 7.0 55.8 58.8 16.5 47.8 46.4 36.1 43.9 16.5 42.2 25.5 10.4 39.5 34.2 10.4 39.7 34.8 17.3 11.7 18.5 9.3 18.7 82.0 13.9 10.5 69.9 38.7 17.8 65.2 30.0 11.8 66.7 44.2 7.0 31.1 9.7 7.5 12.9 15.4 8.8 16.7 94.9 24.3 8.4 9.1 30.7 61.0 26.7 22.8 15.1 30.6 22.1 19.5 25.3 15.5 54.6 21.8 13.1 25.2 14.2 16.3 35.4 30.4 19.5 39.8 32.7 51.0 34.2 43.3 44.8 36.5 27.0 41.0 41.8 8.7 40.0 33.2 59.3 44.1 63.5 14.6 15.5 10.3 13.0 15.7 15.0 19.0 10.4 14.6 16.0 TRAM1L1 MGC26568 ENSG00000174599 "Translocation associated membrane protein 1 like 1" Q8N609 4 117083554-117085576 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 9.5;U-138 MG: 11.6;U-266/70: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044560 Uncertain Approved Mitochondria Mitochondria "HPA044560: AB_10796097" "unprognostic (9.06e-2)" "unprognostic (2.87e-2)" "unprognostic (4.40e-2)" "unprognostic (2.17e-3)" "unprognostic (9.77e-2)" "unprognostic (2.37e-2)" "unprognostic (5.97e-2)" "unprognostic (3.02e-1)" "unprognostic (1.14e-1)" "unprognostic (3.25e-1)" "unprognostic (1.09e-3)" "unprognostic (1.56e-2)" "unprognostic (2.76e-2)" "unprognostic (1.68e-2)" "unprognostic (1.62e-1)" "unprognostic (4.82e-3)" "unprognostic (1.23e-2)" 2.1 4.3 7.8 1.1 10.0 0.3 7.3 5.6 14.9 4.6 1.8 9.4 0.0 0.9 3.4 10.5 1.6 6.8 3.1 2.2 8.8 8.6 11.9 0.5 2.9 1.0 8.5 5.9 4.1 5.0 0.6 8.5 1.2 10.3 7.5 2.2 4.5 2.5 4.7 0.7 4.1 1.1 3.6 10.3 1.2 3.2 5.9 7.4 0.0 8.4 0.3 0.9 3.2 1.2 0.1 0.2 0.0 0.0 0.1 0.2 0.0 1.4 1.0 4.4 2.2 0.0 0.0 0.0 0.6 0.5 0.9 2.7 0.1 5.2 0.0 0.5 1.2 0.1 2.1 2.3 3.6 0.0 0.1 1.2 1.2 0.6 1.3 1.3 0.0 4.9 2.0 1.1 0.0 0.0 0.0 2.7 7.2 0.3 2.3 0.0 0.3 1.1 0.0 5.7 0.0 0.7 0.3 2.6 9.5 0.0 3.7 4.4 6.4 1.4 3.1 11.6 5.2 0.1 1.8 9.5 2.1 0.0 4.5 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 7.8 10.0 5.6 13.9 8.8 8.6 8.5 5.9 10.3 7.4 TRPC1 HTRP-1 ENSG00000144935 "Transient receptor potential cation channel subfamily C member 1" P48995 3 142724074-142807888 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 19.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009387, HPA021130" Supported Approved Vesicles Vesicles "CAB009387: AB_2240941, HPA021130: AB_1858361" "unprognostic (1.66e-1)" "unprognostic (7.38e-2)" "unprognostic (1.56e-2)" "unprognostic (4.37e-5)" "unprognostic (5.53e-1)" "unprognostic (1.40e-2)" "unprognostic (5.90e-3)" "unprognostic (1.59e-2)" "unprognostic (1.36e-1)" "unprognostic (2.17e-1)" "unprognostic (8.46e-3)" "unprognostic (6.25e-2)" "prognostic unfavourable (2.72e-5)" "unprognostic (1.44e-3)" "unprognostic (1.57e-1)" "unprognostic (1.61e-1)" "unprognostic (2.49e-2)" 6.8 8.3 8.5 3.5 13.4 1.2 6.8 23.0 15.9 17.7 8.3 11.4 4.3 2.6 20.4 9.2 6.5 10.1 9.1 15.9 10.0 11.4 6.0 2.0 5.4 3.3 9.4 12.2 24.5 3.0 12.2 14.4 6.1 14.7 12.3 4.9 13.0 3.7 13.6 2.4 6.2 4.7 17.6 11.4 5.0 4.4 8.0 7.9 0.4 8.9 3.9 2.3 9.3 8.9 0.6 0.0 0.0 0.0 0.3 1.3 0.3 3.3 4.7 8.6 1.0 7.8 19.1 3.9 5.3 8.3 6.7 9.8 1.5 0.9 0.0 1.7 5.4 0.3 2.4 2.4 9.6 0.8 3.4 5.2 2.0 2.2 3.2 0.3 0.0 9.1 2.4 6.2 7.4 3.8 0.2 0.0 9.3 2.1 0.3 0.4 4.8 2.5 0.0 4.1 0.0 4.6 0.1 5.5 4.0 6.4 0.0 1.1 2.7 0.0 3.5 8.4 1.3 11.2 7.0 3.5 1.5 1.7 6.4 0.1 2.5 0.0 0.0 0.0 0.2 0.0 1.2 0.6 1.3 0.6 0.0 0.3 1.2 1.3 0.0 0.3 0.0 0.0 0.0 0.3 8.5 13.4 23.0 15.9 10.0 11.4 9.4 12.2 14.7 7.9 TRPC6 "FSGS2, TRP6" ENSG00000137672 "Transient receptor potential cation channel subfamily C member 6" Q9Y210 11 101451564-101872562 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 35.3;placenta: 20.6" "Cell line enhanced" "Detected in some" "A549: 4.6;ASC diff: 8.6;BJ hTERT+: 4.6;HEL: 4.3;RPTEC TERT1: 20.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "eosinophil: 5.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebral cortex: 7.1;hippocampal formation: 12.5;midbrain: 9.6" HPA045098 Approved 140000 "HPA045098: AB_10959600" "unprognostic (1.45e-1)" "unprognostic (4.21e-1)" "unprognostic (2.43e-1)" "unprognostic (8.71e-5)" "unprognostic (1.86e-1)" "unprognostic (1.36e-2)" "unprognostic (4.33e-2)" "unprognostic (1.14e-1)" "unprognostic (4.30e-2)" "unprognostic (3.04e-1)" "unprognostic (1.98e-2)" "unprognostic (1.30e-1)" "unprognostic (5.47e-4)" "unprognostic (1.99e-3)" "unprognostic (4.88e-2)" "unprognostic (7.16e-2)" "unprognostic (1.32e-2)" 6.0 0.5 1.5 0.6 2.4 0.1 9.7 0.8 2.0 7.6 3.9 1.1 7.5 1.1 6.6 7.0 10.8 5.3 3.2 1.1 2.0 1.5 1.6 0.4 35.3 0.9 2.2 3.4 2.2 1.0 1.0 0.6 20.6 2.9 2.3 1.6 0.3 3.3 7.2 0.8 3.0 1.9 3.9 0.7 2.0 1.5 1.0 0.1 0.1 9.6 2.7 1.1 1.6 3.8 0.0 1.0 5.5 0.5 0.0 0.0 0.3 0.0 4.6 0.2 0.0 8.6 2.1 0.0 3.0 4.6 0.7 0.1 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 4.3 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.5 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.3 1.5 2.4 0.8 2.0 2.0 1.5 2.2 3.4 2.9 0.1 TRPM1 "CSNB1C, LTRPC1, MLSN1" ENSG00000134160 "Transient receptor potential cation channel subfamily M member 1" Q7Z4N2 15 31001061-31161273 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 99.0" "Cell line enriched" "Detected in single" 122 "SK-MEL-30: 15.9" "Cancer enriched" "Detected in single" 179 "melanoma: 14.6" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014779, HPA071139" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Centriolar satellite" "Centriolar satellite" "Golgi apparatus, Plasma membrane" "HPA014779: , HPA071139: " "unprognostic (5.28e-2)" "unprognostic (1.35e-1)" "unprognostic (9.89e-2)" "unprognostic (3.07e-1)" "unprognostic (1.97e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-3)" "unprognostic (2.83e-1)" "unprognostic (2.89e-2)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" "unprognostic (2.58e-1)" "unprognostic (7.84e-2)" "unprognostic (6.20e-4)" "unprognostic (1.48e-1)" "unprognostic (2.63e-2)" 0.1 0.0 0.4 0.0 0.6 0.0 0.1 0.1 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.3 0.1 0.1 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 99.0 0.4 0.0 0.2 10.4 0.0 0.1 1.9 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.1 0.3 0.7 0.2 1.6 0.0 0.3 0.1 TRPM3 "GON-2, KIAA1616, LTRPC3" ENSG00000083067 "Transient receptor potential cation channel subfamily M member 3" Q9HCF6 9 70529063-71446904 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 36.6;kidney: 28.0;retina: 105.2" "Cell line enriched" "Detected in some" 4 "HAP1: 19.0" "Cancer enhanced" "Detected in single" "renal cancer: 0.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "NK-cell: 2.1" "Lineage enriched" "Detected in single" 16 "NK-cells: 2.1" "Low region specificity" "Detected in all" "HPA072650, HPA074393" Enhanced Approved Vesicles Vesicles "HPA072650: , HPA074393: " "unprognostic (3.74e-1)" "unprognostic (6.30e-2)" "unprognostic (4.79e-2)" "unprognostic (4.81e-2)" "unprognostic (1.38e-2)" "unprognostic (8.88e-2)" "unprognostic (1.49e-2)" "unprognostic (2.19e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-2)" "unprognostic (6.10e-2)" "unprognostic (1.15e-2)" "unprognostic (1.82e-7)" "unprognostic (3.51e-2)" "unprognostic (5.64e-2)" "unprognostic (1.74e-2)" "unprognostic (1.50e-2)" 0.9 1.7 6.0 0.7 4.5 1.1 0.8 36.6 5.1 0.8 0.7 9.6 2.1 1.8 2.4 3.0 0.7 1.3 1.3 1.4 9.4 6.0 28.0 0.9 0.8 0.7 8.3 3.5 5.3 1.5 0.7 6.8 0.8 34.8 1.4 0.7 105.2 0.8 5.0 1.1 0.8 0.7 1.0 8.1 1.1 1.6 5.3 5.9 0.0 2.1 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 1.0 0.1 1.2 2.9 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 19.0 0.0 0.1 0.0 0.1 0.1 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.1 4.4 0.0 0.0 0.0 1.3 0.1 0.0 0.2 0.0 0.9 0.0 1.3 0.0 0.2 0.0 0.3 0.0 0.0 3.5 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 6.0 4.5 36.6 3.8 9.4 6.0 8.3 3.5 34.8 5.9 UBIAD1 "SCCD, TERE1" ENSG00000120942 "UbiA prenyltransferase domain containing 1" Q9Y5Z9 1 11273206-11296049 "Disease related genes, Predicted membrane proteins" "Menaquinone biosynthesis, Ubiquinone biosynthesis" "Prenyltransferase, Transferase" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044862 Approved Vesicles Vesicles "HPA044862: " "unprognostic (1.79e-2)" "unprognostic (2.26e-1)" "unprognostic (5.06e-2)" "unprognostic (1.74e-1)" "unprognostic (7.95e-3)" "unprognostic (7.55e-2)" "unprognostic (1.16e-2)" "unprognostic (2.01e-1)" "unprognostic (1.61e-1)" "unprognostic (2.55e-1)" "unprognostic (1.20e-1)" "unprognostic (1.63e-1)" "prognostic favourable (6.80e-5)" "unprognostic (3.00e-1)" "unprognostic (3.89e-1)" "unprognostic (2.03e-2)" "unprognostic (1.25e-1)" 12.1 11.8 9.2 10.2 11.8 9.2 12.0 10.2 13.1 9.6 9.8 17.6 5.0 7.8 13.0 9.7 8.8 14.4 11.9 11.6 9.0 8.3 9.9 38.1 8.7 18.6 14.1 6.1 17.5 23.4 14.6 10.0 9.1 11.0 10.6 10.0 11.9 11.2 10.2 24.8 11.3 9.5 11.5 15.5 12.9 10.7 17.7 13.6 17.9 12.2 9.6 17.5 11.7 8.7 22.0 10.7 9.5 8.7 9.6 27.0 11.4 8.5 8.5 6.8 13.1 5.1 4.7 9.2 9.5 7.7 10.2 9.4 9.8 8.0 17.0 9.7 6.7 11.8 17.2 11.3 12.5 11.8 14.7 11.4 9.1 13.0 9.2 17.3 9.9 7.1 15.4 13.7 16.4 7.4 13.5 14.1 6.8 8.7 11.1 8.7 8.2 12.7 10.6 15.2 20.5 7.8 5.7 8.4 9.0 10.1 10.0 12.8 7.4 9.1 6.2 9.0 9.7 9.3 12.3 11.5 15.9 31.6 5.7 22.9 11.1 4.8 6.5 9.5 13.1 8.7 14.6 22.0 17.8 13.3 8.6 20.7 27.0 18.3 2.0 9.6 7.3 10.7 16.6 11.4 9.2 11.8 10.2 13.1 9.0 8.3 14.1 6.1 11.0 13.6 VN1R2 V1RL2 ENSG00000196131 "Vomeronasal 1 receptor 2" Q8NFZ6 19 53258292-53261837 "G-protein coupled receptors, Predicted membrane proteins" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 5.0;testis: 3.2" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA044551 Uncertain "HPA044551: " "unprognostic (9.54e-2)" "unprognostic (3.17e-1)" "unprognostic (1.06e-1)" 0.2 0.2 0.4 0.8 0.4 0.5 0.3 0.6 0.8 0.2 0.3 0.2 0.5 1.6 0.3 0.2 0.0 5.0 0.4 0.4 0.3 0.3 0.2 1.7 0.3 0.6 0.2 0.3 0.2 0.0 0.3 0.0 0.4 0.0 0.4 0.9 0.6 0.0 0.3 0.3 0.2 3.2 0.5 0.0 0.3 0.3 0.8 0.5 1.3 0.5 0.6 1.1 0.2 0.8 0.8 0.8 1.3 0.0 0.0 0.3 1.0 0.0 0.0 0.3 0.0 2.2 1.9 0.5 0.5 0.6 0.0 0.0 0.0 0.8 0.7 1.2 2.6 1.5 0.0 0.2 1.7 0.6 0.4 0.1 0.0 0.0 0.8 0.6 0.4 0.9 0.4 1.1 0.5 0.7 1.1 2.1 0.0 0.5 2.2 1.3 1.2 0.2 0.8 0.3 1.3 0.1 1.6 1.0 0.8 1.3 0.4 1.7 0.6 0.8 1.2 0.5 0.8 0.4 0.5 0.5 1.1 0.3 0.4 0.2 0.4 0.2 0.2 0.8 0.3 1.0 1.3 0.6 0.4 0.5 0.1 0.2 VN1R4 V1RL4 ENSG00000228567 "Vomeronasal 1 receptor 4" Q7Z5H5 19 53266676-53267723 "G-protein coupled receptors, Predicted membrane proteins" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 2.5" "Cell line enhanced" "Detected in single" "U-2 OS: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA027018 Uncertain "HPA027018: AB_10603142" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WFS1 "DFNA14, DFNA38, DFNA6, DIDMOAD, WFS" ENSG00000109501 "Wolframin ER transmembrane glycoprotein" O76024 4 6269849-6303265 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cataract, Deafness, Diabetes insipidus, Diabetes mellitus, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029128 Approved "HPA029128: AB_10603460" "unprognostic (4.27e-2)" "unprognostic (5.05e-2)" "unprognostic (1.58e-1)" "prognostic favourable (1.13e-6)" "unprognostic (7.35e-2)" "unprognostic (1.29e-2)" "unprognostic (2.73e-2)" "unprognostic (6.97e-3)" "unprognostic (2.37e-1)" "unprognostic (1.78e-1)" "unprognostic (8.36e-3)" "unprognostic (5.33e-3)" "unprognostic (6.20e-2)" "unprognostic (5.02e-2)" "unprognostic (9.10e-2)" "prognostic unfavourable (3.13e-4)" "unprognostic (3.64e-2)" 28.5 13.3 17.9 7.0 52.5 1.5 16.5 9.4 24.2 22.3 15.5 13.2 21.9 12.0 31.2 15.1 12.1 28.9 24.0 27.8 19.4 12.2 7.1 7.6 30.2 7.4 13.5 16.5 51.0 12.4 8.8 20.7 25.4 13.6 22.6 4.5 16.6 12.1 39.0 10.3 10.0 11.1 28.1 14.2 16.9 12.5 18.3 14.9 1.3 23.4 4.4 3.2 24.2 12.2 4.4 0.6 0.0 1.6 2.5 6.9 2.4 5.3 10.9 3.7 13.3 15.2 4.0 40.1 9.5 12.5 6.5 5.7 9.4 14.6 2.4 14.0 10.2 2.4 2.7 5.3 2.7 2.1 5.5 0.0 4.8 29.0 13.6 0.0 0.4 13.5 7.5 5.6 5.3 10.0 0.1 9.8 3.8 9.9 0.4 0.1 5.2 15.5 1.2 3.7 2.7 2.6 23.2 2.3 6.2 5.5 6.8 5.1 11.9 0.1 8.2 7.5 9.7 7.3 5.7 10.8 3.5 0.0 9.5 0.0 7.5 0.0 1.0 0.0 4.9 1.6 6.9 4.4 2.6 3.5 0.3 2.3 2.3 2.8 0.0 2.5 1.6 0.6 1.3 2.4 17.9 52.5 9.4 24.2 19.4 12.2 13.5 16.5 13.6 14.9 XK "Kx, NA, NAC, X1k, XKR1" ENSG00000047597 "X-linked Kx blood group" P51811 X 37685756-37732130 "Blood group antigen proteins, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Blood group antigen" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.6" "Cell line enhanced" "Detected in many" "HEL: 24.7;HL-60: 12.7;K-562: 15.9;NB-4: 11.7;RPMI-8226: 11.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 40 "basophil: 9.4;eosinophil: 6.8" "Lineage enriched" "Detected in single" 94 "granulocytes: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019036 Approved Approved Nucleoplasm,Vesicles,Mitochondria Mitochondria "Nucleoplasm, Vesicles" "HPA019036: AB_1846286" "unprognostic (2.37e-2)" "unprognostic (7.13e-3)" "unprognostic (5.03e-2)" "unprognostic (1.00e-2)" "unprognostic (7.97e-2)" "unprognostic (4.56e-1)" "unprognostic (3.59e-2)" "unprognostic (4.00e-2)" "unprognostic (4.77e-3)" "unprognostic (5.07e-2)" "unprognostic (6.63e-2)" "unprognostic (5.90e-2)" "unprognostic (4.44e-8)" "unprognostic (1.74e-1)" "unprognostic (4.75e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" 0.6 2.9 4.9 3.0 5.1 14.0 1.1 10.2 8.3 1.8 16.5 1.2 0.0 12.9 1.2 0.8 2.7 4.8 2.0 8.1 4.7 6.6 1.4 2.1 1.5 0.7 3.0 5.9 1.2 7.9 2.2 3.8 1.4 4.4 2.1 13.8 1.0 8.6 1.5 5.9 1.2 23.6 3.2 1.6 1.2 13.3 3.5 0.2 0.1 1.4 5.9 0.8 2.9 2.5 0.0 0.0 9.4 0.0 0.0 0.0 0.7 9.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 8.2 0.1 0.0 1.5 8.8 0.0 0.0 0.0 2.4 24.7 1.4 0.0 0.0 12.7 2.0 0.0 0.4 0.0 0.0 0.0 15.9 6.3 0.0 0.9 0.1 11.7 3.1 3.2 0.0 0.0 11.2 0.0 0.6 2.3 0.0 0.4 0.8 0.0 1.2 3.1 0.0 0.0 0.4 0.0 1.3 5.4 8.9 0.0 0.1 6.8 0.0 9.4 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 4.9 5.1 10.2 8.3 4.7 6.6 3.0 5.9 4.4 0.2 XKR3 "MGC57211, XTES" ENSG00000172967 "XK related 3" Q5GH77 22 16783412-16821699 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 44 "blood: 4.7;testis: 13.5" "Cell line enriched" "Detected in some" 16 "Karpas-707: 71.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "basophil: 1.5;neutrophil: 4.7" "Lineage enriched" "Detected in single" 13 "granulocytes: 4.7" "HPA003379, HPA035081" Uncertain "HPA003379: AB_10602682, HPA035081: " "unprognostic (4.57e-1)" "unprognostic (3.37e-1)" "unprognostic (3.11e-2)" "unprognostic (3.13e-2)" "unprognostic (5.77e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.2 4.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.4 71.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 1.5 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.1 XKR6 "C8orf21, C8orf5, C8orf7" ENSG00000171044 "XK related 6" Q5GH73 8 10896045-11201366 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.4" "Cell line enhanced" "Detected in many" "Karpas-707: 6.2;U-266/84: 10.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA024828, HPA064769" Uncertain Approved "Actin filaments" "Actin filaments" "HPA024828: AB_2215165, HPA064769: " "unprognostic (8.63e-3)" "unprognostic (8.45e-2)" "unprognostic (1.50e-1)" "unprognostic (9.92e-6)" "unprognostic (2.09e-1)" "unprognostic (2.51e-2)" "unprognostic (1.18e-1)" "unprognostic (8.75e-3)" "unprognostic (8.65e-2)" "unprognostic (7.09e-2)" "unprognostic (2.87e-1)" "unprognostic (1.31e-1)" "unprognostic (3.78e-2)" "unprognostic (3.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.58e-1)" "unprognostic (3.29e-3)" 2.0 2.9 3.0 4.8 13.1 4.1 2.5 21.4 6.3 1.9 2.7 1.4 1.9 1.7 2.4 1.3 3.8 2.2 2.0 1.5 3.4 1.6 2.3 1.0 2.7 3.9 1.3 4.4 0.9 5.1 3.3 8.8 1.2 5.3 3.2 2.1 1.1 5.2 5.0 0.8 3.9 3.3 1.6 1.4 3.8 3.3 7.5 2.4 0.1 3.0 0.2 3.6 3.0 2.3 1.3 0.6 0.0 0.0 1.2 0.3 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.0 2.0 0.6 0.6 1.7 0.0 0.5 4.9 0.0 1.0 0.2 2.2 2.7 0.9 0.1 0.6 1.6 0.2 0.0 0.9 0.0 4.2 0.5 1.8 0.0 2.1 1.1 0.1 6.2 0.8 0.5 0.0 0.0 3.2 1.2 0.0 0.0 1.2 2.3 1.8 3.2 1.8 1.0 0.1 0.0 0.0 0.8 0.0 2.6 1.2 0.0 0.9 1.7 10.0 4.6 1.0 0.0 2.1 0.0 0.0 0.0 0.3 0.0 0.2 1.0 0.0 0.1 0.0 1.3 0.2 0.0 0.0 1.2 0.0 0.6 0.2 0.1 3.0 13.1 21.4 6.3 3.4 1.6 1.3 4.4 5.3 2.4 XKR7 "C20orf159, dJ310O13.4" ENSG00000260903 "XK related 7" Q5GH72 20 31968002-32003387 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 28.0;pituitary gland: 12.3" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 21.2" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 25.6" HPA040854 Uncertain "HPA040854: AB_10795481" "unprognostic (2.74e-2)" "unprognostic (5.60e-3)" "unprognostic (8.03e-2)" "unprognostic (3.74e-7)" "unprognostic (4.29e-2)" "unprognostic (9.34e-2)" "unprognostic (1.45e-1)" "unprognostic (2.69e-2)" "unprognostic (4.47e-2)" "unprognostic (2.68e-3)" "unprognostic (2.12e-1)" "unprognostic (1.26e-3)" "unprognostic (3.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.82e-5)" "unprognostic (1.99e-1)" 0.5 1.5 2.9 0.6 4.4 0.5 0.4 28.0 10.0 0.4 0.5 0.0 0.0 0.6 0.4 0.5 0.4 0.5 0.5 0.4 1.2 1.5 0.5 0.4 0.5 0.4 0.8 4.6 0.4 1.8 0.4 12.3 0.4 3.5 0.4 0.6 2.0 0.4 0.5 0.4 0.5 0.5 0.4 0.6 0.5 1.7 1.2 0.0 0.0 0.4 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 21.2 4.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.9 4.4 28.0 8.7 1.2 1.5 0.8 4.6 3.5 0.0 XKR8 FLJ10307 ENSG00000158156 "XK related 8" Q9H6D3 1 27959462-27968096 "Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "blood: 47.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 10 "eosinophil: 47.1;neutrophil: 24.3" "Lineage enriched" "Detected in all" 15 "granulocytes: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049984, HPA053529" Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA049984: , HPA053529: " "prognostic favourable (8.63e-4)" "unprognostic (2.15e-1)" "unprognostic (2.40e-1)" "unprognostic (1.10e-3)" "unprognostic (1.97e-2)" "unprognostic (1.38e-2)" "unprognostic (6.25e-3)" "unprognostic (1.64e-1)" "unprognostic (7.87e-2)" "unprognostic (8.41e-2)" "unprognostic (1.83e-3)" "unprognostic (6.29e-2)" "unprognostic (8.55e-2)" "unprognostic (2.93e-2)" "unprognostic (1.02e-1)" "unprognostic (3.33e-1)" "unprognostic (4.20e-2)" 2.6 2.3 2.8 4.2 3.8 10.3 1.8 8.3 1.8 2.3 2.5 4.1 3.3 2.9 2.4 3.2 2.9 3.2 2.8 1.9 3.3 8.6 3.1 3.0 3.0 3.6 8.7 3.5 2.4 7.8 3.5 2.4 5.6 3.7 2.9 2.0 3.1 3.5 4.9 5.6 4.7 1.6 3.5 2.4 2.8 2.4 1.3 2.6 47.1 2.5 2.8 3.0 1.9 4.5 2.4 2.9 2.9 3.3 6.1 7.5 6.8 7.4 8.6 8.9 6.5 3.6 0.0 5.6 7.5 2.5 5.5 3.2 3.1 7.4 9.8 6.0 2.0 4.4 5.3 0.0 0.0 6.5 5.4 9.4 2.6 8.5 0.0 1.8 4.9 2.2 3.3 2.2 13.7 5.6 5.3 0.0 3.2 5.6 2.4 2.1 0.0 2.0 2.7 0.1 2.0 4.6 3.6 6.9 0.2 12.9 2.2 7.2 6.9 0.7 17.1 0.0 0.3 3.5 2.5 47.1 3.0 2.4 2.9 1.3 3.0 2.6 2.6 1.3 2.6 2.6 24.3 2.8 1.7 1.2 2.9 1.9 XKR9 ENSG00000221947 "XK related 9" Q5GH70 8 70669365-70790371 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 17.1" "Cell line enhanced" "Detected in some" "CACO-2: 5.3;hTCEpi: 10.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA044430 Enhanced Approved Mitochondria Mitochondria "HPA044430: AB_10961283" "unprognostic (1.79e-2)" "unprognostic (7.31e-2)" "unprognostic (1.42e-1)" "unprognostic (1.40e-3)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-2)" "unprognostic (9.33e-2)" "unprognostic (1.63e-1)" "unprognostic (2.63e-2)" "prognostic unfavourable (7.20e-4)" "unprognostic (2.29e-1)" "unprognostic (6.96e-6)" "unprognostic (3.65e-1)" "unprognostic (3.26e-1)" "unprognostic (4.04e-3)" "unprognostic (3.71e-2)" 0.9 3.4 1.9 0.8 4.3 0.9 1.1 0.6 6.4 0.9 1.7 1.9 0.0 4.9 0.7 2.5 1.1 0.7 4.1 1.0 2.3 1.5 1.0 7.5 2.1 1.0 1.3 7.3 1.0 1.3 0.3 2.1 0.8 7.4 1.4 1.0 2.6 2.0 0.2 0.9 1.7 9.6 3.5 1.7 1.0 3.6 17.1 0.7 0.0 1.0 0.0 1.0 2.5 1.2 1.2 0.3 0.9 0.2 0.6 3.1 0.2 3.8 0.3 0.8 0.4 0.0 1.0 0.6 1.6 0.8 0.5 1.6 5.3 0.4 0.5 2.7 0.1 0.1 0.1 0.9 2.0 0.7 0.5 0.4 0.3 0.6 0.1 1.2 2.2 1.1 10.9 0.3 0.0 0.0 0.2 3.9 0.3 0.5 0.7 0.6 2.1 0.5 0.5 1.1 0.2 0.3 2.9 2.3 0.4 0.9 1.6 0.5 0.5 0.1 0.4 0.5 1.1 0.8 0.6 3.4 0.9 2.5 0.2 0.4 0.3 0.9 0.1 0.3 0.9 0.1 1.7 0.9 1.7 0.8 0.1 1.2 2.6 1.7 0.6 0.6 0.2 0.3 3.1 0.2 1.9 4.3 0.6 6.4 2.3 1.5 1.3 7.3 7.4 0.7 XPR1 "SLC53A1, SYG1, X3" ENSG00000143324 "Xenotropic and polytropic retrovirus receptor 1" Q9UBH6 1 180632004-180890251 "Disease related genes, Predicted membrane proteins" "Host cell receptor for virus entry, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 56.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016557 Supported "HPA016557: " "unprognostic (2.65e-1)" "unprognostic (2.68e-2)" "unprognostic (1.92e-2)" "unprognostic (1.42e-2)" "unprognostic (2.86e-1)" "unprognostic (1.30e-3)" "prognostic unfavourable (3.04e-4)" "unprognostic (2.76e-1)" "unprognostic (2.59e-1)" "unprognostic (3.78e-2)" "unprognostic (4.72e-2)" "unprognostic (6.44e-2)" "unprognostic (8.82e-2)" "unprognostic (7.04e-2)" "unprognostic (1.38e-1)" "unprognostic (2.59e-1)" "unprognostic (8.44e-2)" 10.1 13.6 10.6 7.4 13.1 5.7 9.5 13.5 14.7 21.7 16.0 8.4 14.3 11.3 11.9 8.2 9.8 16.3 9.0 30.3 9.2 15.7 21.4 6.7 12.1 5.8 11.0 9.1 9.9 13.6 20.3 27.3 14.5 11.4 8.3 10.7 10.2 10.7 11.5 8.8 6.4 20.3 10.3 8.1 7.8 5.3 16.7 9.5 9.6 14.4 5.3 8.7 12.0 7.3 2.4 4.3 4.9 13.5 3.0 3.8 3.5 5.9 8.5 20.9 7.3 7.0 9.6 19.9 6.8 9.1 4.6 5.0 12.1 8.8 5.6 16.4 7.9 16.1 8.3 12.1 6.9 7.8 5.3 7.3 6.0 8.6 8.2 6.0 8.0 7.9 12.0 6.6 13.8 10.1 22.2 9.4 10.9 5.4 5.7 2.8 19.7 1.8 6.1 7.5 7.4 11.9 12.3 13.3 56.4 9.4 8.4 5.9 7.4 7.0 8.4 6.1 6.0 8.8 8.5 10.5 9.9 11.3 4.5 6.1 10.0 0.9 5.2 2.3 3.8 9.4 3.2 2.0 3.5 3.4 4.3 2.4 3.3 3.3 4.9 3.0 13.5 1.2 3.5 3.5 10.6 13.1 13.5 14.7 9.2 15.7 11.0 9.1 11.4 9.5